P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
7.393e-11 | -23.33 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 43 | 16828 | 49 |
SLC1A3,TNS3,SLC1A2,NHSL1,FARP1,CTNND2,SNTB1,EGF,GRK5,COL11A1,ITPK1,SORCS2,USP6NL,ITPR2,GPC5,NFIA,GPM6B,PRDM16,GRIP1,RORA,ELOVL2,LRIG1,SLC6A11,ADAM12,PREX1,FHOD3,PTN,DGKB,NCKAP5,QKI,PREX2,SLC4A4,NTRK2,ZBTB20,SOX5,TRPS1,RFX4,SLC13A5,FKBP5,NPAS3,LPIN2,PTPRZ1,SLC39A12 |
2.612e-09 | -19.76 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 20 | 16828 | 49 |
NTRK2,ITPR2,GPC5,GRK5,PREX2,ITPK1,SORCS2,NCKAP5,DGKB,QKI,TNS3,SLC1A3,CTNND2,FARP1,PREX1,FHOD3,SLC6A11,PRDM16,RORA,SOX5 |
2.612e-09 | -19.76 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 20 | 16828 | 49 |
SOX5,PRDM16,RORA,SLC6A11,PREX1,FHOD3,TNS3,SLC1A3,CTNND2,FARP1,NCKAP5,DGKB,QKI,PREX2,GRK5,SORCS2,ITPK1,NTRK2,ITPR2,GPC5 |
3.883e-09 | -19.37 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 23 | 16828 | 49 |
PREX2,NTRK2,DGKB,NCKAP5,RFX4,SOX5,NPAS3,SORCS2,ITPK1,COL11A1,GRK5,GPC5,ITPR2,CTNND2,SLC1A2,NHSL1,SLC1A3,EGF,SNTB1,LRIG1,FHOD3,GRIP1,PRDM16 |
3.883e-09 | -19.37 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 23 | 16828 | 49 |
PREX2,NTRK2,DGKB,NCKAP5,SOX5,RFX4,NPAS3,GRK5,ITPK1,SORCS2,COL11A1,ITPR2,GPC5,SLC1A3,CTNND2,SLC1A2,NHSL1,SNTB1,EGF,LRIG1,FHOD3,PRDM16,GRIP1 |
4.955e-09 | -19.12 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 41 | 16828 | 49 |
NPAS3,RFX4,SOX5,TRPS1,SLC39A12,PTPRZ1,QKI,DGKB,NCKAP5,NRCAM,PTN,ZBTB20,NTRK2,SLC4A4,PREX2,RORA,GRIP1,PRDM16,NFIA,AQP4,CTBP1,FHOD3,FGFRL1,PREX1,ADAM12,SLC6A11,LRIG1,APOA1,EGF,SNTB1,CTNND2,SLC1A2,NHSL1,FARP1,TNS3,ITPR2,SORCS2,USP6NL,ITPK1,COL11A1,GRK5 |
4.955e-09 | -19.12 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 41 | 16828 | 49 |
ITPK1,USP6NL,SORCS2,COL11A1,GRK5,ITPR2,CTNND2,FARP1,SLC1A2,NHSL1,TNS3,APOA1,EGF,SNTB1,ADAM12,SLC6A11,LRIG1,CTBP1,FGFRL1,FHOD3,PREX1,AQP4,NFIA,RORA,PRDM16,GRIP1,SLC4A4,PREX2,ZBTB20,NTRK2,PTN,NRCAM,QKI,DGKB,NCKAP5,SLC39A12,PTPRZ1,RFX4,SOX5,TRPS1,NPAS3 |
9.497e-09 | -18.47 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 27 | 16828 | 49 |
ELOVL2,FHOD3,PREX1,RORA,GRIP1,PRDM16,COL11A1,ITPK1,USP6NL,GRK5,GPC5,ITPR2,SLC1A2,CTNND2,SLC1A3,TNS3,EGF,SNTB1,PTPRZ1,SLC39A12,SOX5,NPAS3,PREX2,ZBTB20,PTN,QKI,NCKAP5 |
2.195e-08 | -17.63 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 24 | 16828 | 49 |
SOX5,PTPRZ1,SLC39A12,PTN,NCKAP5,QKI,PREX2,ZBTB20,PRDM16,GRIP1,RORA,ELOVL2,PREX1,FHOD3,SLC1A3,TNS3,CTNND2,SNTB1,GRK5,COL11A1,USP6NL,ITPK1,ITPR2,GPC5 |
8.769e-08 | -16.25 | nervous system development | biological process | GO:0007399 | 2185 | 21 | 18204 | 50 |
RFX4,ITPK1,GPM6B,PTN,NFIA,MSI2,SLC39A12,SLC1A3,NTRK2,NRCAM,QKI,RORA,PTPRZ1,SOX5,PREX2,CTNND2,SLC1A2,ADGRB3,LRIG1,FARP1,EGF |
2.059e-07 | -15.40 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 28 | 16828 | 49 |
NFIA,RORA,GRIP1,PRDM16,SLC6A11,FHOD3,CTNND2,SLC1A2,TNS3,SLC1A3,EGF,SNTB1,USP6NL,ITPK1,SORCS2,COL11A1,GRK5,GPC5,ITPR2,SOX5,LPIN2,PTPRZ1,NRCAM,NCKAP5,SLC4A4,PREX2,ZBTB20,NTRK2 |
2.059e-07 | -15.40 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 28 | 16828 | 49 |
COL11A1,SORCS2,USP6NL,ITPK1,GRK5,GPC5,ITPR2,SLC1A2,CTNND2,SLC1A3,TNS3,EGF,SNTB1,SLC6A11,FHOD3,NFIA,RORA,GRIP1,PRDM16,SLC4A4,PREX2,NTRK2,ZBTB20,NRCAM,NCKAP5,LPIN2,PTPRZ1,SOX5 |
2.356e-07 | -15.26 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 21 | 16828 | 49 |
TNS3,PTN,SLC1A3,CTNND2,SLC1A2,FARP1,DGKB,NCKAP5,SNTB1,PREX2,SORCS2,COL11A1,NTRK2,ITPR2,GPC5,SOX5,PRDM16,GRIP1,SLC39A12,PTPRZ1,FHOD3 |
2.356e-07 | -15.26 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 21 | 16828 | 49 |
SNTB1,NCKAP5,DGKB,CTNND2,SLC1A2,FARP1,TNS3,PTN,SLC1A3,GPC5,ITPR2,NTRK2,SORCS2,COL11A1,PREX2,GRIP1,PRDM16,SOX5,FHOD3,SLC39A12,PTPRZ1 |
2.546e-07 | -15.18 | system development | biological process | GO:0048731 | 3533 | 26 | 18204 | 50 |
APOA1,EGF,FARP1,LRIG1,FGFRL1,SOX5,PTPRZ1,RORA,NTRK2,NRCAM,COL11A1,NFIA,ITPK1,FHOD3,ADGRB3,SLC1A2,CTNND2,PREX2,QKI,SLC39A12,SLC1A3,MSI2,PTN,GPM6B,TRPS1,RFX4 |
2.687e-07 | -15.13 | cell periphery | cellular component | GO:0071944 | 6020 | 33 | 19108 | 49 |
GRIP1,ADAM12,EGF,PREX2,NRCAM,ADGRB3,GPC5,FARP1,SLC1A2,SLC1A3,ITPR2,SLC39A12,PTPRZ1,DGKB,CTBP1,PTN,SLC13A5,SNTB1,SORCS2,NTRK2,CTNND2,SLC6A11,USP6NL,GPM6B,ITPK1,SLC4A4,AQP4,LRIG1,APOA1,COL11A1,PREX1,FGFRL1,GRK5 |
2.732e-07 | -15.11 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 21 | 16828 | 49 |
GPC5,ITPR2,NTRK2,SORCS2,COL11A1,PREX2,SNTB1,DGKB,NCKAP5,CTNND2,FARP1,SLC1A2,TNS3,PTN,SLC1A3,FHOD3,SLC39A12,PTPRZ1,PRDM16,GRIP1,SOX5 |
4.168e-07 | -14.69 | synapse | cellular component | GO:0045202 | 1473 | 16 | 19108 | 49 |
FARP1,SLC1A2,SLC1A3,DGKB,PTPRZ1,PTN,QKI,CTBP1,SORCS2,SNTB1,NTRK2,GRIP1,CTNND2,NRCAM,SLC6A11,ADGRB3 |
6.193e-07 | -14.29 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 20 | 18204 | 50 |
SLC39A12,SLC1A3,NTRK2,NRCAM,COL11A1,ADAM12,NFIA,PTN,EGF,FHOD3,FARP1,CTNND2,LRIG1,ADGRB3,PTPRZ1,QKI,RORA,PREX2,SOX5,FGFRL1 |
6.317e-07 | -14.27 | solute:monoatomic cation symporter activity | molecular function | GO:0015294 | 117 | 6 | 18094 | 48 |
SLC1A3,SLC39A12,SLC4A4,SLC13A5,SLC6A11,SLC1A2 |
6.436e-07 | -14.26 | plasma membrane | cellular component | GO:0005886 | 5538 | 31 | 19108 | 49 |
SORCS2,SLC13A5,SNTB1,NTRK2,CTNND2,USP6NL,SLC6A11,SLC4A4,ITPK1,GPM6B,AQP4,LRIG1,APOA1,FGFRL1,PREX1,GRK5,GRIP1,ADAM12,PREX2,EGF,ADGRB3,NRCAM,GPC5,SLC1A2,FARP1,ITPR2,SLC1A3,SLC39A12,PTPRZ1,DGKB,PTN |
9.787e-07 | -13.84 | cell junction | cellular component | GO:0030054 | 2224 | 19 | 19108 | 49 |
GRIP1,NTRK2,SORCS2,SNTB1,NFIA,SLC6A11,ADGRB3,NRCAM,CTNND2,SLC1A3,TNS3,SLC1A2,FARP1,CTBP1,QKI,PTN,FGFRL1,PTPRZ1,DGKB |
1.475e-06 | -13.43 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 12 | 16828 | 49 |
GRIP1,PRDM16,NPAS3,PTPRZ1,FHOD3,QKI,NRCAM,CTNND2,ITPR2,NTRK2,GPC5,SORCS2 |
1.699e-06 | -13.29 | neurogenesis | biological process | GO:0022008 | 1334 | 15 | 18204 | 50 |
NRCAM,NTRK2,SLC39A12,SLC1A3,NFIA,PTN,GPM6B,FARP1,SOX5,PREX2,RORA,QKI,PTPRZ1,ADGRB3,CTNND2 |
1.771e-06 | -13.24 | generation of neurons | biological process | GO:0048699 | 1158 | 14 | 18204 | 50 |
PTN,NFIA,GPM6B,NRCAM,NTRK2,SLC1A3,SLC39A12,SOX5,PREX2,RORA,PTPRZ1,ADGRB3,CTNND2,FARP1 |
1.845e-06 | -13.20 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 42 | 16828 | 49 |
ADAM12,LRIG1,ELOVL2,FHOD3,FGFRL1,PREX1,NFIA,RORA,PRDM16,GRIP1,COL11A1,SORCS2,ITPK1,GRK5,GPC5,ITPR2,SLC1A2,FARP1,NHSL1,CTNND2,SLC1A3,TNS3,EGF,APOA1,SNTB1,LPIN2,PTPRZ1,SLC39A12,RFX4,TRPS1,SOX5,SLC13A5,NPAS3,SLC4A4,PREX2,MSI2,NTRK2,ZBTB20,NRCAM,QKI,NCKAP5,DGKB |
2.083e-06 | -13.08 | developmental process | biological process | GO:0032502 | 5716 | 32 | 18204 | 50 |
MSI2,GPM6B,PTN,RFX4,TRPS1,SLC1A3,SLC39A12,PRDM16,NHSL1,CTBP1,ADGRB3,CTNND2,SLC1A2,PREX2,QKI,FHOD3,PREX1,ADAM12,GRK5,ITPK1,NFIA,NRCAM,NTRK2,COL11A1,LRIG1,SOX5,FGFRL1,RORA,PTPRZ1,EGF,APOA1,FARP1 |
2.148e-06 | -13.05 | organic acid:sodium symporter activity | molecular function | GO:0005343 | 35 | 4 | 18094 | 48 |
SLC13A5,SLC1A2,SLC6A11,SLC1A3 |
2.196e-06 | -13.03 | solute:sodium symporter activity | molecular function | GO:0015370 | 80 | 5 | 18094 | 48 |
SLC6A11,SLC1A3,SLC4A4,SLC1A2,SLC13A5 |
2.259e-06 | -13.00 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 22 | 16828 | 49 |
DGKB,NCKAP5,NTRK2,PREX2,SLC13A5,SOX5,TRPS1,RFX4,SLC1A3,FARP1,SLC1A2,CTNND2,ITPR2,GPC5,COL11A1,SORCS2,ITPK1,GRIP1,PRDM16,PREX1,ELOVL2,LRIG1 |
2.501e-06 | -12.90 | symporter activity | molecular function | GO:0015293 | 148 | 6 | 18094 | 48 |
SLC1A3,SLC39A12,SLC4A4,SLC13A5,SLC6A11,SLC1A2 |
2.521e-06 | -12.89 | multicellular organism development | biological process | GO:0007275 | 3957 | 26 | 18204 | 50 |
QKI,PREX2,CTNND2,SLC1A2,ADGRB3,FHOD3,RFX4,TRPS1,GPM6B,PTN,MSI2,SLC39A12,SLC1A3,RORA,PTPRZ1,SOX5,FGFRL1,LRIG1,FARP1,EGF,APOA1,ITPK1,NFIA,COL11A1,NRCAM,NTRK2 |
3.019e-06 | -12.71 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 33 | 16828 | 49 |
SOX5,TRPS1,NPAS3,SLC39A12,PTPRZ1,PTN,DGKB,NCKAP5,PREX2,NTRK2,NFIA,AQP4,RORA,PRDM16,GRIP1,ELOVL2,CTBP1,FGFRL1,FHOD3,CTNND2,SLC1A2,NHSL1,FARP1,TNS3,SLC1A3,EGF,SNTB1,SORCS2,USP6NL,COL11A1,GRK5,GPC5,ITPR2 |
4.477e-06 | -12.32 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 22 | 16828 | 49 |
DGKB,NCKAP5,NTRK2,PREX2,SLC13A5,TRPS1,SOX5,RFX4,SLC1A3,SLC1A2,FARP1,CTNND2,ITPR2,GPC5,COL11A1,ITPK1,SORCS2,PRDM16,GRIP1,PREX1,LRIG1,ELOVL2 |
4.805e-06 | -12.25 | neuron differentiation | biological process | GO:0030182 | 1081 | 13 | 18204 | 50 |
ADGRB3,CTNND2,PREX2,PTPRZ1,RORA,FARP1,PTN,NFIA,GPM6B,NTRK2,NRCAM,SLC1A3,SLC39A12 |
4.959e-06 | -12.21 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 37 | 16828 | 49 |
NTRK2,PREX2,QKI,NCKAP5,DGKB,PTN,PTPRZ1,LPIN2,SLC13A5,FKBP5,RFX4,SOX5,GPC5,ITPR2,COL11A1,ITPK1,USP6NL,SORCS2,GRK5,EGF,SNTB1,FARP1,NHSL1,SLC1A2,CTNND2,SLC1A3,TNS3,FGFRL1,FHOD3,CTBP1,PREX1,LRIG1,ELOVL2,SLC6A11,RORA,PRDM16,GRIP1 |
6.705e-06 | -11.91 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 38 | 16828 | 49 |
CTNND2,SLC1A2,NHSL1,FARP1,TNS3,SLC1A3,EGF,SNTB1,USP6NL,ITPK1,COL11A1,GRK5,GPC5,ITPR2,RORA,PRDM16,GRIP1,SLC6A11,LRIG1,ELOVL2,CTBP1,FGFRL1,FHOD3,PREX1,NRCAM,PTN,QKI,NCKAP5,DGKB,SLC4A4,PREX2,NTRK2,RFX4,TRPS1,SOX5,SLC13A5,FKBP5,PTPRZ1 |
6.831e-06 | -11.89 | postsynaptic membrane | cellular component | GO:0045211 | 280 | 7 | 19108 | 49 |
ADGRB3,SLC6A11,NRCAM,DGKB,GRIP1,SORCS2,FARP1 |
7.318e-06 | -11.83 | synaptic membrane | cellular component | GO:0097060 | 400 | 8 | 19108 | 49 |
DGKB,NRCAM,SLC6A11,ADGRB3,FARP1,SLC1A2,SORCS2,GRIP1 |
7.407e-06 | -11.81 | bone | COSMIC cancer mutations | bone | 8157 | 39 | 16828 | 49 |
RORA,PRDM16,GRIP1,GPM6B,FGFRL1,FHOD3,PREX1,ADAM12,ELOVL2,LRIG1,SLC6A11,EGF,SNTB1,FARP1,CTNND2,SLC1A3,TNS3,GPC5,ITPR2,COL11A1,ITPK1,USP6NL,SORCS2,GRK5,SLC13A5,NPAS3,TRPS1,SOX5,PTPRZ1,SLC39A12,LPIN2,QKI,DGKB,NCKAP5,NRCAM,NTRK2,ZBTB20,SLC4A4,PREX2 |
8.071e-06 | -11.73 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 37 | 16828 | 49 |
PREX1,FGFRL1,FHOD3,LRIG1,ELOVL2,SLC6A11,ADAM12,GRIP1,PRDM16,RORA,GPM6B,ITPR2,GRK5,COL11A1,ITPK1,USP6NL,SORCS2,SNTB1,EGF,SLC1A3,TNS3,FARP1,CTNND2,PTPRZ1,SLC39A12,LPIN2,SLC13A5,NPAS3,TRPS1,SOX5,NTRK2,ZBTB20,PREX2,SLC4A4,NCKAP5,QKI,NRCAM |
8.161e-06 | -11.72 | cell differentiation | biological process | GO:0030154 | 3645 | 24 | 18204 | 50 |
QKI,PREX2,CTNND2,ADGRB3,FHOD3,GPM6B,PTN,MSI2,CTBP1,NHSL1,PRDM16,SLC39A12,SLC1A3,PTPRZ1,RORA,SOX5,FARP1,NFIA,GRK5,PREX1,ADAM12,COL11A1,NRCAM,NTRK2 |
8.282e-06 | -11.70 | cellular developmental process | biological process | GO:0048869 | 3648 | 24 | 18204 | 50 |
MSI2,GPM6B,PTN,SLC39A12,SLC1A3,CTBP1,NHSL1,PRDM16,CTNND2,ADGRB3,QKI,PREX2,FHOD3,GRK5,PREX1,ADAM12,NFIA,NTRK2,NRCAM,COL11A1,PTPRZ1,RORA,SOX5,FARP1 |
9.417e-06 | -11.57 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 11 | 16828 | 49 |
FHOD3,SLC6A11,SOX5,NTRK2,GPC5,PREX2,GRK5,SORCS2,NCKAP5,DGKB,SLC1A2 |
1.549e-05 | -11.08 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 36 | 16828 | 49 |
FGFRL1,FHOD3,CTBP1,PREX1,LRIG1,ELOVL2,SLC6A11,RORA,GRIP1,PRDM16,GPC5,ITPR2,COL11A1,USP6NL,ITPK1,GRK5,EGF,SNTB1,SLC1A2,NHSL1,FARP1,CTNND2,SLC1A3,TNS3,SLC13A5,FKBP5,RFX4,SOX5,NTRK2,SLC4A4,PREX2,QKI,DGKB,NCKAP5,PTN,NRCAM |
1.611e-05 | -11.04 | face | COSMIC cancer mutations | face | 2139 | 18 | 16828 | 49 |
PTPRZ1,FHOD3,SLC6A11,ADAM12,GRIP1,PRDM16,SLC13A5,RORA,TRPS1,AQP4,ITPR2,GPC5,GRK5,PREX2,MSI2,COL11A1,EGF,FARP1 |
1.668e-05 | -11.00 | neuron development | biological process | GO:0048666 | 859 | 11 | 18204 | 50 |
SLC1A3,SLC39A12,NTRK2,NRCAM,GPM6B,PTN,FARP1,CTNND2,ADGRB3,PTPRZ1,PREX2 |
1.804e-05 | -10.92 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 26 | 16828 | 49 |
QKI,NCKAP5,DGKB,PREX2,NTRK2,TRPS1,SOX5,FARP1,SLC1A2,CTNND2,SLC1A3,TNS3,EGF,SNTB1,COL11A1,SORCS2,USP6NL,GRK5,GPC5,ITPR2,AQP4,RORA,GRIP1,PRDM16,SLC6A11,FHOD3 |
2.020e-05 | -10.81 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 9 | 16828 | 49 |
PREX1,GPC5,FHOD3,SNTB1,NCKAP5,EGF,SOX5,CTNND2,FARP1 |
2.137e-05 | -10.75 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 13 | 16828 | 49 |
NTRK2,SORCS2,PREX2,GRK5,EGF,NCKAP5,DGKB,SLC1A2,FHOD3,SLC6A11,NPAS3,NFIA,SOX5 |
2.137e-05 | -10.75 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 13 | 16828 | 49 |
SLC1A2,NFIA,SOX5,EGF,NPAS3,NCKAP5,DGKB,SORCS2,GRK5,PREX2,SLC6A11,FHOD3,NTRK2 |
2.787e-05 | -10.49 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 44 | 16828 | 49 |
USP6NL,SORCS2,GPC5,NHSL1,FARP1,SLC1A2,CTNND2,SLC1A3,APOA1,ELOVL2,LRIG1,SLC6A11,FHOD3,CTBP1,AQP4,RORA,GRIP1,PREX2,ZBTB20,NRCAM,PTN,QKI,DGKB,NCKAP5,LPIN2,PTPRZ1,RFX4,TRPS1,FKBP5,COL11A1,ITPK1,GRK5,ITPR2,TNS3,EGF,SNTB1,FGFRL1,PREX1,PRDM16,NTRK2,SLC39A12,SOX5,SLC13A5,NPAS3 |
2.834e-05 | -10.47 | dendrite morphogenesis | biological process | GO:0048813 | 64 | 4 | 18204 | 50 |
CTNND2,PTN,FARP1,PREX2 |
2.893e-05 | -10.45 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 20 | 16828 | 49 |
QKI,EGF,NCKAP5,CTNND2,NHSL1,SLC1A2,NRCAM,GPC5,NTRK2,SORCS2,COL11A1,SLC4A4,PREX2,NPAS3,RFX4,NFIA,FGFRL1,SLC39A12,PTPRZ1,ADAM12 |
2.973e-05 | -10.42 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 47 | 16828 | 49 |
NTRK2,SLC4A4,SLC39A12,NPAS3,SLC13A5,SOX5,ITPR2,GRK5,ITPK1,COL11A1,SNTB1,EGF,TNS3,PREX1,FGFRL1,PRDM16,NFIA,ZBTB20,MSI2,PREX2,DGKB,NCKAP5,QKI,PTN,NRCAM,PTPRZ1,LPIN2,FKBP5,TRPS1,RFX4,GPC5,SORCS2,USP6NL,SLC1A3,CTNND2,FARP1,SLC1A2,NHSL1,CTBP1,FHOD3,SLC6A11,LRIG1,ELOVL2,ADAM12,GRIP1,RORA,AQP4 |
2.989e-05 | -10.42 | amino acid:sodium symporter activity | molecular function | GO:0005283 | 23 | 3 | 18094 | 48 |
SLC6A11,SLC1A3,SLC1A2 |
3.002e-05 | -10.41 | functioning | COSMIC cancer mutations | functioning | 1803 | 16 | 16828 | 49 |
TNS3,NRCAM,FARP1,SLC1A2,NHSL1,NCKAP5,GRK5,COL11A1,ZBTB20,NTRK2,SOX5,RFX4,GRIP1,SLC6A11,LPIN2,PTPRZ1 |
3.002e-05 | -10.41 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | 1803 | 16 | 16828 | 49 |
LPIN2,SLC6A11,PTPRZ1,RFX4,SOX5,GRIP1,COL11A1,GRK5,NTRK2,ZBTB20,FARP1,NHSL1,SLC1A2,NRCAM,TNS3,NCKAP5 |
3.062e-05 | -10.39 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 26 | 16828 | 49 |
ITPR2,COL11A1,SORCS2,USP6NL,NHSL1,CTNND2,PREX1,FHOD3,ELOVL2,LRIG1,ADAM12,PRDM16,NFIA,NTRK2,ZBTB20,PREX2,SLC4A4,NCKAP5,PTN,NRCAM,PTPRZ1,SLC39A12,SLC13A5,SOX5,TRPS1,RFX4 |
3.254e-05 | -10.33 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 25 | 16828 | 49 |
FHOD3,PREX1,NFIA,AQP4,GPM6B,PRDM16,COL11A1,USP6NL,SORCS2,SLC1A2,NHSL1,CTNND2,TNS3,EGF,SNTB1,LPIN2,PTPRZ1,RFX4,TRPS1,SLC13A5,NPAS3,SLC4A4,PREX2,NTRK2,NCKAP5 |
3.341e-05 | -10.31 | postsynapse | cellular component | GO:0098794 | 646 | 9 | 19108 | 49 |
NTRK2,GRIP1,SORCS2,FARP1,SLC6A11,ADGRB3,NRCAM,DGKB,CTNND2 |
3.352e-05 | -10.30 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 18 | 16828 | 49 |
LRIG1,LPIN2,SLC6A11,PTPRZ1,SOX5,RFX4,GRIP1,GRK5,COL11A1,NTRK2,ZBTB20,NRCAM,TNS3,NHSL1,FARP1,SLC1A2,CTNND2,NCKAP5 |
3.717e-05 | -10.20 | GOT1L1 (glutamic-oxaloacetic transaminase 1 like 1) | protein interactions | 137362 | 4 | 2 | 19454 | 49 |
GRK5,APOA1 |
3.717e-05 | -10.20 | Ctbp2 (C-terminal binding protein 2) | protein interactions | 13017 | 4 | 2 | 19454 | 49 |
PRDM16,TRPS1 |
4.065e-05 | -10.11 | SOX6 (SRY-box transcription factor 6) | protein interactions | 55553 | 153 | 5 | 19454 | 49 |
NFIA,CTBP1,PRDM16,TRPS1,SOX5 |
4.464e-05 | -10.02 | anatomical structure development | biological process | GO:0048856 | 5207 | 28 | 18204 | 50 |
NTRK2,NRCAM,COL11A1,ADAM12,PREX1,NFIA,ITPK1,APOA1,EGF,FARP1,LRIG1,RORA,PTPRZ1,FGFRL1,SOX5,SLC39A12,SLC1A3,MSI2,TRPS1,RFX4,PTN,GPM6B,FHOD3,SLC1A2,CTNND2,ADGRB3,QKI,PREX2 |
4.501e-05 | -10.01 | multicellular organismal process | biological process | GO:0032501 | 6177 | 31 | 18204 | 50 |
ADGRB3,SLC1A2,CTNND2,PREX2,QKI,FHOD3,SNTB1,MSI2,PTN,GPM6B,TRPS1,RFX4,DGKB,SLC39A12,SLC1A3,LRIG1,AQP4,SOX5,FGFRL1,PTPRZ1,RORA,SLC4A4,EGF,APOA1,FARP1,PREX1,NFIA,ITPK1,NRCAM,NTRK2,COL11A1 |
4.848e-05 | -9.93 | C4-dicarboxylate transport | biological process | GO:0015740 | 26 | 3 | 18204 | 50 |
SLC1A2,SLC13A5,SLC1A3 |
4.917e-05 | -9.92 | Astrocytic Glutamate-Glutamine Uptake And Metabolism | REACTOME pathways | R-HSA-210455 | 4 | 2 | 10285 | 30 |
SLC1A3,SLC1A2 |
4.917e-05 | -9.92 | Neurotransmitter uptake and Metabolism In Glial Cells | REACTOME pathways | R-HSA-112313 | 4 | 2 | 10285 | 30 |
SLC1A2,SLC1A3 |
5.377e-05 | -9.83 | GSC (goosecoid homeobox) | protein interactions | 145258 | 82 | 4 | 19454 | 49 |
TRPS1,SOX5,PRDM16,NFIA |
5.570e-05 | -9.80 | cell development | biological process | GO:0048468 | 2236 | 17 | 18204 | 50 |
RORA,PTPRZ1,QKI,PREX2,CTNND2,ADGRB3,FARP1,FHOD3,GPM6B,PTN,MSI2,PREX1,COL11A1,SLC1A3,SLC39A12,NRCAM,NTRK2 |
6.026e-05 | -9.72 | sodium ion transmembrane transporter activity | molecular function | GO:0015081 | 158 | 5 | 18094 | 48 |
SLC6A11,SLC1A3,SLC13A5,SLC1A2,SLC4A4 |
6.085e-05 | -9.71 | positive regulation of oligodendrocyte differentiation | biological process | GO:0048714 | 28 | 3 | 18204 | 50 |
QKI,PTPRZ1,PTN |
6.099e-05 | -9.70 | amino acid:monoatomic cation symporter activity | molecular function | GO:0005416 | 29 | 3 | 18094 | 48 |
SLC1A2,SLC6A11,SLC1A3 |
6.184e-05 | -9.69 | dicarboxylic acid transport | biological process | GO:0006835 | 78 | 4 | 18204 | 50 |
NTRK2,SLC1A3,SLC1A2,SLC13A5 |
6.236e-05 | -9.68 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 23 | 16828 | 49 |
SOX5,QKI,DGKB,NCKAP5,PREX2,RORA,GRIP1,PRDM16,AQP4,FHOD3,SLC6A11,EGF,SNTB1,CTNND2,FARP1,SLC1A2,TNS3,GPC5,ITPR2,SORCS2,USP6NL,COL11A1,GRK5 |
6.504e-05 | -9.64 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 34 | 16828 | 49 |
RORA,PRDM16,FHOD3,PREX1,ADAM12,ELOVL2,LRIG1,APOA1,SNTB1,NHSL1,SLC1A2,CTNND2,TNS3,GPC5,ITPR2,COL11A1,ITPK1,SORCS2,USP6NL,GRK5,SLC13A5,RFX4,SOX5,TRPS1,PTPRZ1,SLC39A12,QKI,DGKB,NCKAP5,PTN,NRCAM,ZBTB20,SLC4A4,PREX2 |
6.856e-05 | -9.59 | glutamate:sodium symporter activity | molecular function | GO:0015501 | 5 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
6.856e-05 | -9.59 | high-affinity L-glutamate transmembrane transporter activity | molecular function | GO:0005314 | 5 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
6.922e-05 | -9.58 | plasma membrane region | cellular component | GO:0098590 | 1278 | 12 | 19108 | 49 |
DGKB,SLC4A4,ITPK1,FARP1,AQP4,SLC1A2,SLC1A3,NRCAM,ADGRB3,SLC6A11,SORCS2,GRIP1 |
7.115e-05 | -9.55 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 11 | 16828 | 49 |
NCKAP5,SNTB1,GRIP1,PRDM16,EGF,PTN,SLC1A2,PREX1,ITPR2,GPC5,PREX2 |
7.115e-05 | -9.55 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 11 | 16828 | 49 |
PREX1,GRIP1,PRDM16,PREX2,GPC5,ITPR2,SLC1A2,PTN,EGF,SNTB1,NCKAP5 |
7.270e-05 | -9.53 | organic anion transmembrane transporter activity | molecular function | GO:0008514 | 268 | 6 | 18094 | 48 |
SLC6A11,SLC1A2,SLC39A12,SLC1A3,SLC13A5,SLC4A4 |
7.355e-05 | -9.52 | D-aspartate transmembrane transport | biological process | GO:0070777 | 5 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
7.355e-05 | -9.52 | D-aspartate import across plasma membrane | biological process | GO:0070779 | 5 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
7.513e-05 | -9.50 | neurotransmitter uptake | biological process | GO:0001504 | 30 | 3 | 18204 | 50 |
SLC1A3,SLC1A2,SLC6A11 |
7.933e-05 | -9.44 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 6 | 16828 | 49 |
DGKB,GPC5,NPAS3,GRK5,NFIA,SORCS2 |
7.933e-05 | -9.44 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 6 | 16828 | 49 |
GRK5,SORCS2,NFIA,DGKB,NPAS3,GPC5 |
7.937e-05 | -9.44 | prostate | COSMIC cancer mutations | prostate | 13883 | 49 | 16828 | 49 |
NTRK2,SLC4A4,SLC39A12,SLC13A5,NPAS3,SOX5,ITPR2,GRK5,COL11A1,ITPK1,SNTB1,EGF,TNS3,PREX1,FGFRL1,PRDM16,NFIA,ZBTB20,PREX2,MSI2,NCKAP5,DGKB,QKI,NRCAM,PTN,PTPRZ1,LPIN2,FKBP5,TRPS1,RFX4,GPC5,USP6NL,SORCS2,APOA1,SLC1A3,NHSL1,FARP1,SLC1A2,CTNND2,FHOD3,CTBP1,LRIG1,ELOVL2,SLC6A11,ADAM12,GRIP1,RORA,AQP4,GPM6B |
8.215e-05 | -9.41 | active monoatomic ion transmembrane transporter activity | molecular function | GO:0022853 | 274 | 6 | 18094 | 48 |
SLC6A11,SLC1A2,SLC39A12,SLC1A3,SLC13A5,SLC4A4 |
9.218e-05 | -9.29 | cell morphogenesis | biological process | GO:0000902 | 687 | 9 | 18204 | 50 |
CTNND2,NFIA,PTN,PREX2,PTPRZ1,NRCAM,SLC1A3,SLC39A12,FARP1 |
9.314e-05 | -9.28 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 24 | 16828 | 49 |
GPM6B,NFIA,AQP4,PRDM16,PREX1,FHOD3,TNS3,CTNND2,SLC1A2,SNTB1,EGF,USP6NL,SORCS2,COL11A1,TRPS1,RFX4,NPAS3,SLC13A5,LPIN2,PTPRZ1,NCKAP5,PREX2,SLC4A4,NTRK2 |
9.354e-05 | -9.28 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 24 | 16828 | 49 |
PTPRZ1,LPIN2,SLC13A5,NPAS3,TRPS1,RFX4,NTRK2,PREX2,SLC4A4,NCKAP5,PREX1,FHOD3,PRDM16,AQP4,NFIA,GPM6B,COL11A1,SORCS2,USP6NL,SNTB1,EGF,TNS3,SLC1A2,CTNND2 |
9.404e-05 | -9.27 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 11 | 16828 | 49 |
ITPR2,FHOD3,GPC5,COL11A1,SORCS2,NCKAP5,PRDM16,DGKB,RORA,SOX5,CTNND2 |
9.646e-05 | -9.25 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 9 | 16828 | 49 |
SORCS2,ITPR2,NTRK2,PTPRZ1,FHOD3,NRCAM,CTNND2,GRIP1,NPAS3 |
9.759e-05 | -9.23 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 9 | 16828 | 49 |
NRCAM,CTNND2,GRIP1,NPAS3,SORCS2,ITPR2,NTRK2,PTPRZ1,FHOD3 |
1.006e-04 | -9.20 | organic anion transport | biological process | GO:0015711 | 398 | 7 | 18204 | 50 |
SLC13A5,SLC39A12,SLC1A3,NTRK2,SLC4A4,SLC6A11,SLC1A2 |
1.077e-04 | -9.14 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 32 | 16828 | 49 |
PRDM16,RORA,PREX1,FHOD3,CTBP1,SLC1A3,TNS3,SLC1A2,NHSL1,CTNND2,SNTB1,EGF,APOA1,GRK5,COL11A1,SORCS2,ITPK1,USP6NL,GPC5,TRPS1,SOX5,RFX4,SLC13A5,NPAS3,SLC39A12,NRCAM,NCKAP5,DGKB,QKI,PREX2,SLC4A4,ZBTB20 |
1.101e-04 | -9.11 | secondary active transmembrane transporter activity | molecular function | GO:0015291 | 289 | 6 | 18094 | 48 |
SLC4A4,SLC1A2,SLC13A5,SLC6A11,SLC1A3,SLC39A12 |
1.101e-04 | -9.11 | D-amino acid transport | biological process | GO:0042940 | 6 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
1.101e-04 | -9.11 | L-aspartate import across plasma membrane | biological process | GO:0140009 | 6 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
1.101e-04 | -9.11 | CARM1 (coactivator associated arginine methyltransferase 1) | protein interactions | 10498 | 304 | 6 | 19454 | 49 |
NCKAP5,CTBP1,RORA,QKI,GRIP1,SNTB1 |
1.191e-04 | -9.04 | Pcbp1 (poly(rC) binding protein 1) | protein interactions | 23983 | 38 | 3 | 19454 | 49 |
CTBP1,MSI2,QKI |
1.317e-04 | -8.94 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 16 | 16828 | 49 |
PTPRZ1,FHOD3,PRDM16,GRIP1,SLC13A5,RORA,TRPS1,AQP4,ITPR2,GPC5,GRK5,PREX2,MSI2,COL11A1,EGF,FARP1 |
1.342e-04 | -8.92 | mouth | COSMIC cancer mutations | mouth | 9004 | 39 | 16828 | 49 |
QKI,DGKB,NCKAP5,NRCAM,PTN,NTRK2,ZBTB20,SLC4A4,PREX2,SLC13A5,NPAS3,RFX4,TRPS1,SOX5,PTPRZ1,SLC39A12,EGF,APOA1,SNTB1,SLC1A2,NHSL1,CTNND2,SLC1A3,TNS3,GPC5,ITPR2,COL11A1,SORCS2,ITPK1,USP6NL,GRK5,RORA,PRDM16,FHOD3,CTBP1,PREX1,ADAM12,ELOVL2,LRIG1 |
1.367e-04 | -8.90 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 12 | 16828 | 49 |
FHOD3,PRDM16,RORA,SOX5,AQP4,ITPR2,GPC5,SORCS2,COL11A1,DGKB,NCKAP5,CTNND2 |
1.487e-04 | -8.81 | Na:dicarbo_symporter_sf | interpro domains | IPR036458 | 7 | 2 | 18521 | 50 |
SLC1A3,SLC1A2 |
1.487e-04 | -8.81 | Na-dicarboxylate_symporter | interpro domains | IPR001991 | 7 | 2 | 18521 | 50 |
SLC1A2,SLC1A3 |
1.487e-04 | -8.81 | Na-dicarboxylate_symporter_CS | interpro domains | IPR018107 | 7 | 2 | 18521 | 50 |
SLC1A2,SLC1A3 |
1.525e-04 | -8.79 | postsynaptic density | cellular component | GO:0014069 | 317 | 6 | 19108 | 49 |
ADGRB3,NRCAM,CTNND2,GRIP1,NTRK2,SORCS2 |
1.534e-04 | -8.78 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 7 | 18094 | 48 |
SLC6A11,SLC1A2,SLC39A12,ITPR2,SLC1A3,SLC13A5,SLC4A4 |
1.551e-04 | -8.77 | Sodium:dicarboxylate symporter | gene3d domains | 1.10.3860.10 | 7 | 2 | 14470 | 40 |
SLC1A3,SLC1A2 |
1.610e-04 | -8.73 | SDF | pfam domains | PF00375 | 7 | 2 | 17795 | 50 |
SLC1A3,SLC1A2 |
1.949e-04 | -8.54 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 7 | 18204 | 50 |
FARP1,NRCAM,SLC1A3,PTN,PREX2,PTPRZ1,CTNND2 |
1.963e-04 | -8.54 | neural precursor cell proliferation | biological process | GO:0061351 | 105 | 4 | 18204 | 50 |
EGF,RORA,NFIA,SOX5 |
1.992e-04 | -8.52 | asymmetric synapse | cellular component | GO:0032279 | 333 | 6 | 19108 | 49 |
SORCS2,NTRK2,GRIP1,CTNND2,NRCAM,ADGRB3 |
2.048e-04 | -8.49 | cell proliferation in external granule layer | biological process | GO:0021924 | 8 | 2 | 18204 | 50 |
EGF,RORA |
2.048e-04 | -8.49 | cerebellar granule cell precursor proliferation | biological process | GO:0021930 | 8 | 2 | 18204 | 50 |
RORA,EGF |
2.048e-04 | -8.49 | cell proliferation in hindbrain | biological process | GO:0021534 | 8 | 2 | 18204 | 50 |
RORA,EGF |
2.071e-04 | -8.48 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 42 | 16828 | 49 |
SLC39A12,PTPRZ1,LPIN2,NPAS3,SLC13A5,SOX5,TRPS1,RFX4,ZBTB20,NTRK2,PREX2,SLC4A4,NCKAP5,DGKB,NRCAM,PTN,PREX1,CTBP1,FGFRL1,FHOD3,SLC6A11,LRIG1,ELOVL2,ADAM12,GRIP1,PRDM16,RORA,GPM6B,NFIA,ITPR2,GPC5,GRK5,SORCS2,USP6NL,COL11A1,APOA1,EGF,TNS3,SLC1A3,CTNND2,FARP1,SLC1A2 |
2.071e-04 | -8.48 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 42 | 16828 | 49 |
SLC13A5,NPAS3,TRPS1,SOX5,RFX4,PTPRZ1,SLC39A12,LPIN2,NCKAP5,DGKB,PTN,NRCAM,NTRK2,ZBTB20,PREX2,SLC4A4,GRIP1,PRDM16,RORA,NFIA,GPM6B,PREX1,FHOD3,FGFRL1,CTBP1,LRIG1,ELOVL2,SLC6A11,ADAM12,EGF,APOA1,SLC1A3,TNS3,SLC1A2,FARP1,CTNND2,ITPR2,GPC5,GRK5,COL11A1,SORCS2,USP6NL |
2.071e-04 | -8.48 | EDTRNSPORT | prints domains | PR00173 | 7 | 2 | 5227 | 17 |
SLC1A2,SLC1A3 |
2.136e-04 | -8.45 | ELK3 (ETS transcription factor ELK3) | protein interactions | 2004 | 117 | 4 | 19454 | 49 |
NFIA,CTBP1,PRDM16,TRPS1 |
2.282e-04 | -8.39 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 6 | 16828 | 49 |
EGF,GPC5,FHOD3,NCKAP5,FARP1,SOX5 |
2.300e-04 | -8.38 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 45 | 16828 | 49 |
LPIN2,PTPRZ1,TRPS1,RFX4,FKBP5,PREX2,ZBTB20,NRCAM,DGKB,NCKAP5,QKI,LRIG1,ELOVL2,SLC6A11,ADAM12,FHOD3,CTBP1,GPM6B,GRIP1,RORA,USP6NL,SORCS2,GPC5,SLC1A3,FARP1,NHSL1,SLC1A2,CTNND2,SLC39A12,SOX5,SLC13A5,NPAS3,SLC4A4,NTRK2,PREX1,FGFRL1,NFIA,PRDM16,GRK5,COL11A1,ITPK1,ITPR2,TNS3,SNTB1,EGF |
2.328e-04 | -8.37 | cervix | COSMIC cancer mutations | cervix | 11793 | 45 | 16828 | 49 |
RORA,GRIP1,GPM6B,CTBP1,FHOD3,ADAM12,SLC6A11,ELOVL2,LRIG1,CTNND2,NHSL1,FARP1,SLC1A2,SLC1A3,GPC5,USP6NL,SORCS2,FKBP5,RFX4,TRPS1,PTPRZ1,LPIN2,QKI,NCKAP5,DGKB,NRCAM,ZBTB20,PREX2,PRDM16,NFIA,FGFRL1,PREX1,EGF,SNTB1,TNS3,ITPR2,ITPK1,COL11A1,GRK5,NPAS3,SLC13A5,SOX5,SLC39A12,NTRK2,SLC4A4 |
2.411e-04 | -8.33 | postsynaptic specialization | cellular component | GO:0099572 | 345 | 6 | 19108 | 49 |
NTRK2,NRCAM,GRIP1,ADGRB3,CTNND2,SORCS2 |
2.494e-04 | -8.30 | KLF3 (KLF transcription factor 3) | protein interactions | 51274 | 225 | 5 | 19454 | 49 |
CTBP1,NFIA,TRPS1,SOX5,PRDM16 |
2.498e-04 | -8.29 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 30 | 16828 | 49 |
NCKAP5,NRCAM,ZBTB20,NTRK2,SLC4A4,PREX2,NPAS3,SLC13A5,SOX5,SLC39A12,PTPRZ1,LPIN2,EGF,CTNND2,FARP1,TNS3,SLC1A3,ITPR2,SORCS2,ITPK1,COL11A1,RORA,GRIP1,PRDM16,GPM6B,FGFRL1,FHOD3,PREX1,SLC6A11,LRIG1 |
2.521e-04 | -8.29 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 18 | 16828 | 49 |
SOX5,RFX4,GRIP1,SLC6A11,LRIG1,LPIN2,PTPRZ1,TNS3,NRCAM,CTNND2,FARP1,NHSL1,SLC1A2,NCKAP5,GRK5,COL11A1,ZBTB20,NTRK2 |
2.526e-04 | -8.28 | NA_DICARBOXYL_SYMP_2 | prosite domains | PS00714 | 7 | 2 | 12186 | 43 |
SLC1A3,SLC1A2 |
2.526e-04 | -8.28 | NA_DICARBOXYL_SYMP_1 | prosite domains | PS00713 | 7 | 2 | 12186 | 43 |
SLC1A3,SLC1A2 |
2.551e-04 | -8.27 | acidic amino acid transport | biological process | GO:0015800 | 45 | 3 | 18204 | 50 |
NTRK2,SLC1A3,SLC1A2 |
2.601e-04 | -8.25 | dendrite development | biological process | GO:0016358 | 113 | 4 | 18204 | 50 |
PREX2,FARP1,PTN,CTNND2 |
2.723e-04 | -8.21 | regulation of oligodendrocyte differentiation | biological process | GO:0048713 | 46 | 3 | 18204 | 50 |
QKI,PTPRZ1,PTN |
2.723e-04 | -8.21 | positive regulation of glial cell differentiation | biological process | GO:0045687 | 46 | 3 | 18204 | 50 |
QKI,PTPRZ1,PTN |
2.855e-04 | -8.16 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 15 | 16828 | 49 |
COL11A1,SLC4A4,SORCS2,ITPR2,ZBTB20,PTN,DGKB,NCKAP5,ADAM12,PREX1,SLC39A12,FHOD3,SOX5,RORA,NPAS3 |
2.877e-04 | -8.15 | positive regulation of developmental process | biological process | GO:0051094 | 1385 | 12 | 18204 | 50 |
EGF,SLC39A12,NRCAM,NTRK2,GRIP1,ADAM12,ADGRB3,QKI,PTPRZ1,PTN,SOX5,GPM6B |
2.887e-04 | -8.15 | larynx | COSMIC cancer mutations | larynx | 1948 | 15 | 16828 | 49 |
SOX5,NPAS3,RORA,ADAM12,FHOD3,SLC39A12,PREX1,PTN,DGKB,NCKAP5,SORCS2,COL11A1,SLC4A4,ZBTB20,ITPR2 |
2.946e-04 | -8.13 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 11 | 16828 | 49 |
FHOD3,GPC5,SORCS2,COL11A1,GRK5,QKI,PRDM16,NCKAP5,DGKB,SLC1A2,SOX5 |
3.165e-04 | -8.06 | central nervous system development | biological process | GO:0007417 | 995 | 10 | 18204 | 50 |
SLC1A2,MSI2,RORA,QKI,PTPRZ1,RFX4,GPM6B,EGF,NTRK2,NRCAM |
3.260e-04 | -8.03 | neuron to neuron synapse | cellular component | GO:0098984 | 365 | 6 | 19108 | 49 |
SORCS2,CTNND2,NTRK2,GRIP1,ADGRB3,NRCAM |
3.281e-04 | -8.02 | cellular response to cocaine | biological process | GO:0071314 | 10 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
3.281e-04 | -8.02 | action potential propagation | biological process | GO:0098870 | 10 | 2 | 18204 | 50 |
NRCAM,NTRK2 |
3.281e-04 | -8.02 | neuronal action potential propagation | biological process | GO:0019227 | 10 | 2 | 18204 | 50 |
NRCAM,NTRK2 |
3.283e-04 | -8.02 | glial cell differentiation | biological process | GO:0010001 | 219 | 5 | 18204 | 50 |
NTRK2,GPM6B,NFIA,PTPRZ1,QKI |
3.424e-04 | -7.98 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 7 | 18204 | 50 |
NRCAM,SLC39A12,FARP1,CTNND2,PTN,PREX2,PTPRZ1 |
3.471e-04 | -7.97 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 43 | 16828 | 49 |
FGFRL1,FHOD3,CTBP1,PREX1,ADAM12,LRIG1,ELOVL2,SLC6A11,RORA,PRDM16,GRIP1,GPM6B,GPC5,ITPR2,COL11A1,ITPK1,USP6NL,SORCS2,GRK5,EGF,SNTB1,SLC1A2,NHSL1,FARP1,CTNND2,SLC1A3,TNS3,PTPRZ1,SLC39A12,LPIN2,FKBP5,NPAS3,TRPS1,SOX5,NTRK2,ZBTB20,SLC4A4,PREX2,MSI2,QKI,DGKB,NCKAP5,NRCAM |
3.642e-04 | -7.92 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 7 | 18204 | 50 |
CTNND2,PTPRZ1,PREX2,PTN,SLC39A12,NRCAM,FARP1 |
3.870e-04 | -7.86 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 7 | 18204 | 50 |
PTPRZ1,FARP1,PREX2,PTN,CTNND2,SLC39A12,NRCAM |
3.977e-04 | -7.83 | PRNP (prion protein (Kanno blood group)) | protein interactions | 5621 | 1118 | 10 | 19454 | 49 |
NHSL1,SLC1A3,QKI,TRPS1,MSI2,AQP4,SLC4A4,ITPK1,PTPRZ1,COL11A1 |
4.003e-04 | -7.82 | L-aspartate transmembrane transport | biological process | GO:0070778 | 11 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
4.003e-04 | -7.82 | L-glutamate import across plasma membrane | biological process | GO:0098712 | 11 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
4.010e-04 | -7.82 | NFIB (nuclear factor I B) | protein interactions | 4781 | 138 | 4 | 19454 | 49 |
GRK5,SOX5,TRPS1,NFIA |
4.244e-04 | -7.76 | Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-112310 | 51 | 3 | 10285 | 30 |
SLC1A2,SLC1A3,SLC6A11 |
4.404e-04 | -7.73 | Ig_I-set | interpro domains | IPR013098 | 132 | 4 | 18521 | 50 |
NRCAM,NTRK2,LRIG1,FGFRL1 |
4.698e-04 | -7.66 | amino acid transport | biological process | GO:0006865 | 132 | 4 | 18204 | 50 |
SLC1A3,SLC1A2,NTRK2,SLC6A11 |
4.724e-04 | -7.66 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 24 | 16828 | 49 |
CTNND2,FARP1,NHSL1,SLC1A3,PTN,QKI,DGKB,SNTB1,NCKAP5,SORCS2,COL11A1,PREX2,RFX4,SOX5,TRPS1,FKBP5,GRIP1,ADAM12,SLC6A11,ELOVL2,FHOD3,SLC39A12,PREX1,PTPRZ1 |
4.724e-04 | -7.66 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 24 | 16828 | 49 |
COL11A1,SORCS2,PREX2,QKI,DGKB,NCKAP5,SNTB1,FARP1,NHSL1,CTNND2,PTN,SLC1A3,FHOD3,PREX1,PTPRZ1,SLC39A12,ADAM12,ELOVL2,SLC6A11,FKBP5,GRIP1,RFX4,SOX5,TRPS1 |
4.781e-04 | -7.65 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 23 | 16828 | 49 |
SLC4A4,COL11A1,PREX2,GPC5,ITPR2,SLC1A2,CTNND2,PTN,NRCAM,TNS3,EGF,QKI,ADAM12,LRIG1,SLC6A11,FHOD3,PREX1,SLC39A12,RFX4,TRPS1,FKBP5,RORA,GRIP1 |
4.899e-04 | -7.62 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 13 | 18204 | 50 |
SLC39A12,NTRK2,PRDM16,ADAM12,PTN,GPM6B,EGF,ZBTB20,ADGRB3,RORA,PTPRZ1,QKI,SOX5 |
5.016e-04 | -7.60 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 8 | 18204 | 50 |
NRCAM,NTRK2,SLC39A12,PTN,ADGRB3,PREX1,USP6NL,GRIP1 |
5.114e-04 | -7.58 | organic acid transmembrane transport | biological process | GO:1903825 | 135 | 4 | 18204 | 50 |
SLC6A11,SLC1A3,SLC13A5,SLC1A2 |
5.115e-04 | -7.58 | I-set | pfam domains | PF07679 | 132 | 4 | 17795 | 50 |
LRIG1,FGFRL1,NTRK2,NRCAM |
5.194e-04 | -7.56 | muscle structure development | biological process | GO:0061061 | 521 | 7 | 18204 | 50 |
FHOD3,COL11A1,ADAM12,ADGRB3,RORA,QKI,FGFRL1 |
5.266e-04 | -7.55 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 8 | 18094 | 48 |
AQP4,SLC6A11,SLC1A2,SLC1A3,ITPR2,SLC39A12,SLC4A4,SLC13A5 |
5.276e-04 | -7.55 | monoatomic cation:bicarbonate symporter activity | molecular function | GO:0140410 | 13 | 2 | 18094 | 48 |
SLC4A4,SLC39A12 |
5.357e-04 | -7.53 | NR3C1 (nuclear receptor subfamily 3 group C member 1) | protein interactions | 2908 | 950 | 9 | 19454 | 49 |
PREX1,SLC1A3,APOA1,NFIA,GRIP1,TRPS1,FKBP5,CTNND2,ZBTB20 |
5.522e-04 | -7.50 | neuron projection development | biological process | GO:0031175 | 693 | 8 | 18204 | 50 |
CTNND2,PTN,PREX2,GPM6B,PTPRZ1,NRCAM,SLC39A12,FARP1 |
5.566e-04 | -7.49 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 42 | 16828 | 49 |
GPM6B,GRIP1,PRDM16,RORA,ELOVL2,LRIG1,SLC6A11,ADAM12,PREX1,FHOD3,FGFRL1,CTBP1,SLC1A3,TNS3,SLC1A2,NHSL1,FARP1,CTNND2,SNTB1,GRK5,COL11A1,SORCS2,ITPK1,USP6NL,ITPR2,GPC5,SOX5,TRPS1,FKBP5,NPAS3,LPIN2,PTPRZ1,SLC39A12,NRCAM,DGKB,NCKAP5,QKI,PREX2,MSI2,SLC4A4,NTRK2,ZBTB20 |
6.057e-04 | -7.41 | prostate-adenoma | COSMIC cancer mutations | prostate-adenoma | 1634 | 13 | 16828 | 49 |
FARP1,SOX5,PTN,NPAS3,EGF,ADAM12,COL11A1,SLC6A11,FHOD3,GPC5,ZBTB20,PREX1,PTPRZ1 |
6.145e-04 | -7.39 | L-glutamate transmembrane transporter activity | molecular function | GO:0005313 | 14 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
6.239e-04 | -7.38 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 49 |
FGFRL1,ADAM12,NFIA,RFX4,NTRK2,SLC4A4,PREX2,QKI,NCKAP5,NHSL1,SLC1A2,CTNND2 |
6.239e-04 | -7.38 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 12 | 16828 | 49 |
SLC4A4,ADAM12,PREX2,FGFRL1,NTRK2,RFX4,NFIA,NHSL1,SLC1A2,CTNND2,QKI,NCKAP5 |
6.440e-04 | -7.35 | PDZ | interpro domains | IPR001478 | 146 | 4 | 18521 | 50 |
PREX2,GRIP1,PREX1,SNTB1 |
6.850e-04 | -7.29 | scalp | COSMIC cancer mutations | scalp | 2110 | 15 | 16828 | 49 |
PREX2,COL11A1,SLC4A4,GPC5,NRCAM,PTN,FARP1,SLC6A11,ADAM12,PTPRZ1,PREX1,SOX5,TRPS1,NFIA,RORA |
6.950e-04 | -7.27 | PDZ_sf | interpro domains | IPR036034 | 149 | 4 | 18521 | 50 |
PREX1,PREX2,GRIP1,SNTB1 |
7.397e-04 | -7.21 | - | gene3d domains | 2.30.42.10 | 149 | 4 | 14470 | 40 |
SNTB1,GRIP1,PREX2,PREX1 |
7.686e-04 | -7.17 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 18 | 16828 | 49 |
FHOD3,PREX1,PTPRZ1,ADAM12,SLC6A11,NPAS3,PRDM16,GRIP1,SOX5,GPC5,ZBTB20,NTRK2,COL11A1,EGF,NCKAP5,CTNND2,FARP1,PTN |
7.853e-04 | -7.15 | EGR2 (early growth response 2) | protein interactions | 1959 | 165 | 4 | 19454 | 49 |
SOX5,TRPS1,PRDM16,NFIA |
8.075e-04 | -7.12 | kidney-carcinoma-renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-renal_cell_carcinoma | 4535 | 24 | 16828 | 49 |
GRK5,PREX2,MSI2,USP6NL,NTRK2,ITPR2,FARP1,CTNND2,DGKB,SNTB1,QKI,LPIN2,LRIG1,ADAM12,PREX1,PTPRZ1,SLC39A12,SOX5,TRPS1,GPM6B,PRDM16,RORA,SLC13A5,FKBP5 |
8.075e-04 | -7.12 | renal_cell_carcinoma | COSMIC cancer mutations | renal_cell_carcinoma | 4535 | 24 | 16828 | 49 |
NTRK2,PREX2,MSI2,DGKB,QKI,PTPRZ1,SLC39A12,LPIN2,SLC13A5,FKBP5,SOX5,TRPS1,ITPR2,GRK5,USP6NL,SNTB1,FARP1,CTNND2,PREX1,LRIG1,ADAM12,PRDM16,RORA,GPM6B |
8.632e-04 | -7.05 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 7 | 18094 | 48 |
SLC1A3,ITPR2,SLC39A12,SLC4A4,SLC13A5,SLC6A11,SLC1A2 |
8.923e-04 | -7.02 | DH-domain | interpro domains | IPR000219 | 70 | 3 | 18521 | 50 |
PREX2,PREX1,FARP1 |
8.960e-04 | -7.02 | skin-leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-leg-malignant_melanoma-nodular | 258 | 5 | 16828 | 49 |
GRK5,SLC4A4,COL11A1,PTPRZ1,EGF |
9.223e-04 | -6.99 | gliogenesis | biological process | GO:0042063 | 275 | 5 | 18204 | 50 |
NFIA,GPM6B,PTPRZ1,QKI,NTRK2 |
9.254e-04 | -6.99 | kidney-carcinoma | COSMIC cancer mutations | kidney-carcinoma | 3720 | 21 | 16828 | 49 |
PREX1,PTPRZ1,ADAM12,LPIN2,LRIG1,RORA,FKBP5,PRDM16,TRPS1,SOX5,ITPR2,NTRK2,USP6NL,MSI2,PREX2,GRK5,QKI,SNTB1,DGKB,CTNND2,FARP1 |
9.299e-04 | -6.98 | DBL_dom_sf | interpro domains | IPR035899 | 71 | 3 | 18521 | 50 |
FARP1,PREX2,PREX1 |
9.794e-04 | -6.93 | viral genome replication | biological process | GO:0019079 | 17 | 2 | 18204 | 50 |
NFIA,CTBP1 |
9.819e-04 | -6.93 | Dbl homology (DH) domain | gene3d domains | 1.20.900.10 | 71 | 3 | 14470 | 40 |
PREX1,PREX2,FARP1 |
1.001e-03 | -6.91 | RhoGEF | pfam domains | PF00621 | 70 | 3 | 17795 | 50 |
PREX1,FARP1,PREX2 |
1.026e-03 | -6.88 | acidic amino acid transmembrane transporter activity | molecular function | GO:0015172 | 18 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
1.064e-03 | -6.85 | pleura | COSMIC cancer mutations | pleura | 4914 | 25 | 16828 | 49 |
ITPR2,USP6NL,GRK5,SNTB1,CTNND2,FARP1,FGFRL1,FHOD3,PREX1,ADAM12,LRIG1,RORA,PRDM16,GPM6B,NTRK2,MSI2,PREX2,QKI,DGKB,NCKAP5,PTPRZ1,LPIN2,FKBP5,TRPS1,SOX5 |
1.066e-03 | -6.84 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 7 | 16828 | 49 |
CTNND2,TRPS1,DGKB,SLC4A4,SLC6A11,PREX1,NTRK2 |
1.071e-03 | -6.84 | astrocyte projection | cellular component | GO:0097449 | 19 | 2 | 19108 | 49 |
SLC1A2,AQP4 |
1.082e-03 | -6.83 | active transmembrane transporter activity | molecular function | GO:0022804 | 444 | 6 | 18094 | 48 |
SLC6A11,SLC1A2,SLC1A3,SLC39A12,SLC4A4,SLC13A5 |
1.089e-03 | -6.82 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 7 | 16828 | 49 |
SLC6A11,TRPS1,CTNND2,SLC4A4,DGKB,PREX1,NTRK2 |
1.102e-03 | -6.81 | positive regulation of gliogenesis | biological process | GO:0014015 | 74 | 3 | 18204 | 50 |
PTN,QKI,PTPRZ1 |
1.151e-03 | -6.77 | muscle cell differentiation | biological process | GO:0042692 | 289 | 5 | 18204 | 50 |
ADAM12,ADGRB3,FHOD3,RORA,QKI |
1.181e-03 | -6.74 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 20 | 16828 | 49 |
TNS3,NRCAM,SLC1A3,CTNND2,DGKB,SNTB1,NCKAP5,EGF,MSI2,PREX2,ITPK1,COL11A1,SLC4A4,NTRK2,GPC5,GRIP1,NPAS3,PTPRZ1,FGFRL1,FHOD3 |
1.181e-03 | -6.74 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 20 | 16828 | 49 |
FHOD3,FGFRL1,PTPRZ1,NPAS3,GRIP1,GPC5,NTRK2,SLC4A4,COL11A1,ITPK1,PREX2,MSI2,EGF,NCKAP5,SNTB1,DGKB,CTNND2,SLC1A3,NRCAM,TNS3 |
1.201e-03 | -6.72 | KLF12 (KLF transcription factor 12) | protein interactions | 11278 | 185 | 4 | 19454 | 49 |
PRDM16,TRPS1,NFIA,CTBP1 |
1.227e-03 | -6.70 | cartilage condensation | biological process | GO:0001502 | 19 | 2 | 18204 | 50 |
COL11A1,SOX5 |
1.240e-03 | -6.69 | FXYD6 (FXYD domain containing ion transport regulator 6) | protein interactions | 53826 | 84 | 3 | 19454 | 49 |
GPC5,ELOVL2,SLC39A12 |
1.265e-03 | -6.67 | adenoid_cystic_carcinoma | COSMIC cancer mutations | adenoid_cystic_carcinoma | 1123 | 10 | 16828 | 49 |
GPM6B,CTNND2,NRCAM,RORA,SLC13A5,EGF,PRDM16,ITPK1,GRK5,NTRK2 |
1.277e-03 | -6.66 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 7 | 18094 | 48 |
SLC1A3,ITPR2,SLC39A12,SLC4A4,SLC13A5,SLC6A11,SLC1A2 |
1.280e-03 | -6.66 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 5 | 18204 | 50 |
PTN,QKI,PTPRZ1,NTRK2,ADGRB3 |
1.283e-03 | -6.66 | positive regulation of carbohydrate metabolic process | biological process | GO:0045913 | 78 | 3 | 18204 | 50 |
EGF,ZBTB20,SLC4A4 |
1.289e-03 | -6.65 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 6 | 18204 | 50 |
NTRK2,PREX1,NRCAM,ADGRB3,SLC39A12,PTN |
1.299e-03 | -6.65 | carboxylic acid transport | biological process | GO:0046942 | 297 | 5 | 18204 | 50 |
SLC13A5,SLC1A2,SLC1A3,NTRK2,SLC6A11 |
1.313e-03 | -6.64 | SLC-mediated transmembrane transport | REACTOME pathways | R-HSA-425407 | 287 | 5 | 10285 | 30 |
SLC4A4,SLC6A11,SLC1A3,SLC13A5,SLC1A2 |
1.314e-03 | -6.63 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 748 | 8 | 16828 | 49 |
ITPR2,NTRK2,FHOD3,GRK5,TRPS1,SLC1A3,SOX5,CTNND2 |
1.317e-03 | -6.63 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 45 | 16828 | 49 |
GPC5,USP6NL,SORCS2,SLC1A2,NHSL1,FARP1,CTNND2,SLC1A3,FHOD3,CTBP1,ADAM12,ELOVL2,LRIG1,SLC6A11,RORA,GRIP1,AQP4,GPM6B,ZBTB20,PREX2,QKI,NCKAP5,DGKB,NRCAM,PTN,PTPRZ1,FKBP5,RFX4,TRPS1,ITPR2,COL11A1,ITPK1,GRK5,EGF,SNTB1,TNS3,FGFRL1,PREX1,PRDM16,NFIA,NTRK2,SLC39A12,SLC13A5,NPAS3,SOX5 |
1.318e-03 | -6.63 | organic acid transport | biological process | GO:0015849 | 298 | 5 | 18204 | 50 |
SLC1A2,SLC13A5,SLC1A3,NTRK2,SLC6A11 |
1.331e-03 | -6.62 | regulation of glial cell differentiation | biological process | GO:0045685 | 79 | 3 | 18204 | 50 |
PTPRZ1,QKI,PTN |
1.361e-03 | -6.60 | aspartate transmembrane transport | biological process | GO:0015810 | 20 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
1.390e-03 | -6.58 | Dusp14 (dual specificity phosphatase 14) | protein interactions | 56405 | 22 | 2 | 19454 | 49 |
QKI,CTBP1 |
1.408e-03 | -6.57 | salivary_gland | COSMIC cancer mutations | salivary_gland | 1139 | 10 | 16828 | 49 |
NTRK2,ITPK1,GRK5,SLC13A5,EGF,RORA,PRDM16,CTNND2,GPM6B,NRCAM |
1.418e-03 | -6.56 | DYRK1B (dual specificity tyrosine phosphorylation regulated kinase 1B) | protein interactions | 9149 | 88 | 3 | 19454 | 49 |
LPIN2,FKBP5,CTBP1 |
1.425e-03 | -6.55 | behavior | biological process | GO:0007610 | 619 | 7 | 18204 | 50 |
NTRK2,SLC1A3,PTN,PREX2,PTPRZ1,ADGRB3,SLC1A2 |
1.452e-03 | -6.54 | GDS_CDC24_CS | interpro domains | IPR001331 | 21 | 2 | 18521 | 50 |
PREX2,PREX1 |
1.456e-03 | -6.53 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 34 | 16828 | 49 |
ITPR2,GPC5,COL11A1,SORCS2,SNTB1,APOA1,TNS3,FARP1,CTNND2,PREX1,FHOD3,LRIG1,SLC6A11,ADAM12,PRDM16,GRIP1,RORA,AQP4,GPM6B,NTRK2,ZBTB20,PREX2,SLC4A4,DGKB,NCKAP5,QKI,PTPRZ1,SLC39A12,LPIN2,SLC13A5,FKBP5,NPAS3,TRPS1,SOX5 |
1.478e-03 | -6.52 | carboxylic acid transmembrane transporter activity | molecular function | GO:0046943 | 186 | 4 | 18094 | 48 |
SLC6A11,SLC1A3,SLC13A5,SLC1A2 |
1.502e-03 | -6.50 | positive regulation of glycolytic process | biological process | GO:0045821 | 21 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
1.502e-03 | -6.50 | positive regulation of purine nucleotide catabolic process | biological process | GO:0033123 | 21 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
1.502e-03 | -6.50 | positive regulation of nucleotide catabolic process | biological process | GO:0030813 | 21 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
1.502e-03 | -6.50 | positive regulation of stem cell differentiation | biological process | GO:2000738 | 21 | 2 | 18204 | 50 |
PTN,SOX5 |
1.502e-03 | -6.50 | cell aggregation | biological process | GO:0098743 | 21 | 2 | 18204 | 50 |
SOX5,COL11A1 |
1.507e-03 | -6.50 | organic acid transmembrane transporter activity | molecular function | GO:0005342 | 187 | 4 | 18094 | 48 |
SLC6A11,SLC1A3,SLC1A2,SLC13A5 |
1.519e-03 | -6.49 | enzyme-linked receptor protein signaling pathway | biological process | GO:0007167 | 626 | 7 | 18204 | 50 |
NFIA,PTN,FGFRL1,FARP1,NTRK2,APOA1,EGF |
1.520e-03 | -6.49 | Rbm38 (RNA binding motif protein 38) | protein interactions | 56190 | 23 | 2 | 19454 | 49 |
QKI,MSI2 |
1.570e-03 | -6.46 | DEP | pfam domains | PF00610 | 21 | 2 | 17795 | 50 |
PREX2,PREX1 |
1.573e-03 | -6.45 | PDZ | prosite domains | PS50106 | 143 | 4 | 12186 | 43 |
PREX2,GRIP1,PREX1,SNTB1 |
1.582e-03 | -6.45 | ERK Pathway in Huntington's Disease | WikiPathways | WP3853 | 14 | 2 | 5310 | 23 |
NTRK2,EGF |
1.587e-03 | -6.45 | regulation of carbohydrate metabolic process | biological process | GO:0006109 | 183 | 4 | 18204 | 50 |
EGF,ZBTB20,SLC4A4,RORA |
1.594e-03 | -6.44 | DEP_dom | interpro domains | IPR000591 | 22 | 2 | 18521 | 50 |
PREX1,PREX2 |
1.615e-03 | -6.43 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 29 | 16828 | 49 |
LPIN2,PTPRZ1,SLC39A12,SOX5,TRPS1,FKBP5,NPAS3,PREX2,NTRK2,ZBTB20,QKI,NCKAP5,DGKB,ADAM12,SLC6A11,FHOD3,PREX1,AQP4,GPM6B,RORA,GRIP1,COL11A1,SORCS2,GPC5,ITPR2,FARP1,CTNND2,APOA1,SNTB1 |
1.644e-03 | -6.41 | oligodendrocyte differentiation | biological process | GO:0048709 | 85 | 3 | 18204 | 50 |
NTRK2,GPM6B,PTPRZ1 |
1.649e-03 | -6.41 | neurotransmitter reuptake | biological process | GO:0098810 | 22 | 2 | 18204 | 50 |
SLC6A11,SLC1A2 |
1.652e-03 | -6.41 | PDZ | smart domains | SM00228 | 143 | 4 | 9717 | 35 |
GRIP1,PREX2,SNTB1,PREX1 |
1.659e-03 | -6.40 | pancreas-carcinoma | COSMIC cancer mutations | pancreas-carcinoma | 14770 | 49 | 16828 | 49 |
ZBTB20,MSI2,PREX2,QKI,DGKB,NCKAP5,PTN,NRCAM,PTPRZ1,LPIN2,FKBP5,RFX4,TRPS1,GPC5,USP6NL,SORCS2,APOA1,CTNND2,FARP1,NHSL1,SLC1A2,SLC1A3,CTBP1,FHOD3,ADAM12,SLC6A11,ELOVL2,LRIG1,RORA,GRIP1,GPM6B,AQP4,NTRK2,SLC4A4,SLC39A12,NPAS3,SLC13A5,SOX5,ITPR2,ITPK1,COL11A1,GRK5,EGF,SNTB1,TNS3,FGFRL1,PREX1,PRDM16,NFIA |
1.662e-03 | -6.40 | DMRTB1 (DMRT like family B with proline rich C-terminal 1) | protein interactions | 63948 | 93 | 3 | 19454 | 49 |
CTBP1,MSI2,QKI |
1.667e-03 | -6.40 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 28 | 18204 | 50 |
ZBTB20,SLC1A2,ADGRB3,QKI,SLC39A12,SLC1A3,GPC5,CTBP1,PRDM16,RFX4,GPM6B,PTN,EGF,APOA1,NPAS3,SLC4A4,FARP1,LPIN2,RORA,PTPRZ1,SOX5,NTRK2,NRCAM,GRK5,GRIP1,PREX1,ADAM12,NFIA |
1.689e-03 | -6.38 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 12 | 16828 | 49 |
COL11A1,SLC4A4,GPC5,FARP1,PTN,NRCAM,ADAM12,PREX1,PTPRZ1,SOX5,TRPS1,RORA |
1.700e-03 | -6.38 | vascular transport | biological process | GO:0010232 | 86 | 3 | 18204 | 50 |
SLC1A3,SLC1A2,SLC4A4 |
1.700e-03 | -6.38 | transport across blood-brain barrier | biological process | GO:0150104 | 86 | 3 | 18204 | 50 |
SLC4A4,SLC1A2,SLC1A3 |
1.702e-03 | -6.38 | abdomen | COSMIC cancer mutations | abdomen | 603 | 7 | 16828 | 49 |
CTNND2,PRDM16,COL11A1,SLC6A11,LRIG1,PREX2,ITPR2 |
1.758e-03 | -6.34 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 27 | 16828 | 49 |
PREX1,FHOD3,CTBP1,LRIG1,SLC6A11,ADAM12,PRDM16,GRIP1,GPM6B,ITPR2,GPC5,GRK5,COL11A1,USP6NL,SLC1A3,CTNND2,PTPRZ1,SLC39A12,NPAS3,SOX5,TRPS1,NTRK2,SLC4A4,NCKAP5,DGKB,NRCAM,PTN |
1.758e-03 | -6.34 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 27 | 16828 | 49 |
ITPR2,GPC5,GRK5,USP6NL,COL11A1,SLC1A3,CTNND2,PREX1,CTBP1,FHOD3,SLC6A11,LRIG1,ADAM12,GRIP1,PRDM16,GPM6B,NTRK2,SLC4A4,NCKAP5,DGKB,PTN,NRCAM,SLC39A12,PTPRZ1,NPAS3,SOX5,TRPS1 |
1.777e-03 | -6.33 | pleura-mesothelioma | COSMIC cancer mutations | pleura-mesothelioma | 4189 | 22 | 16828 | 49 |
PREX1,LRIG1,ADAM12,PRDM16,RORA,GPM6B,ITPR2,GRK5,USP6NL,SNTB1,FARP1,CTNND2,PTPRZ1,LPIN2,FKBP5,SOX5,TRPS1,NTRK2,PREX2,MSI2,DGKB,QKI |
1.808e-03 | -6.32 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 39 | 16828 | 49 |
SLC4A4,MSI2,PREX2,NTRK2,NRCAM,PTN,QKI,DGKB,LPIN2,SLC39A12,PTPRZ1,RFX4,TRPS1,SOX5,NPAS3,SLC13A5,FKBP5,ITPK1,USP6NL,COL11A1,GRK5,GPC5,ITPR2,CTNND2,FARP1,TNS3,APOA1,EGF,SNTB1,ADAM12,LRIG1,FGFRL1,FHOD3,PREX1,GPM6B,NFIA,RORA,GRIP1,PRDM16 |
1.808e-03 | -6.32 | nucleoside-triphosphatase regulator activity | molecular function | GO:0060589 | 491 | 6 | 18094 | 48 |
PREX2,PREX1,USP6NL,ADGRB3,EGF,FARP1 |
1.808e-03 | -6.32 | GTPase regulator activity | molecular function | GO:0030695 | 491 | 6 | 18094 | 48 |
EGF,PREX1,USP6NL,ADGRB3,FARP1,PREX2 |
1.828e-03 | -6.30 | RhoGEF | smart domains | SM00325 | 68 | 3 | 9717 | 35 |
PREX1,PREX2,FARP1 |
1.831e-03 | -6.30 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 39 | 16828 | 49 |
APOA1,EGF,SNTB1,CTNND2,FARP1,TNS3,GPC5,ITPR2,USP6NL,ITPK1,COL11A1,GRK5,RORA,GRIP1,PRDM16,GPM6B,NFIA,FHOD3,FGFRL1,PREX1,ADAM12,LRIG1,QKI,DGKB,NRCAM,PTN,NTRK2,SLC4A4,MSI2,PREX2,NPAS3,FKBP5,SLC13A5,RFX4,SOX5,TRPS1,SLC39A12,PTPRZ1,LPIN2 |
1.900e-03 | -6.27 | DH_2 | prosite domains | PS50010 | 70 | 3 | 12186 | 43 |
PREX1,FARP1,PREX2 |
1.909e-03 | -6.26 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 12 | 16828 | 49 |
NRCAM,CTNND2,FARP1,DGKB,QKI,RORA,PREX2,ADAM12,COL11A1,SLC39A12,PTPRZ1,FHOD3 |
1.909e-03 | -6.26 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 12 | 16828 | 49 |
QKI,DGKB,CTNND2,FARP1,NRCAM,COL11A1,PREX2,RORA,FHOD3,SLC39A12,PTPRZ1,ADAM12 |
1.913e-03 | -6.26 | human chr6q12-q13 | chromosome location | human chr6q12-q13 | 1 | 1 | 26134 | 50 |
ADGRB3 |
1.925e-03 | -6.25 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 29 | 16828 | 49 |
FGFRL1,FHOD3,PREX1,ADAM12,LRIG1,RORA,PRDM16,NFIA,GPC5,ITPR2,COL11A1,ITPK1,GRK5,EGF,SNTB1,FARP1,CTNND2,TNS3,PTPRZ1,LPIN2,SLC13A5,RFX4,SOX5,NTRK2,ZBTB20,SLC4A4,PREX2,NCKAP5,NRCAM |
1.925e-03 | -6.25 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 29 | 16828 | 49 |
SLC13A5,SOX5,RFX4,PTPRZ1,LPIN2,NCKAP5,NRCAM,ZBTB20,NTRK2,PREX2,SLC4A4,PRDM16,RORA,NFIA,PREX1,FGFRL1,FHOD3,LRIG1,ADAM12,SNTB1,EGF,TNS3,CTNND2,FARP1,ITPR2,GPC5,GRK5,ITPK1,COL11A1 |
1.943e-03 | -6.24 | TSSK2 (testis specific serine kinase 2) | protein interactions | 23617 | 26 | 2 | 19454 | 49 |
FKBP5,APOA1 |
1.952e-03 | -6.24 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 11 | 18204 | 50 |
ADGRB3,ADAM12,QKI,TRPS1,PTPRZ1,SOX5,GPM6B,PTN,SLC39A12,EGF,NTRK2 |
1.957e-03 | -6.24 | bone-femur-other-chondroblastoma | COSMIC cancer mutations | bone-femur-other-chondroblastoma | 183 | 4 | 16828 | 49 |
GPC5,PREX1,NCKAP5,SNTB1 |
2.095e-03 | -6.17 | MBNL2 (muscleblind like splicing regulator 2) | protein interactions | 10150 | 27 | 2 | 19454 | 49 |
MSI2,QKI |
2.127e-03 | -6.15 | large_cell | COSMIC cancer mutations | large_cell | 14845 | 49 | 16828 | 49 |
GPC5,USP6NL,SORCS2,APOA1,CTNND2,FARP1,NHSL1,SLC1A2,SLC1A3,CTBP1,FHOD3,ADAM12,SLC6A11,ELOVL2,LRIG1,RORA,GRIP1,GPM6B,AQP4,ZBTB20,MSI2,PREX2,QKI,NCKAP5,DGKB,NRCAM,PTN,PTPRZ1,LPIN2,FKBP5,RFX4,TRPS1,ITPR2,ITPK1,COL11A1,GRK5,EGF,SNTB1,TNS3,FGFRL1,PREX1,PRDM16,NFIA,NTRK2,SLC4A4,SLC39A12,NPAS3,SLC13A5,SOX5 |
2.130e-03 | -6.15 | L-glutamate transmembrane transport | biological process | GO:0015813 | 25 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
2.146e-03 | -6.14 | synapse organization | biological process | GO:0050808 | 333 | 5 | 18204 | 50 |
FARP1,NFIA,CTNND2,NRCAM,ADGRB3 |
2.149e-03 | -6.14 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 11 | 16828 | 49 |
PRDM16,NCKAP5,GRIP1,SNTB1,FARP1,TNS3,GPC5,FHOD3,SLC39A12,COL11A1,GRK5 |
2.161e-03 | -6.14 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 7 | 18204 | 50 |
NRCAM,NTRK2,SLC39A12,PTN,ADGRB3,PREX1,USP6NL |
2.181e-03 | -6.13 | Glutamate Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-210500 | 24 | 2 | 10285 | 30 |
SLC1A3,SLC1A2 |
2.203e-03 | -6.12 | lung-carcinoma | COSMIC cancer mutations | lung-carcinoma | 4255 | 22 | 16828 | 49 |
GPM6B,PRDM16,RORA,LRIG1,ADAM12,PREX1,CTNND2,FARP1,SNTB1,GRK5,USP6NL,ITPR2,TRPS1,SOX5,FKBP5,LPIN2,PTPRZ1,DGKB,QKI,MSI2,PREX2,NTRK2 |
2.214e-03 | -6.11 | postsynaptic density membrane | cellular component | GO:0098839 | 101 | 3 | 19108 | 49 |
NRCAM,ADGRB3,SORCS2 |
2.226e-03 | -6.11 | membrane | cellular component | GO:0016020 | 9220 | 34 | 19108 | 49 |
LRIG1,APOA1,SLC4A4,ITPK1,GPM6B,AQP4,FGFRL1,PREX1,GRK5,NTRK2,SLC13A5,SORCS2,SNTB1,SLC6A11,USP6NL,FKBP5,CTNND2,ITPR2,SLC1A3,SLC39A12,GPC5,SLC1A2,FARP1,PTN,PTPRZ1,DGKB,GRIP1,ADAM12,ADGRB3,NRCAM,ELOVL2,LPIN2,PREX2,EGF |
2.253e-03 | -6.10 | EGF (epidermal growth factor) | protein interactions | 1950 | 28 | 2 | 19454 | 49 |
ADAM12,EGF |
2.253e-03 | -6.10 | RCOR2 (REST corepressor 2) | protein interactions | 283248 | 28 | 2 | 19454 | 49 |
PRDM16,CTBP1 |
2.287e-03 | -6.08 | NS-malignant_melanoma | COSMIC cancer mutations | NS-malignant_melanoma | 3420 | 19 | 16828 | 49 |
COL11A1,ITPK1,GRK5,PREX2,GPC5,ITPR2,CTNND2,TNS3,DGKB,SNTB1,NCKAP5,LRIG1,ELOVL2,PTPRZ1,SLC39A12,RFX4,SLC13A5,PRDM16,GRIP1 |
2.362e-03 | -6.05 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 48 | 16828 | 49 |
SLC39A12,NPAS3,SLC13A5,SOX5,NTRK2,SLC4A4,PREX1,FGFRL1,PRDM16,NFIA,ITPR2,GRK5,ITPK1,COL11A1,SNTB1,EGF,TNS3,PTPRZ1,LPIN2,FKBP5,TRPS1,RFX4,ZBTB20,PREX2,DGKB,NCKAP5,QKI,NRCAM,PTN,CTBP1,FHOD3,SLC6A11,LRIG1,ELOVL2,ADAM12,GRIP1,RORA,GPM6B,AQP4,GPC5,SORCS2,USP6NL,APOA1,SLC1A3,CTNND2,SLC1A2,FARP1,NHSL1 |
2.366e-03 | -6.05 | amino acid transmembrane transporter activity | molecular function | GO:0015171 | 100 | 3 | 18094 | 48 |
SLC1A2,SLC1A3,SLC6A11 |
2.398e-03 | -6.03 | amino acid transmembrane transport | biological process | GO:0003333 | 97 | 3 | 18204 | 50 |
SLC1A2,SLC1A3,SLC6A11 |
2.440e-03 | -6.02 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 11 | 16828 | 49 |
COL11A1,SLC4A4,GPC5,FARP1,CTNND2,DGKB,NCKAP5,EGF,FHOD3,TRPS1,PRDM16 |
2.448e-03 | -6.01 | DH_1 | prosite domains | PS00741 | 21 | 2 | 12186 | 43 |
PREX1,PREX2 |
2.448e-03 | -6.01 | DEP | prosite domains | PS50186 | 21 | 2 | 12186 | 43 |
PREX2,PREX1 |
2.519e-03 | -5.98 | Dynlt1 (dynein light chain Tctex-type 1) | protein interactions | 83462 | 1 | 1 | 19454 | 49 |
NTRK2 |
2.519e-03 | -5.98 | Apob (apolipoprotein B) | protein interactions | 238055 | 1 | 1 | 19454 | 49 |
APOA1 |
2.519e-03 | -5.98 | Syf2 (SYF2 homolog, RNA splicing factor (S. cerevisiae)) | protein interactions | 68592 | 1 | 1 | 19454 | 49 |
GRIP1 |
2.519e-03 | -5.98 | E1A (E1A) | protein interactions | 2958468 | 1 | 1 | 19454 | 49 |
CTBP1 |
2.519e-03 | -5.98 | C1QL2 (complement C1q like 2) | protein interactions | 165257 | 1 | 1 | 19454 | 49 |
ADGRB3 |
2.519e-03 | -5.98 | Bdnf (brain derived neurotrophic factor) | protein interactions | 12064 | 1 | 1 | 19454 | 49 |
NTRK2 |
2.519e-03 | -5.98 | ERVK-10 (endogenous retrovirus group K member 10) | protein interactions | 100616101 | 1 | 1 | 19454 | 49 |
APOA1 |
2.519e-03 | -5.98 | SNCA (synuclein alpha) | protein interactions | 282857 | 1 | 1 | 19454 | 49 |
GRK5 |
2.519e-03 | -5.98 | HDAC2 (histone deacetylase 2) | protein interactions | 395635 | 1 | 1 | 19454 | 49 |
PRDM16 |
2.519e-03 | -5.98 | MSB4 (Rab GTPase-activating protein MSB4) | protein interactions | 854037 | 1 | 1 | 19454 | 49 |
USP6NL |
2.536e-03 | -5.98 | DEP | smart domains | SM00049 | 21 | 2 | 9717 | 35 |
PREX2,PREX1 |
2.550e-03 | -5.97 | non_small_cell_carcinoma | COSMIC cancer mutations | non_small_cell_carcinoma | 5198 | 25 | 16828 | 49 |
SNTB1,FARP1,CTNND2,SLC1A3,ITPR2,USP6NL,GRK5,RORA,PRDM16,GPM6B,FHOD3,PREX1,ADAM12,LRIG1,QKI,DGKB,NTRK2,PREX2,MSI2,FKBP5,NPAS3,SOX5,TRPS1,PTPRZ1,LPIN2 |
2.550e-03 | -5.97 | lung-carcinoma-non_small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-non_small_cell_carcinoma | 5198 | 25 | 16828 | 49 |
SOX5,TRPS1,FKBP5,NPAS3,LPIN2,PTPRZ1,QKI,DGKB,PREX2,MSI2,NTRK2,GPM6B,RORA,PRDM16,ADAM12,LRIG1,FHOD3,PREX1,FARP1,CTNND2,SLC1A3,SNTB1,USP6NL,GRK5,ITPR2 |
2.587e-03 | -5.96 | regulation of developmental process | biological process | GO:0050793 | 2540 | 15 | 18204 | 50 |
EGF,SOX5,PTPRZ1,QKI,RORA,ADGRB3,NRCAM,NTRK2,SLC39A12,PTN,GPM6B,TRPS1,ADAM12,PREX1,GRIP1 |
2.614e-03 | -5.95 | regulation of dendrite development | biological process | GO:0050773 | 100 | 3 | 18204 | 50 |
PREX1,ADGRB3,PTN |
2.653e-03 | -5.93 | inositol-1,3,4-trisphosphate 6-kinase activity | molecular function | GO:0052725 | 1 | 1 | 18094 | 48 |
ITPK1 |
2.653e-03 | -5.93 | inositol-3,4,6-trisphosphate 1-kinase activity | molecular function | GO:0052835 | 1 | 1 | 18094 | 48 |
ITPK1 |
2.653e-03 | -5.93 | brain-derived neurotrophic factor receptor activity | molecular function | GO:0060175 | 1 | 1 | 18094 | 48 |
NTRK2 |
2.653e-03 | -5.93 | internal N(7)-methylguanine-containing RNA reader activity | molecular function | GO:0160089 | 1 | 1 | 18094 | 48 |
QKI |
2.653e-03 | -5.93 | inositol tetrakisphosphate 1-kinase activity | molecular function | GO:0047325 | 1 | 1 | 18094 | 48 |
ITPK1 |
2.653e-03 | -5.93 | inositol-1,3,4-trisphosphate 5-kinase activity | molecular function | GO:0052726 | 1 | 1 | 18094 | 48 |
ITPK1 |
2.700e-03 | -5.91 | InsP(3)kin_ATP-grasp | interpro domains | IPR040464 | 1 | 1 | 18521 | 50 |
ITPK1 |
2.700e-03 | -5.91 | C1_DGKbeta_rpt2 | interpro domains | IPR047470 | 1 | 1 | 18521 | 50 |
DGKB |
2.700e-03 | -5.91 | Na/ntran_symport_GABA_GAT3 | interpro domains | IPR002982 | 1 | 1 | 18521 | 50 |
SLC6A11 |
2.700e-03 | -5.91 | Rex2_DEP_1 | interpro domains | IPR037367 | 1 | 1 | 18521 | 50 |
PREX2 |
2.700e-03 | -5.91 | PRDM16_PR-SET | interpro domains | IPR044410 | 1 | 1 | 18521 | 50 |
PRDM16 |
2.700e-03 | -5.91 | NTRK2 | interpro domains | IPR020455 | 1 | 1 | 18521 | 50 |
NTRK2 |
2.700e-03 | -5.91 | C1_DGKbeta-like_rpt1 | interpro domains | IPR047471 | 1 | 1 | 18521 | 50 |
DGKB |
2.700e-03 | -5.91 | Inositol_tetrakis-P_1-kinase | interpro domains | IPR008656 | 1 | 1 | 18521 | 50 |
ITPK1 |
2.700e-03 | -5.91 | Quaking_NLS | interpro domains | IPR032367 | 1 | 1 | 18521 | 50 |
QKI |
2.700e-03 | -5.91 | TRPS1 | interpro domains | IPR028440 | 1 | 1 | 18521 | 50 |
TRPS1 |
2.700e-03 | -5.91 | ELOVL2 | interpro domains | IPR033680 | 1 | 1 | 18521 | 50 |
ELOVL2 |
2.700e-03 | -5.91 | ITPK1_N | interpro domains | IPR041429 | 1 | 1 | 18521 | 50 |
ITPK1 |
2.700e-03 | -5.91 | STAR_dimer | interpro domains | IPR032377 | 1 | 1 | 18521 | 50 |
QKI |
2.700e-03 | -5.91 | Pro-epidermal_GF | interpro domains | IPR016317 | 1 | 1 | 18521 | 50 |
EGF |
2.747e-03 | -5.90 | trans-synaptic signaling by neuropeptide | biological process | GO:0099540 | 1 | 1 | 18204 | 50 |
NTRK2 |
2.747e-03 | -5.90 | trans-synaptic signaling by neuropeptide, modulating synaptic transmission | biological process | GO:0099551 | 1 | 1 | 18204 | 50 |
NTRK2 |
2.759e-03 | -5.89 | Effects of PIP2 hydrolysis | REACTOME pathways | R-HSA-114508 | 27 | 2 | 10285 | 30 |
DGKB,ITPR2 |
2.764e-03 | -5.89 | - | gene3d domains | 1.20.5.4010 | 1 | 1 | 14470 | 40 |
QKI |
2.764e-03 | -5.89 | - | gene3d domains | 3.40.50.11370 | 1 | 1 | 14470 | 40 |
ITPK1 |
2.764e-03 | -5.89 | - | gene3d domains | 1.20.5.20 | 1 | 1 | 14470 | 40 |
APOA1 |
2.764e-03 | -5.89 | - | gene3d domains | 6.10.140.380 | 1 | 1 | 14470 | 40 |
APOA1 |
2.764e-03 | -5.89 | - | gene3d domains | 3.30.1490.220 | 1 | 1 | 14470 | 40 |
ITPK1 |
2.783e-03 | -5.88 | Transmembrane transport of small molecules | REACTOME pathways | R-HSA-382551 | 677 | 7 | 10285 | 30 |
SLC4A4,SLC6A11,SLC1A3,AQP4,APOA1,SLC13A5,SLC1A2 |
2.810e-03 | -5.87 | Ins134_P3_kin | pfam domains | PF05770 | 1 | 1 | 17795 | 50 |
ITPK1 |
2.810e-03 | -5.87 | Ins134_P3_kin_N | pfam domains | PF17927 | 1 | 1 | 17795 | 50 |
ITPK1 |
2.810e-03 | -5.87 | STAR_dimer | pfam domains | PF16544 | 1 | 1 | 17795 | 50 |
QKI |
2.810e-03 | -5.87 | Quaking_NLS | pfam domains | PF16551 | 1 | 1 | 17795 | 50 |
QKI |
2.823e-03 | -5.87 | TBR1 (T-box brain transcription factor 1) | protein interactions | 10716 | 112 | 3 | 19454 | 49 |
SOX5,TRPS1,NFIA |
2.843e-03 | -5.86 | regulation of neural precursor cell proliferation | biological process | GO:2000177 | 103 | 3 | 18204 | 50 |
PTN,PTPRZ1,EGF |
2.863e-03 | -5.86 | myoblast fusion | biological process | GO:0007520 | 29 | 2 | 18204 | 50 |
ADGRB3,ADAM12 |
2.866e-03 | -5.85 | beta-catenin binding | molecular function | GO:0008013 | 107 | 3 | 18094 | 48 |
GRIP1,RORA,CTNND2 |
2.925e-03 | -5.83 | lymph_node | COSMIC cancer mutations | lymph_node | 1703 | 12 | 16828 | 49 |
SLC1A3,CTNND2,GRK5,COL11A1,SORCS2,ITPK1,NTRK2,ITPR2,GPC5,TRPS1,SOX5,FHOD3 |
2.945e-03 | -5.83 | regulation of cell junction assembly | biological process | GO:1901888 | 217 | 4 | 18204 | 50 |
GPM6B,FARP1,ADGRB3,NTRK2 |
2.990e-03 | -5.81 | tube development | biological process | GO:0035295 | 903 | 8 | 18204 | 50 |
QKI,RORA,NFIA,ITPK1,EGF,SLC39A12,NTRK2,NRCAM |
3.062e-03 | -5.79 | L-glutamate import | biological process | GO:0051938 | 30 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
3.078e-03 | -5.78 | Phosphatidylinositol signaling system | KEGG pathways | ko04070 | 97 | 3 | 7161 | 22 |
ITPR2,ITPK1,DGKB |
3.078e-03 | -5.78 | Phosphatidylinositol signaling system | KEGG pathways | hsa04070 | 97 | 3 | 7161 | 22 |
DGKB,ITPR2,ITPK1 |
3.089e-03 | -5.78 | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-squamous_cell_carcinoma | 3507 | 19 | 16828 | 49 |
CTNND2,FARP1,TNS3,NCKAP5,DGKB,COL11A1,SLC4A4,PREX2,GPC5,ZBTB20,NPAS3,SLC13A5,GRIP1,PRDM16,ADAM12,SLC6A11,LRIG1,SLC39A12,PTPRZ1 |
3.095e-03 | -5.78 | guanyl-nucleotide exchange factor activity | molecular function | GO:0005085 | 228 | 4 | 18094 | 48 |
FARP1,EGF,PREX1,PREX2 |
3.104e-03 | -5.78 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 46 | 16828 | 49 |
CTNND2,SLC1A2,FARP1,NHSL1,SLC1A3,APOA1,USP6NL,SORCS2,GPC5,GPM6B,RORA,ADAM12,ELOVL2,LRIG1,CTBP1,FHOD3,PTN,NRCAM,QKI,NCKAP5,DGKB,MSI2,PREX2,ZBTB20,RFX4,TRPS1,FKBP5,LPIN2,PTPRZ1,TNS3,EGF,SNTB1,ITPK1,COL11A1,GRK5,ITPR2,NFIA,PRDM16,FGFRL1,PREX1,SLC4A4,NTRK2,SOX5,NPAS3,SLC13A5,SLC39A12 |
3.249e-03 | -5.73 | bicarbonate transmembrane transporter activity | molecular function | GO:0015106 | 32 | 2 | 18094 | 48 |
SLC4A4,SLC39A12 |
3.252e-03 | -5.73 | AQUAPORIN4 | prints domains | PR02016 | 1 | 1 | 5227 | 17 |
AQP4 |
3.252e-03 | -5.73 | NTKRECEPTOR2 | prints domains | PR01941 | 1 | 1 | 5227 | 17 |
NTRK2 |
3.252e-03 | -5.73 | GAT3TRNSPORT | prints domains | PR01197 | 1 | 1 | 5227 | 17 |
SLC6A11 |
3.312e-03 | -5.71 | HGH1 (HGH1 homolog) | protein interactions | 51236 | 34 | 2 | 19454 | 49 |
FKBP5,PTN |
3.312e-03 | -5.71 | PTPRZ1 (protein tyrosine phosphatase receptor type Z1) | protein interactions | 5803 | 34 | 2 | 19454 | 49 |
PTN,PTPRZ1 |
3.349e-03 | -5.70 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 19 | 16828 | 49 |
FHOD3,SLC39A12,PTPRZ1,LRIG1,FKBP5,PRDM16,SOX5,GPC5,ZBTB20,ITPK1,SORCS2,SLC4A4,COL11A1,PREX2,GRK5,CTNND2,NHSL1,FARP1,TNS3 |
3.371e-03 | -5.69 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 19 | 16828 | 49 |
ZBTB20,GPC5,GRK5,PREX2,SORCS2,ITPK1,COL11A1,SLC4A4,TNS3,CTNND2,FARP1,NHSL1,SLC39A12,PTPRZ1,FHOD3,LRIG1,PRDM16,FKBP5,SOX5 |
3.404e-03 | -5.68 | cellular response to endogenous stimulus | biological process | GO:0071495 | 1135 | 9 | 18204 | 50 |
LPIN2,NTRK2,APOA1,SLC1A3,ITPR2,NFIA,FGFRL1,SOX5,SLC1A2 |
3.434e-03 | -5.67 | Transmission across Chemical Synapses | REACTOME pathways | R-HSA-112315 | 217 | 4 | 10285 | 30 |
SLC6A11,SLC1A3,GRIP1,SLC1A2 |
3.472e-03 | -5.66 | monoatomic ion transmembrane transporter activity | molecular function | GO:0015075 | 752 | 7 | 18094 | 48 |
SLC6A11,SLC1A2,SLC1A3,ITPR2,SLC39A12,SLC4A4,SLC13A5 |
3.479e-03 | -5.66 | transepithelial transport | biological process | GO:0070633 | 32 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
3.479e-03 | -5.66 | positive regulation of ATP metabolic process | biological process | GO:1903580 | 32 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
3.531e-03 | -5.65 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 3 | 16828 | 49 |
PRDM16,GPC5,QKI |
3.588e-03 | -5.63 | nodular | COSMIC cancer mutations | nodular | 1515 | 11 | 16828 | 49 |
EGF,CTNND2,NTRK2,SLC4A4,COL11A1,PREX2,GRK5,NPAS3,FKBP5,PTPRZ1,SLC6A11 |
3.601e-03 | -5.63 | regulation of gliogenesis | biological process | GO:0014013 | 112 | 3 | 18204 | 50 |
PTN,QKI,PTPRZ1 |
3.624e-03 | -5.62 | Transport of inorganic cations/anions and amino acids/oligopeptides | REACTOME pathways | R-HSA-425393 | 107 | 3 | 10285 | 30 |
SLC1A2,SLC1A3,SLC4A4 |
3.652e-03 | -5.61 | circulatory system development | biological process | GO:0072359 | 933 | 8 | 18204 | 50 |
COL11A1,EGF,FHOD3,NRCAM,NTRK2,QKI,RORA,FGFRL1 |
3.688e-03 | -5.60 | CRX (cone-rod homeobox) | protein interactions | 1406 | 252 | 4 | 19454 | 49 |
NFIA,PRDM16,SOX5,TRPS1 |
3.697e-03 | -5.60 | response to auditory stimulus | biological process | GO:0010996 | 33 | 2 | 18204 | 50 |
PTN,SLC1A3 |
3.707e-03 | -5.60 | PTPRB (protein tyrosine phosphatase receptor type B) | protein interactions | 5787 | 36 | 2 | 19454 | 49 |
PTN,NRCAM |
3.758e-03 | -5.58 | plasma membrane bounded cell projection organization | biological process | GO:0120036 | 1152 | 9 | 18204 | 50 |
CTNND2,PREX2,GPM6B,PTN,RFX4,PTPRZ1,NRCAM,SLC39A12,FARP1 |
3.912e-03 | -5.54 | Ig_sub2 | interpro domains | IPR003598 | 239 | 4 | 18521 | 50 |
FGFRL1,NRCAM,LRIG1,NTRK2 |
3.913e-03 | -5.54 | TRNAU1AP (tRNA selenocysteine 1 associated protein 1) | protein interactions | 54952 | 37 | 2 | 19454 | 49 |
QKI,ZBTB20 |
3.979e-03 | -5.53 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 5 | 19108 | 49 |
SLC1A2,FARP1,CTBP1,ADGRB3,NRCAM |
4.021e-03 | -5.52 | PAX9 (paired box 9) | protein interactions | 5083 | 127 | 3 | 19454 | 49 |
NFIA,TRPS1,QKI |
4.043e-03 | -5.51 | postsynaptic specialization membrane | cellular component | GO:0099634 | 125 | 3 | 19108 | 49 |
NRCAM,ADGRB3,SORCS2 |
4.052e-03 | -5.51 | glial cell projection | cellular component | GO:0097386 | 37 | 2 | 19108 | 49 |
SLC1A2,AQP4 |
4.071e-03 | -5.50 | regulation of synapse assembly | biological process | GO:0051963 | 117 | 3 | 18204 | 50 |
NTRK2,ADGRB3,FARP1 |
4.094e-03 | -5.50 | transporter activity | molecular function | GO:0005215 | 1211 | 9 | 18094 | 48 |
SLC6A11,AQP4,SLC1A2,SLC1A3,SLC39A12,ITPR2,SLC4A4,APOA1,SLC13A5 |
4.151e-03 | -5.48 | astrocytoma_Grade_III | COSMIC cancer mutations | astrocytoma_Grade_III | 1544 | 11 | 16828 | 49 |
COL11A1,GRK5,FHOD3,GPC5,SLC39A12,FARP1,TNS3,GRIP1,PRDM16,SNTB1,NCKAP5 |
4.157e-03 | -5.48 | organic substance transport | biological process | GO:0071702 | 1881 | 12 | 18204 | 50 |
SLC13A5,SLC1A3,SLC39A12,SORCS2,NTRK2,GPM6B,GRIP1,SLC6A11,APOA1,SLC4A4,QKI,SLC1A2 |
4.201e-03 | -5.47 | CHD7 (chromodomain helicase DNA binding protein 7) | protein interactions | 55636 | 129 | 3 | 19454 | 49 |
ZBTB20,FKBP5,SOX5 |
4.356e-03 | -5.44 | mesothelioma | COSMIC cancer mutations | mesothelioma | 4477 | 22 | 16828 | 49 |
ADAM12,LPIN2,LRIG1,PTPRZ1,PREX1,GPM6B,SOX5,TRPS1,FKBP5,RORA,PRDM16,USP6NL,MSI2,GRK5,PREX2,ITPR2,NTRK2,CTNND2,FARP1,QKI,DGKB,SNTB1 |
4.386e-03 | -5.43 | TRPS1 (transcriptional repressor GATA binding 1) | protein interactions | 7227 | 131 | 3 | 19454 | 49 |
SOX5,NFIA,CTBP1 |
4.388e-03 | -5.43 | syncytium formation by plasma membrane fusion | biological process | GO:0000768 | 36 | 2 | 18204 | 50 |
ADGRB3,ADAM12 |
4.388e-03 | -5.43 | cell-cell fusion | biological process | GO:0140253 | 36 | 2 | 18204 | 50 |
ADAM12,ADGRB3 |
4.432e-03 | -5.42 | D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis | BIOCYC pathways | HUMAN_PWY-6365 | 2 | 1 | 902 | 2 |
ITPK1 |
4.432e-03 | -5.42 | D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis | BIOCYC pathways | META_PWY-6365 | 2 | 1 | 902 | 2 |
ITPK1 |
4.448e-03 | -5.42 | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | 114 | 3 | 16828 | 49 |
SLC1A2,SOX5,PREX2 |
4.451e-03 | -5.41 | anatomical structure formation involved in morphogenesis | biological process | GO:0048646 | 964 | 8 | 18204 | 50 |
RORA,ADGRB3,ADAM12,COL11A1,SLC39A12,EGF,FHOD3,NRCAM |
4.480e-03 | -5.41 | DCAF11 (DDB1 and CUL4 associated factor 11) | protein interactions | 80344 | 132 | 3 | 19454 | 49 |
CTBP1,GRIP1,LPIN2 |
4.605e-03 | -5.38 | regulation of synapse organization | biological process | GO:0050807 | 246 | 4 | 18204 | 50 |
NRCAM,NTRK2,ADGRB3,FARP1 |
4.605e-03 | -5.38 | positive regulation of neurogenesis | biological process | GO:0050769 | 246 | 4 | 18204 | 50 |
NTRK2,PTPRZ1,QKI,PTN |
4.607e-03 | -5.38 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 27 | 16828 | 49 |
LPIN2,PTPRZ1,TRPS1,RFX4,FKBP5,PREX2,SLC4A4,ZBTB20,NTRK2,NRCAM,SLC6A11,ELOVL2,LRIG1,ADAM12,PREX1,FGFRL1,NFIA,PRDM16,GRIP1,GRK5,COL11A1,ITPR2,GPC5,TNS3,SLC1A3,FARP1,EGF |
4.631e-03 | -5.38 | positive regulation of purine nucleotide metabolic process | biological process | GO:1900544 | 37 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
4.631e-03 | -5.38 | positive regulation of nucleotide metabolic process | biological process | GO:0045981 | 37 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
4.631e-03 | -5.38 | bicarbonate transport | biological process | GO:0015701 | 37 | 2 | 18204 | 50 |
SLC39A12,SLC4A4 |
4.631e-03 | -5.37 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 27 | 16828 | 49 |
FKBP5,RFX4,TRPS1,PTPRZ1,LPIN2,NRCAM,ZBTB20,NTRK2,SLC4A4,PREX2,GRIP1,PRDM16,NFIA,FGFRL1,PREX1,ADAM12,SLC6A11,ELOVL2,LRIG1,EGF,FARP1,TNS3,SLC1A3,GPC5,ITPR2,COL11A1,GRK5 |
4.648e-03 | -5.37 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 25 | 18204 | 50 |
PRDM16,CTBP1,GPC5,SLC1A3,PTN,RFX4,ZBTB20,QKI,ADGRB3,SLC1A2,NTRK2,NRCAM,NFIA,PREX1,GRK5,GRIP1,FARP1,LPIN2,SLC4A4,EGF,APOA1,NPAS3,SOX5,PTPRZ1,RORA |
4.649e-03 | -5.37 | RND3 (Rho family GTPase 3) | protein interactions | 390 | 269 | 4 | 19454 | 49 |
CTBP1,FARP1,SNTB1,USP6NL |
4.672e-03 | -5.37 | AKT2 (AKT serine/threonine kinase 2) | protein interactions | 208 | 134 | 3 | 19454 | 49 |
GRK5,FKBP5,APOA1 |
4.697e-03 | -5.36 | Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways | WikiPathways | WP706 | 162 | 4 | 5310 | 23 |
NTRK2,SLC1A3,RORA,AQP4 |
4.710e-03 | -5.36 | WDR6 (WD repeat domain 6) | protein interactions | 11180 | 270 | 4 | 19454 | 49 |
FKBP5,NTRK2,GRIP1,FARP1 |
4.770e-03 | -5.35 | FOXP1 (forkhead box P1) | protein interactions | 27086 | 135 | 3 | 19454 | 49 |
SOX5,NFIA,CTBP1 |
4.788e-03 | -5.34 | fat cell differentiation | biological process | GO:0045444 | 124 | 3 | 18204 | 50 |
GRK5,CTBP1,PRDM16 |
4.834e-03 | -5.33 | enzyme activator activity | molecular function | GO:0008047 | 599 | 6 | 18094 | 48 |
EGF,ADGRB3,USP6NL,PREX1,PREX2,APOA1 |
4.853e-03 | -5.33 | Glutamatergic synapse | KEGG pathways | ko04724 | 114 | 3 | 7161 | 22 |
ITPR2,SLC1A2,SLC1A3 |
4.853e-03 | -5.33 | Glutamatergic synapse | KEGG pathways | hsa04724 | 114 | 3 | 7161 | 22 |
SLC1A2,ITPR2,SLC1A3 |
4.858e-03 | -5.33 | humerus | COSMIC cancer mutations | humerus | 546 | 6 | 16828 | 49 |
FARP1,SOX5,EGF,NCKAP5,FHOD3,GPC5 |
4.868e-03 | -5.33 | dendrite | cellular component | GO:0030425 | 620 | 6 | 19108 | 49 |
SORCS2,FARP1,GRIP1,NTRK2,PREX1,CTNND2 |
4.872e-03 | -5.32 | EGFR interacts with phospholipase C-gamma | REACTOME pathways | R-HSA-212718 | 36 | 2 | 10285 | 30 |
ITPR2,EGF |
4.873e-03 | -5.32 | PDZ | pfam domains | PF00595 | 122 | 3 | 17795 | 50 |
GRIP1,PREX2,SNTB1 |
4.880e-03 | -5.32 | amino acid import across plasma membrane | biological process | GO:0089718 | 38 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
4.915e-03 | -5.32 | cell projection organization | biological process | GO:0030030 | 1200 | 9 | 18204 | 50 |
SLC39A12,NRCAM,FARP1,CTNND2,RFX4,PTPRZ1,GPM6B,PREX2,PTN |
4.944e-03 | -5.31 | dendritic tree | cellular component | GO:0097447 | 622 | 6 | 19108 | 49 |
PREX1,SORCS2,CTNND2,FARP1,GRIP1,NTRK2 |
4.969e-03 | -5.30 | TBL1X (transducin beta like 1 X-linked) | protein interactions | 6907 | 137 | 3 | 19454 | 49 |
CTBP1,NFIA,SOX5 |
4.977e-03 | -5.30 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 21 | 16828 | 49 |
ELOVL2,CTBP1,FGFRL1,FHOD3,PTPRZ1,AQP4,NFIA,TRPS1,NPAS3,RORA,PRDM16,USP6NL,SORCS2,PREX2,GRK5,CTNND2,NHSL1,SLC1A3,EGF,NCKAP5,DGKB |
5.014e-03 | -5.30 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 4 | 18204 | 50 |
NTRK2,ADGRB3,NRCAM,FARP1 |
5.031e-03 | -5.29 | Fkbp3 (FK506 binding protein 3) | protein interactions | 30795 | 2 | 1 | 19454 | 49 |
CTBP1 |
5.031e-03 | -5.29 | MSB3 (Rab GTPase-activating protein MSB3) | protein interactions | 855423 | 2 | 1 | 19454 | 49 |
USP6NL |
5.031e-03 | -5.29 | BTBD17 (BTB domain containing 17) | protein interactions | 388419 | 2 | 1 | 19454 | 49 |
PRDM16 |
5.134e-03 | -5.27 | syncytium formation | biological process | GO:0006949 | 39 | 2 | 18204 | 50 |
ADAM12,ADGRB3 |
5.134e-03 | -5.27 | cellular response to alkaloid | biological process | GO:0071312 | 39 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
5.231e-03 | -5.25 | myelination | biological process | GO:0042552 | 128 | 3 | 18204 | 50 |
NTRK2,QKI,GPM6B |
5.254e-03 | -5.25 | SDC3 (syndecan 3) | protein interactions | 9672 | 43 | 2 | 19454 | 49 |
PTN,FARP1 |
5.299e-03 | -5.24 | inositol tetrakisphosphate 6-kinase activity | molecular function | GO:0000825 | 2 | 1 | 18094 | 48 |
ITPK1 |
5.377e-03 | -5.23 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 7 | 19108 | 49 |
SORCS2,CTNND2,FARP1,PREX1,NTRK2,GRIP1,SLC1A3 |
5.382e-03 | -5.22 | SNTB2 (syntrophin beta 2) | protein interactions | 6645 | 141 | 3 | 19454 | 49 |
SNTB1,GRIP1,TNS3 |
5.392e-03 | -5.22 | GRIP1/2 | interpro domains | IPR043545 | 2 | 1 | 18521 | 50 |
GRIP1 |
5.392e-03 | -5.22 | Midkine_heparin-bd_GF | interpro domains | IPR000762 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | CtBP | interpro domains | IPR043322 | 2 | 1 | 18521 | 50 |
CTBP1 |
5.392e-03 | -5.22 | MSI_RRM2 | interpro domains | IPR034126 | 2 | 1 | 18521 | 50 |
MSI2 |
5.392e-03 | -5.22 | ZIP4_12_EF-hand | interpro domains | IPR049406 | 2 | 1 | 18521 | 50 |
SLC39A12 |
5.392e-03 | -5.22 | NCKAP5_C | interpro domains | IPR032769 | 2 | 1 | 18521 | 50 |
NCKAP5 |
5.392e-03 | -5.22 | ZIP4_N | interpro domains | IPR041137 | 2 | 1 | 18521 | 50 |
SLC39A12 |
5.392e-03 | -5.22 | PTN/MK_diS_sf | interpro domains | IPR020091 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | Alpha_CARP_receptor-type | interpro domains | IPR041887 | 2 | 1 | 18521 | 50 |
PTPRZ1 |
5.392e-03 | -5.22 | PTN/MK_C_dom | interpro domains | IPR020090 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | Nckap5l | interpro domains | IPR026163 | 2 | 1 | 18521 | 50 |
NCKAP5 |
5.392e-03 | -5.22 | PTN_MK_heparin-bd_GF_CS | interpro domains | IPR020092 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | FHOD1_GBD_N | interpro domains | IPR041387 | 2 | 1 | 18521 | 50 |
FHOD3 |
5.392e-03 | -5.22 | PTN/MK_C_dom_sf | interpro domains | IPR038130 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | PTN/MK_N_dom | interpro domains | IPR020089 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | PTN/MK_N_dom_sf | interpro domains | IPR037122 | 2 | 1 | 18521 | 50 |
PTN |
5.461e-03 | -5.21 | ensheathment of neurons | biological process | GO:0007272 | 130 | 3 | 18204 | 50 |
NTRK2,GPM6B,QKI |
5.461e-03 | -5.21 | axon ensheathment | biological process | GO:0008366 | 130 | 3 | 18204 | 50 |
QKI,GPM6B,NTRK2 |
5.486e-03 | -5.21 | fumarate transport | biological process | GO:0015741 | 2 | 1 | 18204 | 50 |
SLC13A5 |
5.486e-03 | -5.21 | tricarboxylic acid transmembrane transport | biological process | GO:0035674 | 2 | 1 | 18204 | 50 |
SLC13A5 |
5.486e-03 | -5.21 | negative regulation of 3'-UTR-mediated mRNA stabilization | biological process | GO:1905869 | 2 | 1 | 18204 | 50 |
QKI |
5.486e-03 | -5.21 | retrograde transport, plasma membrane to Golgi | biological process | GO:0035526 | 2 | 1 | 18204 | 50 |
USP6NL |
5.486e-03 | -5.21 | dendrite regeneration | biological process | GO:0031104 | 2 | 1 | 18204 | 50 |
PTN |
5.486e-03 | -5.21 | retrograde trans-synaptic signaling by trans-synaptic protein complex | biological process | GO:0098942 | 2 | 1 | 18204 | 50 |
FARP1 |
5.486e-03 | -5.21 | myofibroblast contraction | biological process | GO:1990764 | 2 | 1 | 18204 | 50 |
QKI |
5.521e-03 | -5.20 | Pleiotrophin/Midkine, N-terminal domain | gene3d domains | 2.20.60.10 | 2 | 1 | 14470 | 40 |
PTN |
5.521e-03 | -5.20 | - | gene3d domains | 6.10.250.2260 | 2 | 1 | 14470 | 40 |
GRK5 |
5.545e-03 | -5.19 | neutral L-amino acid transmembrane transporter activity | molecular function | GO:0015175 | 42 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
5.578e-03 | -5.19 | carboxylic acid transmembrane transport | biological process | GO:1905039 | 131 | 3 | 18204 | 50 |
SLC1A3,SLC1A2,SLC13A5 |
5.612e-03 | -5.18 | PTN_MK_C | pfam domains | PF01091 | 2 | 1 | 17795 | 50 |
PTN |
5.612e-03 | -5.18 | NCKAP5 | pfam domains | PF15246 | 2 | 1 | 17795 | 50 |
NCKAP5 |
5.612e-03 | -5.18 | EF-hand_Zip | pfam domains | PF21116 | 2 | 1 | 17795 | 50 |
SLC39A12 |
5.612e-03 | -5.18 | Formin_GBD_N | pfam domains | PF18382 | 2 | 1 | 17795 | 50 |
FHOD3 |
5.612e-03 | -5.18 | PTN_MK_N | pfam domains | PF05196 | 2 | 1 | 17795 | 50 |
PTN |
5.612e-03 | -5.18 | ZIP4_domain | pfam domains | PF18292 | 2 | 1 | 17795 | 50 |
SLC39A12 |
5.621e-03 | -5.18 | skin-ear-malignant_melanoma | COSMIC cancer mutations | skin-ear-malignant_melanoma | 124 | 3 | 16828 | 49 |
FGFRL1,SLC6A11,GRK5 |
5.706e-03 | -5.17 | PH_domain | interpro domains | IPR001849 | 266 | 4 | 18521 | 50 |
PREX1,PREX2,FARP1,SNTB1 |
5.755e-03 | -5.16 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 47 | 16828 | 49 |
NTRK2,SLC4A4,SLC39A12,NPAS3,SLC13A5,SOX5,ITPR2,GRK5,ITPK1,COL11A1,SNTB1,EGF,TNS3,PREX1,FGFRL1,PRDM16,NFIA,ZBTB20,MSI2,PREX2,NCKAP5,DGKB,QKI,NRCAM,PTN,PTPRZ1,LPIN2,FKBP5,TRPS1,GPC5,USP6NL,SORCS2,SLC1A3,CTNND2,FARP1,SLC1A2,NHSL1,CTBP1,FHOD3,SLC6A11,LRIG1,ELOVL2,ADAM12,GRIP1,RORA,GPM6B,AQP4 |
5.755e-03 | -5.16 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 47 | 16828 | 49 |
FGFRL1,PREX1,NFIA,PRDM16,ITPK1,COL11A1,GRK5,ITPR2,TNS3,EGF,SNTB1,SLC39A12,SOX5,NPAS3,SLC13A5,SLC4A4,NTRK2,ADAM12,SLC6A11,LRIG1,ELOVL2,CTBP1,FHOD3,GPM6B,AQP4,RORA,GRIP1,SORCS2,USP6NL,GPC5,CTNND2,SLC1A2,FARP1,NHSL1,SLC1A3,LPIN2,PTPRZ1,TRPS1,FKBP5,MSI2,PREX2,ZBTB20,PTN,NRCAM,QKI,DGKB,NCKAP5 |
5.755e-03 | -5.16 | SOX2 (SRY-box transcription factor 2) | protein interactions | 6657 | 1342 | 9 | 19454 | 49 |
NFIA,APOA1,QKI,MSI2,TRPS1,ITPR2,CTBP1,COL11A1,SOX5 |
5.826e-03 | -5.15 | Signaling by Overexpressed Wild-Type EGFR in Cancer | REACTOME pathways | R-HSA-5638302 | 2 | 1 | 10285 | 30 |
EGF |
5.826e-03 | -5.15 | Inhibition of Signaling by Overexpressed EGFR | REACTOME pathways | R-HSA-5638303 | 2 | 1 | 10285 | 30 |
EGF |
5.859e-03 | -5.14 | GTPase activator activity | molecular function | GO:0005096 | 273 | 4 | 18094 | 48 |
ADGRB3,PREX2,USP6NL,PREX1 |
5.924e-03 | -5.13 | Fatty acid, triacylglycerol, and ketone body metabolism | REACTOME pathways | R-HSA-535734 | 253 | 4 | 10285 | 30 |
ELOVL2,APOA1,RORA,LPIN2 |
5.935e-03 | -5.13 | regulation of protein localization to cell surface | biological process | GO:2000008 | 42 | 2 | 18204 | 50 |
GPM6B,EGF |
5.935e-03 | -5.13 | neuron maturation | biological process | GO:0042551 | 42 | 2 | 18204 | 50 |
NRCAM,ADGRB3 |
5.935e-03 | -5.13 | triglyceride homeostasis | biological process | GO:0070328 | 42 | 2 | 18204 | 50 |
APOA1,RORA |
5.978e-03 | -5.12 | PH-like_dom_sf | interpro domains | IPR011993 | 431 | 5 | 18521 | 50 |
PREX1,PREX2,FARP1,TNS3,SNTB1 |
5.994e-03 | -5.12 | TRIM47 (tripartite motif containing 47) | protein interactions | 91107 | 46 | 2 | 19454 | 49 |
TNS3,CTNND2 |
6.041e-03 | -5.11 | TFAP4 (transcription factor AP-4) | protein interactions | 7023 | 147 | 3 | 19454 | 49 |
PRDM16,CTBP1,NFIA |
6.087e-03 | -5.10 | regulation of cellular component biogenesis | biological process | GO:0044087 | 1016 | 8 | 18204 | 50 |
FARP1,NTRK2,SLC39A12,APOA1,GPM6B,ADGRB3,PREX1,USP6NL |
6.090e-03 | -5.10 | monoatomic ion transmembrane transport | biological process | GO:0034220 | 804 | 7 | 18204 | 50 |
SLC6A11,ITPR2,SLC1A3,SLC39A12,SLC13A5,SLC4A4,SLC1A2 |
6.126e-03 | -5.10 | neuron projection | cellular component | GO:0043005 | 1331 | 9 | 19108 | 49 |
NRCAM,PREX1,CTNND2,GRIP1,SLC1A3,NTRK2,SLC1A2,SORCS2,FARP1 |
6.155e-03 | -5.09 | ATXN1L (ataxin 1 like) | protein interactions | 342371 | 148 | 3 | 19454 | 49 |
SOX5,CTBP1,NFIA |
6.213e-03 | -5.08 | acylglycerol homeostasis | biological process | GO:0055090 | 43 | 2 | 18204 | 50 |
APOA1,RORA |
6.213e-03 | -5.08 | positive regulation of substrate adhesion-dependent cell spreading | biological process | GO:1900026 | 43 | 2 | 18204 | 50 |
APOA1,PREX1 |
6.276e-03 | -5.07 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 28 | 16828 | 49 |
FKBP5,NPAS3,TRPS1,SOX5,PTPRZ1,SLC39A12,LPIN2,NCKAP5,DGKB,ZBTB20,PREX2,SLC4A4,GRIP1,PRDM16,AQP4,FGFRL1,ADAM12,SNTB1,EGF,APOA1,TNS3,FARP1,CTNND2,ITPR2,GPC5,COL11A1,ITPK1,SORCS2 |
6.324e-03 | -5.06 | monoatomic anion transmembrane transporter activity | molecular function | GO:0008509 | 142 | 3 | 18094 | 48 |
SLC6A11,SLC4A4,SLC1A2 |
6.372e-03 | -5.06 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 39 | 16828 | 49 |
SLC39A12,PTPRZ1,LPIN2,NPAS3,FKBP5,SLC13A5,SOX5,RFX4,NTRK2,MSI2,PREX2,SLC4A4,DGKB,NCKAP5,QKI,PREX1,FHOD3,SLC6A11,LRIG1,ELOVL2,ADAM12,GRIP1,PRDM16,RORA,NFIA,ITPR2,GPC5,GRK5,USP6NL,ITPK1,SORCS2,COL11A1,EGF,TNS3,SLC1A3,CTNND2,FARP1,NHSL1,SLC1A2 |
6.372e-03 | -5.06 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 39 | 16828 | 49 |
SLC39A12,PTPRZ1,LPIN2,NPAS3,SLC13A5,FKBP5,SOX5,RFX4,NTRK2,MSI2,PREX2,SLC4A4,NCKAP5,DGKB,QKI,PREX1,FHOD3,SLC6A11,ELOVL2,LRIG1,ADAM12,PRDM16,GRIP1,RORA,NFIA,ITPR2,GPC5,GRK5,USP6NL,ITPK1,SORCS2,COL11A1,EGF,TNS3,SLC1A3,CTNND2,NHSL1,FARP1,SLC1A2 |
6.387e-03 | -5.05 | KDM2B (lysine demethylase 2B) | protein interactions | 84678 | 150 | 3 | 19454 | 49 |
NFIA,CTBP1,SOX5 |
6.388e-03 | -5.05 | Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB) | gene3d domains | 2.30.29.30 | 431 | 5 | 14470 | 40 |
SNTB1,FARP1,PREX1,PREX2,TNS3 |
6.402e-03 | -5.05 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 12 | 16828 | 49 |
PTPRZ1,FHOD3,CTBP1,SLC6A11,ADAM12,PRDM16,FKBP5,NTRK2,PREX2,USP6NL,SORCS2,APOA1 |
6.420e-03 | -5.05 | response to wounding | biological process | GO:0009611 | 431 | 5 | 18204 | 50 |
ITPK1,NFIA,DGKB,SLC1A3,SLC1A2 |
6.429e-03 | -5.05 | extremity | COSMIC cancer mutations | extremity | 1876 | 12 | 16828 | 49 |
ADAM12,SLC6A11,CTBP1,FHOD3,PTPRZ1,FKBP5,PRDM16,SORCS2,USP6NL,PREX2,NTRK2,APOA1 |
6.441e-03 | -5.04 | sodium ion transmembrane transport | biological process | GO:0035725 | 138 | 3 | 18204 | 50 |
SLC4A4,SLC13A5,SLC6A11 |
6.441e-03 | -5.04 | regulation of generation of precursor metabolites and energy | biological process | GO:0043467 | 138 | 3 | 18204 | 50 |
ZBTB20,SLC4A4,PRDM16 |
6.495e-03 | -5.04 | PTNMIDKINE | prints domains | PR00269 | 2 | 1 | 5227 | 17 |
PTN |
6.498e-03 | -5.04 | positive regulation of bone mineralization | biological process | GO:0030501 | 44 | 2 | 18204 | 50 |
PTN,GPM6B |
6.576e-03 | -5.02 | SP7 (Sp7 transcription factor) | protein interactions | 121340 | 297 | 4 | 19454 | 49 |
QKI,SOX5,TRPS1,NFIA |
6.645e-03 | -5.01 | 1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3) | BIOCYC pathways | HUMAN_PWY-6554 | 3 | 1 | 902 | 2 |
ITPK1 |
6.645e-03 | -5.01 | D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis | BIOCYC pathways | META_PWY-6366 | 3 | 1 | 902 | 2 |
ITPK1 |
6.645e-03 | -5.01 | docosahexaenoate biosynthesis IV (4-desaturase, mammals) | BIOCYC pathways | META_PWY-7727 | 3 | 1 | 902 | 2 |
ELOVL2 |
6.645e-03 | -5.01 | D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis | BIOCYC pathways | HUMAN_PWY-6366 | 3 | 1 | 902 | 2 |
ITPK1 |
6.645e-03 | -5.01 | (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis II (4-desaturase) | BIOCYC pathways | META_PWY-7728 | 3 | 1 | 902 | 2 |
ELOVL2 |
6.645e-03 | -5.01 | docosahexaenoate biosynthesis III (mammals) | BIOCYC pathways | HUMAN_PWY-7606 | 3 | 1 | 902 | 2 |
ELOVL2 |
6.670e-03 | -5.01 | blood vessel morphogenesis | biological process | GO:0048514 | 435 | 5 | 18204 | 50 |
QKI,RORA,NRCAM,NTRK2,EGF |
6.676e-03 | -5.01 | inorganic cation transmembrane transport | biological process | GO:0098662 | 618 | 6 | 18204 | 50 |
SLC6A11,SLC4A4,SLC39A12,SLC1A3,ITPR2,SLC13A5 |
6.702e-03 | -5.01 | neurotransmitter transport | biological process | GO:0006836 | 140 | 3 | 18204 | 50 |
SLC6A11,SLC1A2,SLC1A3 |
6.833e-03 | -4.99 | perikaryon | cellular component | GO:0043204 | 151 | 3 | 19108 | 49 |
GRIP1,CTNND2,SORCS2 |
6.890e-03 | -4.98 | learning or memory | biological process | GO:0007611 | 276 | 4 | 18204 | 50 |
PTPRZ1,PTN,ADGRB3,NTRK2 |
6.904e-03 | -4.98 | transcription corepressor binding | molecular function | GO:0001222 | 47 | 2 | 18094 | 48 |
CTBP1,RORA |
6.969e-03 | -4.97 | monoatomic anion transmembrane transport | biological process | GO:0098656 | 142 | 3 | 18204 | 50 |
SLC4A4,SLC1A2,SLC1A3 |
6.969e-03 | -4.97 | positive regulation of small molecule metabolic process | biological process | GO:0062013 | 142 | 3 | 18204 | 50 |
SLC4A4,APOA1,ZBTB20 |
7.045e-03 | -4.96 | D_2_HYDROXYACID_DH_1 | prosite domains | PS00065 | 2 | 1 | 12186 | 43 |
CTBP1 |
7.045e-03 | -4.96 | PTN_MK_1 | prosite domains | PS00619 | 2 | 1 | 12186 | 43 |
PTN |
7.045e-03 | -4.96 | PTN_MK_2 | prosite domains | PS00620 | 2 | 1 | 12186 | 43 |
PTN |
7.049e-03 | -4.95 | ZNF516 (zinc finger protein 516) | protein interactions | 9658 | 50 | 2 | 19454 | 49 |
CTBP1,PRDM16 |
7.065e-03 | -4.95 | regulation of GTPase activity | biological process | GO:0043087 | 278 | 4 | 18204 | 50 |
PREX2,USP6NL,PREX1,NTRK2 |
7.084e-03 | -4.95 | regulation of myelination | biological process | GO:0031641 | 46 | 2 | 18204 | 50 |
PTPRZ1,PTN |
7.096e-03 | -4.95 | NRAS (NRAS proto-oncogene, GTPase) | protein interactions | 4893 | 683 | 6 | 19454 | 49 |
SLC39A12,USP6NL,FGFRL1,PREX1,FARP1,SLC1A3 |
7.119e-03 | -4.94 | oligoastrocytoma_Grade_III | COSMIC cancer mutations | oligoastrocytoma_Grade_III | 263 | 4 | 16828 | 49 |
PREX2,SOX5,SLC1A2,GRIP1 |
7.191e-03 | -4.93 | PTN | smart domains | SM00193 | 2 | 1 | 9717 | 35 |
PTN |
7.211e-03 | -4.93 | Retinoid metabolism and transport | REACTOME pathways | R-HSA-975634 | 44 | 2 | 10285 | 30 |
GPC5,APOA1 |
7.213e-03 | -4.93 | system process | biological process | GO:0003008 | 2015 | 12 | 18204 | 50 |
SLC1A3,NRCAM,NTRK2,COL11A1,PTN,SLC4A4,SNTB1,AQP4,SLC1A2,ADGRB3,LRIG1,PTPRZ1 |
7.272e-03 | -4.92 | Ig_3 | pfam domains | PF13927 | 141 | 3 | 17795 | 50 |
NRCAM,FGFRL1,LRIG1 |
7.312e-03 | -4.92 | metal ion transport | biological process | GO:0030001 | 630 | 6 | 18204 | 50 |
SLC6A11,SLC39A12,SLC1A3,ITPR2,SLC13A5,SLC4A4 |
7.400e-03 | -4.91 | skin-face-malignant_melanoma | COSMIC cancer mutations | skin-face-malignant_melanoma | 137 | 3 | 16828 | 49 |
PREX2,SLC6A11,ADAM12 |
7.496e-03 | -4.89 | ITGAV (integrin subunit alpha V) | protein interactions | 3685 | 159 | 3 | 19454 | 49 |
PTN,COL11A1,PTPRZ1 |
7.538e-03 | -4.89 | SMPDL3A (sphingomyelin phosphodiesterase acid like 3A) | protein interactions | 10924 | 3 | 1 | 19454 | 49 |
APOA1 |
7.538e-03 | -4.89 | IL34 (interleukin 34) | protein interactions | 146433 | 3 | 1 | 19454 | 49 |
PTPRZ1 |
7.538e-03 | -4.89 | Lep (leptin) | protein interactions | 16846 | 3 | 1 | 19454 | 49 |
APOA1 |
7.538e-03 | -4.89 | Eif1b (eukaryotic translation initiation factor 1B) | protein interactions | 68969 | 3 | 1 | 19454 | 49 |
GRIP1 |
7.538e-03 | -4.89 | APOL1 (apolipoprotein L1) | protein interactions | 8542 | 3 | 1 | 19454 | 49 |
APOA1 |
7.538e-03 | -4.89 | E1A (control protein E1A;control protein E1A 243R) | protein interactions | 2652980 | 3 | 1 | 19454 | 49 |
CTBP1 |
7.538e-03 | -4.89 | cbx2.L (chromobox 2 L homeolog) | protein interactions | 398110 | 3 | 1 | 19454 | 49 |
CTBP1 |
7.538e-03 | -4.89 | FAM83C (family with sequence similarity 83 member C) | protein interactions | 128876 | 3 | 1 | 19454 | 49 |
APOA1 |
7.605e-03 | -4.88 | ABCA1 (ATP binding cassette subfamily A member 1) | protein interactions | 19 | 52 | 2 | 19454 | 49 |
SNTB1,APOA1 |
7.626e-03 | -4.88 | NEK6 (NIMA related kinase 6) | protein interactions | 10783 | 160 | 3 | 19454 | 49 |
PTN,GRIP1,PRDM16 |
7.626e-03 | -4.88 | SOX5 (SRY-box transcription factor 5) | protein interactions | 6660 | 160 | 3 | 19454 | 49 |
NFIA,SOX5,TRPS1 |
7.631e-03 | -4.88 | human chr8q23.3 | chromosome location | human chr8q23.3 | 4 | 1 | 26134 | 50 |
TRPS1 |
7.646e-03 | -4.87 | monoatomic cation transmembrane transport | biological process | GO:0098655 | 636 | 6 | 18204 | 50 |
SLC6A11,SLC13A5,SLC39A12,ITPR2,SLC1A3,SLC4A4 |
7.700e-03 | -4.87 | astrocytoma_Grade_I | COSMIC cancer mutations | astrocytoma_Grade_I | 139 | 3 | 16828 | 49 |
PRDM16,QKI,GPC5 |
7.700e-03 | -4.87 | skin-lower_leg-malignant_melanoma | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma | 139 | 3 | 16828 | 49 |
ADAM12,SLC6A11,PREX2 |
7.938e-03 | -4.84 | inositol 1,4,5-trisphosphate-gated calcium channel activity | molecular function | GO:0005220 | 3 | 1 | 18094 | 48 |
ITPR2 |
7.938e-03 | -4.84 | high-density lipoprotein particle receptor binding | molecular function | GO:0070653 | 3 | 1 | 18094 | 48 |
APOA1 |
7.938e-03 | -4.84 | cysteine transmembrane transporter activity | molecular function | GO:0033229 | 3 | 1 | 18094 | 48 |
SLC1A2 |
7.938e-03 | -4.84 | taurine:sodium symporter activity | molecular function | GO:0005369 | 3 | 1 | 18094 | 48 |
SLC6A11 |
7.938e-03 | -4.84 | sodium:dicarboxylate symporter activity | molecular function | GO:0017153 | 3 | 1 | 18094 | 48 |
SLC13A5 |
8.078e-03 | -4.82 | Na/sul_symport_CS | interpro domains | IPR031312 | 3 | 1 | 18521 | 50 |
SLC13A5 |
8.078e-03 | -4.82 | ROR_rcpt | interpro domains | IPR003079 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | LIPIN | interpro domains | IPR026058 | 3 | 1 | 18521 | 50 |
LPIN2 |
8.078e-03 | -4.82 | Lipin_mid | interpro domains | IPR031703 | 3 | 1 | 18521 | 50 |
LPIN2 |
8.078e-03 | -4.82 | Lipin_N | interpro domains | IPR007651 | 3 | 1 | 18521 | 50 |
LPIN2 |
8.078e-03 | -4.82 | LNS2 | interpro domains | IPR013209 | 3 | 1 | 18521 | 50 |
LPIN2 |
8.078e-03 | -4.82 | Myelin_PLP_CS | interpro domains | IPR018237 | 3 | 1 | 18521 | 50 |
GPM6B |
8.078e-03 | -4.82 | NTRK_LRRCT | interpro domains | IPR031635 | 3 | 1 | 18521 | 50 |
NTRK2 |
8.078e-03 | -4.82 | D-isomer_DH_CS1 | interpro domains | IPR029752 | 3 | 1 | 18521 | 50 |
CTBP1 |
8.078e-03 | -4.82 | NTRK | interpro domains | IPR020777 | 3 | 1 | 18521 | 50 |
NTRK2 |
8.078e-03 | -4.82 | AGRB_N | interpro domains | IPR043838 | 3 | 1 | 18521 | 50 |
ADGRB3 |
8.078e-03 | -4.82 | Tensin-like_SH2 | interpro domains | IPR035012 | 3 | 1 | 18521 | 50 |
TNS3 |
8.078e-03 | -4.82 | DGK_typeI_N_sf | interpro domains | IPR038199 | 3 | 1 | 18521 | 50 |
DGKB |
8.078e-03 | -4.82 | DAG_kinase_typeI_N | interpro domains | IPR029477 | 3 | 1 | 18521 | 50 |
DGKB |
8.078e-03 | -4.82 | FARP1/FARP2/FRMD7_FERM_C | interpro domains | IPR041788 | 3 | 1 | 18521 | 50 |
FARP1 |
8.078e-03 | -4.82 | GPCR_2_brain_angio_inhib | interpro domains | IPR008077 | 3 | 1 | 18521 | 50 |
ADGRB3 |
8.078e-03 | -4.82 | NR_DBD_ROR | interpro domains | IPR044101 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | PHsplit_syntrophin | interpro domains | IPR041428 | 3 | 1 | 18521 | 50 |
SNTB1 |
8.078e-03 | -4.82 | InsP3_rcpt | interpro domains | IPR000493 | 3 | 1 | 18521 | 50 |
ITPR2 |
8.078e-03 | -4.82 | Myelin_PLP | interpro domains | IPR001614 | 3 | 1 | 18521 | 50 |
GPM6B |
8.088e-03 | -4.82 | amino acid binding | molecular function | GO:0016597 | 51 | 2 | 18094 | 48 |
SLC1A3,SLC6A11 |
8.097e-03 | -4.82 | regulation of nervous system development | biological process | GO:0051960 | 456 | 5 | 18204 | 50 |
PTN,PTPRZ1,QKI,ADGRB3,NTRK2 |
8.111e-03 | -4.81 | CTNNB1 (catenin beta 1) | protein interactions | 1499 | 926 | 7 | 19454 | 49 |
NHSL1,GRIP1,USP6NL,PTPRZ1,CTNND2,PTN,CTBP1 |
8.181e-03 | -4.81 | EPM2A (EPM2A glucan phosphatase, laforin) | protein interactions | 7957 | 54 | 2 | 19454 | 49 |
FKBP5,PREX1 |
8.181e-03 | -4.81 | NOS1 (nitric oxide synthase 1) | protein interactions | 4842 | 54 | 2 | 19454 | 49 |
SNTB1,CTBP1 |
8.218e-03 | -4.80 | cysteine transport | biological process | GO:0042883 | 3 | 1 | 18204 | 50 |
SLC1A2 |
8.218e-03 | -4.80 | negative regulation of neurotransmitter uptake | biological process | GO:0051581 | 3 | 1 | 18204 | 50 |
GPM6B |
8.218e-03 | -4.80 | cysteine transmembrane transport | biological process | GO:1903712 | 3 | 1 | 18204 | 50 |
SLC1A2 |
8.218e-03 | -4.80 | negative regulation of serotonin uptake | biological process | GO:0051612 | 3 | 1 | 18204 | 50 |
GPM6B |
8.218e-03 | -4.80 | ossification involved in bone remodeling | biological process | GO:0043932 | 3 | 1 | 18204 | 50 |
PTN |
8.218e-03 | -4.80 | trans-synaptic signaling by BDNF, modulating synaptic transmission | biological process | GO:0099183 | 3 | 1 | 18204 | 50 |
NTRK2 |
8.244e-03 | -4.80 | transmembrane transporter activity | molecular function | GO:0022857 | 1110 | 8 | 18094 | 48 |
SLC1A3,ITPR2,SLC39A12,SLC4A4,SLC13A5,AQP4,SLC6A11,SLC1A2 |
8.271e-03 | -4.80 | Diacylglycerol kinase alpha | gene3d domains | 1.10.238.110 | 3 | 1 | 14470 | 40 |
DGKB |
8.406e-03 | -4.78 | DAG_kinase_N | pfam domains | PF14513 | 3 | 1 | 17795 | 50 |
DGKB |
8.406e-03 | -4.78 | AGRB_N | pfam domains | PF19188 | 3 | 1 | 17795 | 50 |
ADGRB3 |
8.406e-03 | -4.78 | LNS2 | pfam domains | PF08235 | 3 | 1 | 17795 | 50 |
LPIN2 |
8.406e-03 | -4.78 | Myelin_PLP | pfam domains | PF01275 | 3 | 1 | 17795 | 50 |
GPM6B |
8.406e-03 | -4.78 | Lipin_mid | pfam domains | PF16876 | 3 | 1 | 17795 | 50 |
LPIN2 |
8.406e-03 | -4.78 | PH_17 | pfam domains | PF18012 | 3 | 1 | 17795 | 50 |
SNTB1 |
8.406e-03 | -4.78 | Lipin_N | pfam domains | PF04571 | 3 | 1 | 17795 | 50 |
LPIN2 |
8.406e-03 | -4.78 | LRRCT_2 | pfam domains | PF16920 | 3 | 1 | 17795 | 50 |
NTRK2 |
8.645e-03 | -4.75 | Platelet activation, signaling and aggregation | REACTOME pathways | R-HSA-76002 | 282 | 4 | 10285 | 30 |
EGF,ITPR2,DGKB,APOA1 |
8.702e-03 | -4.74 | learning | biological process | GO:0007612 | 154 | 3 | 18204 | 50 |
NTRK2,ADGRB3,PTN |
8.726e-03 | -4.74 | TCF7L2 mutants don't bind CTBP | REACTOME pathways | R-HSA-5339700 | 3 | 1 | 10285 | 30 |
CTBP1 |
8.978e-03 | -4.71 | cell communication | biological process | GO:0007154 | 5010 | 22 | 18204 | 50 |
SLC39A12,SLC1A3,SORCS2,NTRK2,NRCAM,DGKB,PTN,NFIA,ITPK1,GRIP1,GRK5,PREX1,FARP1,APOA1,EGF,ITPR2,RORA,PREX2,FGFRL1,SLC1A2,CTNND2,ADGRB3 |
8.982e-03 | -4.71 | regulation of glycolytic process | biological process | GO:0006110 | 52 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
8.982e-03 | -4.71 | regulation of nucleotide catabolic process | biological process | GO:0030811 | 52 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
8.982e-03 | -4.71 | regulation of purine nucleotide catabolic process | biological process | GO:0033121 | 52 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
8.982e-03 | -4.71 | ERK1 and ERK2 cascade | biological process | GO:0070371 | 52 | 2 | 18204 | 50 |
APOA1,EGF |
9.070e-03 | -4.70 | KLF8 (KLF transcription factor 8) | protein interactions | 11279 | 326 | 4 | 19454 | 49 |
CTBP1,NFIA,TRPS1,SOX5 |
9.139e-03 | -4.70 | foot | COSMIC cancer mutations | foot | 148 | 3 | 16828 | 49 |
ADAM12,SLC6A11,PREX2 |
9.172e-03 | -4.69 | MAPT (microtubule associated protein tau) | protein interactions | 4137 | 948 | 7 | 19454 | 49 |
FKBP5,GRIP1,FARP1,SLC1A3,CTBP1,CTNND2,SLC1A2 |
9.190e-03 | -4.69 | Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate | KEGG pathways | M00132 | 3 | 1 | 7161 | 22 |
ITPK1 |
9.190e-03 | -4.69 | Inositol phosphate metabolism, Ins(1,3,4)P3 => phytate | KEGG pathways | hsa_M00132 | 3 | 1 | 7161 | 22 |
ITPK1 |
9.206e-03 | -4.69 | rhabdomyosarcoma | COSMIC cancer mutations | rhabdomyosarcoma | 4150 | 20 | 16828 | 49 |
DGKB,NCKAP5,SLC1A3,CTNND2,NHSL1,PREX2,GRK5,SORCS2,USP6NL,PRDM16,NPAS3,RORA,TRPS1,AQP4,NFIA,PTPRZ1,CTBP1,FHOD3,FGFRL1,ELOVL2 |
9.212e-03 | -4.69 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 45 | 16828 | 49 |
SLC13A5,FKBP5,NPAS3,TRPS1,SOX5,RFX4,PTPRZ1,SLC39A12,LPIN2,DGKB,NCKAP5,QKI,PTN,NRCAM,NTRK2,ZBTB20,PREX2,SLC4A4,GRIP1,PRDM16,RORA,AQP4,PREX1,FHOD3,FGFRL1,CTBP1,LRIG1,ELOVL2,SLC6A11,ADAM12,SNTB1,EGF,SLC1A3,TNS3,NHSL1,SLC1A2,FARP1,CTNND2,ITPR2,GPC5,GRK5,COL11A1,USP6NL,ITPK1,SORCS2 |
9.318e-03 | -4.68 | neutral amino acid transport | biological process | GO:0015804 | 53 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
9.318e-03 | -4.68 | regulation of chondrocyte differentiation | biological process | GO:0032330 | 53 | 2 | 18204 | 50 |
TRPS1,SOX5 |
9.342e-03 | -4.67 | human chr4p16.3 | chromosome location | human chr4p16.3 | 76 | 2 | 26134 | 50 |
CTBP1,FGFRL1 |
9.346e-03 | -4.67 | LRRNT | interpro domains | IPR000372 | 54 | 2 | 18521 | 50 |
NTRK2,LRIG1 |
9.390e-03 | -4.67 | CILK1 (ciliogenesis associated kinase 1) | protein interactions | 22858 | 58 | 2 | 19454 | 49 |
MSI2,FKBP5 |
9.492e-03 | -4.66 | monoatomic anion transport | biological process | GO:0006820 | 159 | 3 | 18204 | 50 |
SLC1A3,SLC1A2,SLC4A4 |
9.530e-03 | -4.65 | human chr13q32.2 | chromosome location | human chr13q32.2 | 5 | 1 | 26134 | 50 |
FARP1 |
9.586e-03 | -4.65 | NME2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 4831 | 174 | 3 | 19454 | 49 |
RORA,CTBP1,PREX1 |
9.659e-03 | -4.64 | positive regulation of biomineral tissue development | biological process | GO:0070169 | 54 | 2 | 18204 | 50 |
PTN,GPM6B |
9.659e-03 | -4.64 | positive regulation of ossification | biological process | GO:0045778 | 54 | 2 | 18204 | 50 |
GPM6B,PTN |
9.659e-03 | -4.64 | regulation of cholesterol efflux | biological process | GO:0010874 | 54 | 2 | 18204 | 50 |
APOA1,EGF |
9.727e-03 | -4.63 | RORNUCRECPTR | prints domains | PR01293 | 3 | 1 | 5227 | 17 |
RORA |
9.727e-03 | -4.63 | INSP3RECEPTR | prints domains | PR00779 | 3 | 1 | 5227 | 17 |
ITPR2 |
9.727e-03 | -4.63 | NTKRECEPTOR | prints domains | PR01939 | 3 | 1 | 5227 | 17 |
NTRK2 |
9.727e-03 | -4.63 | MYELINPLP | prints domains | PR00214 | 3 | 1 | 5227 | 17 |
GPM6B |
9.727e-03 | -4.63 | BAIPRECURSOR | prints domains | PR01694 | 3 | 1 | 5227 | 17 |
ADGRB3 |
9.736e-03 | -4.63 | LHX3 (LIM homeobox 3) | protein interactions | 8022 | 175 | 3 | 19454 | 49 |
NFIA,SOX5,TRPS1 |
9.751e-03 | -4.63 | dendritic spine | cellular component | GO:0043197 | 172 | 3 | 19108 | 49 |
NTRK2,SORCS2,FARP1 |
9.819e-03 | -4.62 | sensory perception of sound | biological process | GO:0007605 | 161 | 3 | 18204 | 50 |
COL11A1,SLC1A3,LRIG1 |
9.858e-03 | -4.62 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 6 | 16828 | 49 |
PTPRZ1,SLC6A11,PREX2,ADAM12,COL11A1,NFIA |
1.001e-02 | -4.60 | response to cocaine | biological process | GO:0042220 | 55 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
1.002e-02 | -4.60 | Znf_NHR/GATA | interpro domains | IPR013088 | 56 | 2 | 18521 | 50 |
TRPS1,RORA |
1.004e-02 | -4.60 | Lrrfip1 (leucine rich repeat (in FLII) interacting protein 1) | protein interactions | 16978 | 4 | 1 | 19454 | 49 |
GRIP1 |
1.004e-02 | -4.60 | APOF (apolipoprotein F) | protein interactions | 319 | 4 | 1 | 19454 | 49 |
APOA1 |
1.004e-02 | -4.60 | Nrip1 (nuclear receptor interacting protein 1) | protein interactions | 268903 | 4 | 1 | 19454 | 49 |
CTBP1 |
1.004e-02 | -4.60 | AVPR1A (arginine vasopressin receptor 1A) | protein interactions | 552 | 4 | 1 | 19454 | 49 |
GRK5 |
1.004e-02 | -4.60 | Nme2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 18103 | 4 | 1 | 19454 | 49 |
RORA |
1.004e-02 | -4.60 | GATA3 (GATA binding protein 3) | protein interactions | 2625 | 177 | 3 | 19454 | 49 |
TRPS1,QKI,NFIA |
1.005e-02 | -4.60 | FAM120A (family with sequence similarity 120 member A) | protein interactions | 23196 | 336 | 4 | 19454 | 49 |
GRK5,PRDM16,QKI,FKBP5 |
1.006e-02 | -4.60 | neuron spine | cellular component | GO:0044309 | 174 | 3 | 19108 | 49 |
FARP1,SORCS2,NTRK2 |
1.009e-02 | -4.60 | C1_1 | pfam domains | PF00130 | 54 | 2 | 17795 | 50 |
TNS3,DGKB |
1.019e-02 | -4.59 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | protein interactions | 2066 | 178 | 3 | 19454 | 49 |
LRIG1,NTRK2,TNS3 |
1.022e-02 | -4.58 | collagen type XI trimer | cellular component | GO:0005592 | 4 | 1 | 19108 | 49 |
COL11A1 |
1.027e-02 | -4.58 | IGc2 | smart domains | SM00408 | 239 | 4 | 9717 | 35 |
NRCAM,NTRK2,LRIG1,FGFRL1 |
1.034e-02 | -4.57 | Metabolism of fat-soluble vitamins | REACTOME pathways | R-HSA-6806667 | 53 | 2 | 10285 | 30 |
APOA1,GPC5 |
1.044e-02 | -4.56 | Erythroid Transcription Factor GATA-1, subunit A | gene3d domains | 3.30.50.10 | 56 | 2 | 14470 | 40 |
RORA,TRPS1 |
1.049e-02 | -4.56 | import across plasma membrane | biological process | GO:0098739 | 165 | 3 | 18204 | 50 |
SLC1A2,SLC39A12,SLC1A3 |
1.051e-02 | -4.56 | MYOD1 (myogenic differentiation 1) | protein interactions | 4654 | 180 | 3 | 19454 | 49 |
NFIA,RORA,TRPS1 |
1.055e-02 | -4.55 | MYELIN_PLP_1 | prosite domains | PS00575 | 3 | 1 | 12186 | 43 |
GPM6B |
1.055e-02 | -4.55 | NA_SULFATE | prosite domains | PS01271 | 3 | 1 | 12186 | 43 |
SLC13A5 |
1.055e-02 | -4.55 | MYELIN_PLP_2 | prosite domains | PS01004 | 3 | 1 | 12186 | 43 |
GPM6B |
1.057e-02 | -4.55 | brain-derived neurotrophic factor binding | molecular function | GO:0048403 | 4 | 1 | 18094 | 48 |
NTRK2 |
1.057e-02 | -4.55 | beta-adrenergic receptor kinase activity | molecular function | GO:0047696 | 4 | 1 | 18094 | 48 |
GRK5 |
1.057e-02 | -4.55 | apolipoprotein A-I receptor binding | molecular function | GO:0034191 | 4 | 1 | 18094 | 48 |
APOA1 |
1.057e-02 | -4.55 | tricarboxylic acid transmembrane transporter activity | molecular function | GO:0015142 | 4 | 1 | 18094 | 48 |
SLC13A5 |
1.057e-02 | -4.55 | citrate transmembrane transporter activity | molecular function | GO:0015137 | 4 | 1 | 18094 | 48 |
SLC13A5 |
1.067e-02 | -4.54 | MTMR7 (myotubularin related protein 7) | protein interactions | 9108 | 62 | 2 | 19454 | 49 |
FKBP5,CTBP1 |
1.071e-02 | -4.54 | sulfur compound transmembrane transporter activity | molecular function | GO:1901682 | 59 | 2 | 18094 | 48 |
SLC1A2,SLC6A11 |
1.076e-02 | -4.53 | CTF/NFI_DNA-bd_CS | interpro domains | IPR019739 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | Neurofascin/L1/NrCAM_C | interpro domains | IPR026966 | 4 | 1 | 18521 | 50 |
NRCAM |
1.076e-02 | -4.53 | Tensin_PTB | interpro domains | IPR033929 | 4 | 1 | 18521 | 50 |
TNS3 |
1.076e-02 | -4.53 | NHS-like | interpro domains | IPR024845 | 4 | 1 | 18521 | 50 |
NHSL1 |
1.076e-02 | -4.53 | CTF/NFI_DNA-bd_N | interpro domains | IPR019548 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | ApoA_E | interpro domains | IPR000074 | 4 | 1 | 18521 | 50 |
APOA1 |
1.076e-02 | -4.53 | D-isomer_DH_CS | interpro domains | IPR029753 | 4 | 1 | 18521 | 50 |
CTBP1 |
1.076e-02 | -4.53 | D-isomer_2_OHA_DH_cat_dom | interpro domains | IPR006139 | 4 | 1 | 18521 | 50 |
CTBP1 |
1.076e-02 | -4.53 | CTF/NFI | interpro domains | IPR000647 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | CTF/NFI_DNA-bd-dom | interpro domains | IPR020604 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | D-isomer_DH_NAD-bd | interpro domains | IPR006140 | 4 | 1 | 18521 | 50 |
CTBP1 |
1.077e-02 | -4.53 | PLP | smart domains | SM00002 | 3 | 1 | 9717 | 35 |
GPM6B |
1.079e-02 | -4.53 | PH_DOMAIN | prosite domains | PS50003 | 246 | 4 | 12186 | 43 |
PREX1,SNTB1,PREX2,FARP1 |
1.080e-02 | -4.53 | tube morphogenesis | biological process | GO:0035239 | 685 | 6 | 18204 | 50 |
RORA,QKI,SLC39A12,EGF,NRCAM,NTRK2 |
1.094e-02 | -4.52 | regulation of serotonin uptake | biological process | GO:0051611 | 4 | 1 | 18204 | 50 |
GPM6B |
1.094e-02 | -4.52 | positive regulation of mesenchymal stem cell differentiation | biological process | GO:2000741 | 4 | 1 | 18204 | 50 |
SOX5 |
1.094e-02 | -4.52 | brain-derived neurotrophic factor receptor signaling pathway | biological process | GO:0031547 | 4 | 1 | 18204 | 50 |
NTRK2 |
1.094e-02 | -4.52 | oxaloacetate transport | biological process | GO:0015729 | 4 | 1 | 18204 | 50 |
SLC13A5 |
1.094e-02 | -4.52 | gamma-aminobutyric acid reuptake | biological process | GO:0051936 | 4 | 1 | 18204 | 50 |
SLC6A11 |
1.094e-02 | -4.52 | positive regulation of hyaluronan biosynthetic process | biological process | GO:1900127 | 4 | 1 | 18204 | 50 |
EGF |
1.094e-02 | -4.52 | positive regulation of phospholipid efflux | biological process | GO:1902995 | 4 | 1 | 18204 | 50 |
APOA1 |
1.094e-02 | -4.52 | trans-synaptic signaling by BDNF | biological process | GO:0099191 | 4 | 1 | 18204 | 50 |
NTRK2 |
1.094e-02 | -4.52 | negative regulation of very-low-density lipoprotein particle remodeling | biological process | GO:0010903 | 4 | 1 | 18204 | 50 |
APOA1 |
1.094e-02 | -4.52 | regulation of phospholipid efflux | biological process | GO:1902994 | 4 | 1 | 18204 | 50 |
APOA1 |
1.098e-02 | -4.51 | primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | primitive_neuroectodermal_tumour-medulloblastoma | 15350 | 49 | 16828 | 49 |
SNTB1,EGF,TNS3,ITPR2,GRK5,COL11A1,ITPK1,PRDM16,NFIA,PREX1,FGFRL1,NTRK2,SLC4A4,SLC13A5,NPAS3,SOX5,SLC39A12,APOA1,SLC1A3,NHSL1,FARP1,SLC1A2,CTNND2,GPC5,USP6NL,SORCS2,GRIP1,RORA,AQP4,GPM6B,FHOD3,CTBP1,ELOVL2,LRIG1,SLC6A11,ADAM12,DGKB,NCKAP5,QKI,PTN,NRCAM,ZBTB20,PREX2,MSI2,FKBP5,TRPS1,RFX4,PTPRZ1,LPIN2 |
1.099e-02 | -4.51 | QKI (QKI, KH domain containing RNA binding) | protein interactions | 9444 | 183 | 3 | 19454 | 49 |
SLC39A12,QKI,MSI2 |
1.101e-02 | -4.51 | heparin binding | molecular function | GO:0008201 | 174 | 3 | 18094 | 48 |
COL11A1,FGFRL1,PTN |
1.106e-02 | -4.50 | (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis (6-desaturase) | BIOCYC pathways | META_PWY-7726 | 5 | 1 | 902 | 2 |
ELOVL2 |
1.106e-02 | -4.50 | docosahexaenoate biosynthesis III (6-desaturase, mammals) | BIOCYC pathways | META_PWY-7606 | 5 | 1 | 902 | 2 |
ELOVL2 |
1.119e-02 | -4.49 | 2-Hacid_dh | pfam domains | PF00389 | 4 | 1 | 17795 | 50 |
CTBP1 |
1.119e-02 | -4.49 | Apolipoprotein | pfam domains | PF01442 | 4 | 1 | 17795 | 50 |
APOA1 |
1.119e-02 | -4.49 | 2-Hacid_dh_C | pfam domains | PF02826 | 4 | 1 | 17795 | 50 |
CTBP1 |
1.119e-02 | -4.49 | CTF_NFI | pfam domains | PF00859 | 4 | 1 | 17795 | 50 |
NFIA |
1.119e-02 | -4.49 | Bravo_FIGEY | pfam domains | PF13882 | 4 | 1 | 17795 | 50 |
NRCAM |
1.119e-02 | -4.49 | NfI_DNAbd_pre-N | pfam domains | PF10524 | 4 | 1 | 17795 | 50 |
NFIA |
1.119e-02 | -4.49 | PKD_4 | pfam domains | PF18911 | 4 | 1 | 17795 | 50 |
SORCS2 |
1.119e-02 | -4.49 | TPR_6 | pfam domains | PF13174 | 4 | 1 | 17795 | 50 |
FKBP5 |
1.119e-02 | -4.49 | NHS | pfam domains | PF15273 | 4 | 1 | 17795 | 50 |
NHSL1 |
1.120e-02 | -4.49 | cellular response to growth factor stimulus | biological process | GO:0071363 | 494 | 5 | 18204 | 50 |
SOX5,FGFRL1,NFIA,NTRK2,APOA1 |
1.132e-02 | -4.48 | cognition | biological process | GO:0050890 | 319 | 4 | 18204 | 50 |
NTRK2,ADGRB3,PTN,PTPRZ1 |
1.134e-02 | -4.48 | VSX1 (visual system homeobox 1) | protein interactions | 30813 | 64 | 2 | 19454 | 49 |
NFIA,TRPS1 |
1.138e-02 | -4.48 | head_neck | COSMIC cancer mutations | head_neck | 15361 | 49 | 16828 | 49 |
NFIA,PRDM16,PREX1,FGFRL1,TNS3,SNTB1,EGF,GRK5,ITPK1,COL11A1,ITPR2,SOX5,NPAS3,SLC13A5,SLC39A12,SLC4A4,NTRK2,GPM6B,AQP4,GRIP1,RORA,SLC6A11,LRIG1,ELOVL2,ADAM12,CTBP1,FHOD3,SLC1A3,CTNND2,SLC1A2,NHSL1,FARP1,APOA1,SORCS2,USP6NL,GPC5,TRPS1,RFX4,FKBP5,LPIN2,PTPRZ1,NRCAM,PTN,DGKB,NCKAP5,QKI,MSI2,PREX2,ZBTB20 |
1.143e-02 | -4.47 | human chr14q13.1 | chromosome location | human chr14q13.1 | 6 | 1 | 26134 | 50 |
NPAS3 |
1.144e-02 | -4.47 | anaplastic_carcinoma | COSMIC cancer mutations | anaplastic_carcinoma | 856 | 7 | 16828 | 49 |
NRCAM,NFIA,FARP1,SNTB1,GRK5,COL11A1,FHOD3 |
1.144e-02 | -4.47 | thyroid-carcinoma-anaplastic_carcinoma | COSMIC cancer mutations | thyroid-carcinoma-anaplastic_carcinoma | 856 | 7 | 16828 | 49 |
SNTB1,NFIA,FARP1,NRCAM,FHOD3,COL11A1,GRK5 |
1.160e-02 | -4.46 | skin-lower_leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma-nodular | 4 | 1 | 16828 | 49 |
PREX2 |
1.160e-02 | -4.46 | skin-face-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-face-malignant_melanoma-superficial_spreading | 4 | 1 | 16828 | 49 |
PREX2 |
1.162e-02 | -4.46 | PLCG1 events in ERBB2 signaling | REACTOME pathways | R-HSA-1251932 | 4 | 1 | 10285 | 30 |
EGF |
1.162e-02 | -4.46 | Reuptake of GABA | REACTOME pathways | R-HSA-888593 | 4 | 1 | 10285 | 30 |
SLC6A11 |
1.165e-02 | -4.45 | Fosphenytoin (Antiarrhythmic) Metabolism Pathway | SMPDB pathways | SMP0000618 | 4 | 1 | 1369 | 4 |
SNTB1 |
1.171e-02 | -4.45 | nervous system process | biological process | GO:0050877 | 1376 | 9 | 18204 | 50 |
COL11A1,SLC1A3,NRCAM,NTRK2,PTPRZ1,PTN,AQP4,LRIG1,ADGRB3 |
1.175e-02 | -4.44 | skeletal system development | biological process | GO:0001501 | 500 | 5 | 18204 | 50 |
TRPS1,SOX5,COL11A1,FGFRL1,NFIA |
1.177e-02 | -4.44 | CTBP2 (C-terminal binding protein 2) | protein interactions | 1488 | 352 | 4 | 19454 | 49 |
TRPS1,MSI2,PRDM16,CTBP1 |
1.178e-02 | -4.44 | transmembrane receptor protein tyrosine kinase activity | molecular function | GO:0004714 | 62 | 2 | 18094 | 48 |
FGFRL1,NTRK2 |
1.181e-02 | -4.44 | C1-like_sf | interpro domains | IPR046349 | 61 | 2 | 18521 | 50 |
TNS3,DGKB |
1.181e-02 | -4.44 | Tyr_Pase_cat | interpro domains | IPR003595 | 61 | 2 | 18521 | 50 |
PTPRZ1,TNS3 |
1.181e-02 | -4.44 | HNF1B (HNF1 homeobox B) | protein interactions | 6928 | 188 | 3 | 19454 | 49 |
TRPS1,SOX5,NFIA |
1.182e-02 | -4.44 | transmission of nerve impulse | biological process | GO:0019226 | 60 | 2 | 18204 | 50 |
NTRK2,NRCAM |
1.190e-02 | -4.43 | gallbladder | COSMIC cancer mutations | gallbladder | 2821 | 15 | 16828 | 49 |
NRCAM,CTNND2,NHSL1,FARP1,PREX2,USP6NL,COL11A1,SLC4A4,ITPR2,TRPS1,GRIP1,PRDM16,LRIG1,SLC39A12,PTPRZ1 |
1.190e-02 | -4.43 | biliary_tract-gallbladder-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-gallbladder-carcinoma-adenocarcinoma | 2821 | 15 | 16828 | 49 |
FARP1,NHSL1,CTNND2,NRCAM,ITPR2,SLC4A4,COL11A1,USP6NL,PREX2,GRIP1,PRDM16,TRPS1,PTPRZ1,SLC39A12,LRIG1 |
1.192e-02 | -4.43 | chemical homeostasis | biological process | GO:0048878 | 914 | 7 | 18204 | 50 |
SLC4A4,APOA1,SLC39A12,SLC1A3,ZBTB20,AQP4,RORA |
1.192e-02 | -4.43 | cartilage development | biological process | GO:0051216 | 173 | 3 | 18204 | 50 |
COL11A1,SOX5,NFIA |
1.203e-02 | -4.42 | MAML1 (mastermind like transcriptional coactivator 1) | protein interactions | 9794 | 66 | 2 | 19454 | 49 |
NFIA,CTBP1 |
1.209e-02 | -4.42 | kidney | COSMIC cancer mutations | kidney | 15380 | 49 | 16828 | 49 |
SLC13A5,NPAS3,SOX5,SLC39A12,NTRK2,SLC4A4,PRDM16,NFIA,PREX1,FGFRL1,SNTB1,EGF,TNS3,ITPR2,GRK5,COL11A1,ITPK1,FKBP5,TRPS1,RFX4,PTPRZ1,LPIN2,NCKAP5,DGKB,QKI,PTN,NRCAM,ZBTB20,PREX2,MSI2,GRIP1,RORA,AQP4,GPM6B,FHOD3,CTBP1,ELOVL2,LRIG1,SLC6A11,ADAM12,APOA1,SLC1A3,NHSL1,SLC1A2,FARP1,CTNND2,GPC5,USP6NL,SORCS2 |
1.211e-02 | -4.41 | TLE3 (TLE family member 3, transcriptional corepressor) | protein interactions | 7090 | 355 | 4 | 19454 | 49 |
NFIA,FKBP5,TRPS1,QKI |
1.219e-02 | -4.41 | skin-arm-malignant_melanoma | COSMIC cancer mutations | skin-arm-malignant_melanoma | 1308 | 9 | 16828 | 49 |
SLC6A11,ADAM12,SLC4A4,ZBTB20,FHOD3,TRPS1,SNTB1,NPAS3,SLC13A5 |
1.231e-02 | -4.40 | GRB2 (growth factor receptor bound protein 2) | protein interactions | 2885 | 769 | 6 | 19454 | 49 |
EGF,MSI2,ADAM12,SLC1A2,NTRK2,USP6NL |
1.253e-02 | -4.38 | SPATA31A7 (SPATA31 subfamily A member 7) | protein interactions | 26165 | 5 | 1 | 19454 | 49 |
GRK5 |
1.253e-02 | -4.38 | SLC25A36 (solute carrier family 25 member 36) | protein interactions | 55186 | 5 | 1 | 19454 | 49 |
PTN |
1.253e-02 | -4.38 | PDE1A (phosphodiesterase 1A) | protein interactions | 5136 | 5 | 1 | 19454 | 49 |
APOA1 |
1.253e-02 | -4.38 | RFX4 (regulatory factor X4) | protein interactions | 5992 | 5 | 1 | 19454 | 49 |
RFX4 |
1.259e-02 | -4.38 | regulation of substrate adhesion-dependent cell spreading | biological process | GO:1900024 | 62 | 2 | 18204 | 50 |
PREX1,APOA1 |
1.259e-02 | -4.38 | regulation of carbohydrate catabolic process | biological process | GO:0043470 | 62 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
1.259e-02 | -4.38 | sulfur compound transport | biological process | GO:0072348 | 62 | 2 | 18204 | 50 |
SLC1A2,SLC6A11 |
1.262e-02 | -4.37 | Ig-like_fold | interpro domains | IPR013783 | 721 | 6 | 18521 | 50 |
NTRK2,PTPRZ1,NRCAM,FGFRL1,LRIG1,SORCS2 |
1.268e-02 | -4.37 | MED1 (mediator complex subunit 1) | protein interactions | 5469 | 193 | 3 | 19454 | 49 |
QKI,RORA,CTBP1 |
1.274e-02 | -4.36 | FOXP2 (forkhead box P2) | protein interactions | 93986 | 68 | 2 | 19454 | 49 |
CTBP1,SOX5 |
1.282e-02 | -4.36 | regulation of small molecule metabolic process | biological process | GO:0062012 | 331 | 4 | 18204 | 50 |
RORA,SLC4A4,APOA1,ZBTB20 |
1.287e-02 | -4.35 | viral life cycle | biological process | GO:0019058 | 178 | 3 | 18204 | 50 |
USP6NL,CTBP1,NFIA |
1.306e-02 | -4.34 | lipid homeostasis | biological process | GO:0055088 | 179 | 3 | 18204 | 50 |
RORA,APOA1,ZBTB20 |
1.313e-02 | -4.33 | response to endogenous stimulus | biological process | GO:0009719 | 1402 | 9 | 18204 | 50 |
APOA1,SLC1A3,ITPR2,NTRK2,LPIN2,SLC1A2,NFIA,FGFRL1,SOX5 |
1.313e-02 | -4.33 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | 14773 | 48 | 16828 | 49 |
PTPRZ1,LPIN2,FKBP5,RFX4,TRPS1,ZBTB20,PREX2,MSI2,QKI,DGKB,PTN,NRCAM,FHOD3,CTBP1,ADAM12,LRIG1,ELOVL2,SLC6A11,RORA,GRIP1,AQP4,GPM6B,GPC5,SORCS2,USP6NL,APOA1,NHSL1,SLC1A2,FARP1,CTNND2,SLC1A3,SLC39A12,SLC13A5,NPAS3,SOX5,NTRK2,SLC4A4,FGFRL1,PREX1,PRDM16,NFIA,ITPR2,COL11A1,ITPK1,GRK5,EGF,SNTB1,TNS3 |
1.313e-02 | -4.33 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | 14773 | 48 | 16828 | 49 |
PREX1,FGFRL1,NFIA,PRDM16,GRK5,ITPK1,COL11A1,ITPR2,TNS3,SNTB1,EGF,SLC39A12,SOX5,NPAS3,SLC13A5,SLC4A4,NTRK2,SLC6A11,LRIG1,ELOVL2,ADAM12,CTBP1,FHOD3,GPM6B,AQP4,GRIP1,RORA,SORCS2,USP6NL,GPC5,SLC1A3,CTNND2,FARP1,SLC1A2,NHSL1,APOA1,LPIN2,PTPRZ1,TRPS1,RFX4,FKBP5,MSI2,PREX2,ZBTB20,PTN,NRCAM,DGKB,QKI |
1.313e-02 | -4.33 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | 14773 | 48 | 16828 | 49 |
GRK5,COL11A1,ITPK1,ITPR2,TNS3,SNTB1,EGF,PREX1,FGFRL1,NFIA,PRDM16,SLC4A4,NTRK2,SLC39A12,SOX5,SLC13A5,NPAS3,SORCS2,USP6NL,GPC5,SLC1A3,SLC1A2,NHSL1,FARP1,CTNND2,APOA1,ELOVL2,LRIG1,SLC6A11,ADAM12,FHOD3,CTBP1,AQP4,GPM6B,GRIP1,RORA,PREX2,MSI2,ZBTB20,PTN,NRCAM,DGKB,QKI,LPIN2,PTPRZ1,TRPS1,RFX4,FKBP5 |
1.313e-02 | -4.33 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 14773 | 48 | 16828 | 49 |
SLC39A12,SOX5,NPAS3,SLC13A5,SLC4A4,NTRK2,PREX1,FGFRL1,NFIA,PRDM16,GRK5,ITPK1,COL11A1,ITPR2,TNS3,SNTB1,EGF,LPIN2,PTPRZ1,TRPS1,RFX4,FKBP5,MSI2,PREX2,ZBTB20,NRCAM,PTN,DGKB,QKI,SLC6A11,LRIG1,ELOVL2,ADAM12,CTBP1,FHOD3,GPM6B,AQP4,GRIP1,RORA,SORCS2,USP6NL,GPC5,SLC1A3,CTNND2,NHSL1,FARP1,SLC1A2,APOA1 |
1.314e-02 | -4.33 | inorganic ion transmembrane transport | biological process | GO:0098660 | 715 | 6 | 18204 | 50 |
SLC4A4,ITPR2,SLC39A12,SLC1A3,SLC13A5,SLC6A11 |
1.317e-02 | -4.33 | classic | COSMIC cancer mutations | classic | 14774 | 48 | 16828 | 49 |
SOX5,SLC13A5,NPAS3,SLC39A12,SLC4A4,NTRK2,NFIA,PRDM16,PREX1,FGFRL1,TNS3,SNTB1,EGF,GRK5,COL11A1,ITPK1,ITPR2,TRPS1,RFX4,FKBP5,LPIN2,PTPRZ1,NRCAM,PTN,DGKB,QKI,PREX2,MSI2,ZBTB20,AQP4,GPM6B,GRIP1,RORA,LRIG1,ELOVL2,SLC6A11,ADAM12,FHOD3,CTBP1,SLC1A3,NHSL1,FARP1,SLC1A2,CTNND2,APOA1,USP6NL,SORCS2,GPC5 |
1.318e-02 | -4.33 | main axon | cellular component | GO:0044304 | 68 | 2 | 19108 | 49 |
SLC1A2,NRCAM |
1.320e-02 | -4.33 | inositol tetrakisphosphate kinase activity | molecular function | GO:0051765 | 5 | 1 | 18094 | 48 |
ITPK1 |
1.320e-02 | -4.33 | neurotrophin receptor activity | molecular function | GO:0005030 | 5 | 1 | 18094 | 48 |
NTRK2 |
1.320e-02 | -4.33 | taurine transmembrane transporter activity | molecular function | GO:0005368 | 5 | 1 | 18094 | 48 |
SLC6A11 |
1.320e-02 | -4.33 | fibroblast growth factor receptor activity | molecular function | GO:0005007 | 5 | 1 | 18094 | 48 |
FGFRL1 |
1.320e-02 | -4.33 | inositol trisphosphate kinase activity | molecular function | GO:0051766 | 5 | 1 | 18094 | 48 |
ITPK1 |
1.327e-02 | -4.32 | L-amino acid transmembrane transporter activity | molecular function | GO:0015179 | 66 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
1.332e-02 | -4.32 | human chr8q13.2 | chromosome location | human chr8q13.2 | 7 | 1 | 26134 | 50 |
PREX2 |
1.332e-02 | -4.32 | medulla | COSMIC cancer mutations | medulla | 14778 | 48 | 16828 | 49 |
PREX2,MSI2,ZBTB20,NRCAM,PTN,DGKB,QKI,LPIN2,PTPRZ1,TRPS1,RFX4,FKBP5,SORCS2,USP6NL,GPC5,SLC1A3,NHSL1,FARP1,SLC1A2,CTNND2,APOA1,ELOVL2,LRIG1,SLC6A11,ADAM12,FHOD3,CTBP1,AQP4,GPM6B,GRIP1,RORA,SLC4A4,NTRK2,SLC39A12,SOX5,SLC13A5,NPAS3,GRK5,COL11A1,ITPK1,ITPR2,TNS3,SNTB1,EGF,PREX1,FGFRL1,NFIA,PRDM16 |
1.336e-02 | -4.32 | desmoplastic | COSMIC cancer mutations | desmoplastic | 14779 | 48 | 16828 | 49 |
SLC13A5,NPAS3,SOX5,SLC39A12,NTRK2,SLC4A4,PRDM16,NFIA,PREX1,FGFRL1,SNTB1,EGF,TNS3,ITPR2,GRK5,COL11A1,ITPK1,FKBP5,TRPS1,RFX4,PTPRZ1,LPIN2,DGKB,QKI,NRCAM,PTN,ZBTB20,PREX2,MSI2,GRIP1,RORA,AQP4,GPM6B,FHOD3,CTBP1,ELOVL2,LRIG1,SLC6A11,ADAM12,APOA1,SLC1A3,NHSL1,FARP1,SLC1A2,CTNND2,GPC5,USP6NL,SORCS2 |
1.343e-02 | -4.31 | Sortilin_N | interpro domains | IPR031778 | 5 | 1 | 18521 | 50 |
SORCS2 |
1.343e-02 | -4.31 | Sortilin_C | interpro domains | IPR031777 | 5 | 1 | 18521 | 50 |
SORCS2 |
1.343e-02 | -4.31 | BBP-like | interpro domains | IPR045071 | 5 | 1 | 18521 | 50 |
QKI |
1.343e-02 | -4.31 | SLC13A/DASS | interpro domains | IPR001898 | 5 | 1 | 18521 | 50 |
SLC13A5 |
1.343e-02 | -4.31 | VPS10 | interpro domains | IPR006581 | 5 | 1 | 18521 | 50 |
SORCS2 |
1.343e-02 | -4.31 | Syntrophin | interpro domains | IPR015482 | 5 | 1 | 18521 | 50 |
SNTB1 |
1.343e-02 | -4.31 | Na/HCO3_transpt | interpro domains | IPR003024 | 5 | 1 | 18521 | 50 |
SLC4A4 |
1.346e-02 | -4.31 | sodium ion transport | biological process | GO:0006814 | 181 | 3 | 18204 | 50 |
SLC4A4,SLC13A5,SLC6A11 |
1.346e-02 | -4.31 | TSHZ3 (teashirt zinc finger homeobox 3) | protein interactions | 57616 | 70 | 2 | 19454 | 49 |
SOX5,CTBP1 |
1.346e-02 | -4.31 | ITGB3 (integrin subunit beta 3) | protein interactions | 3690 | 70 | 2 | 19454 | 49 |
PTPRZ1,PTN |
1.348e-02 | -4.31 | - | gene3d domains | 3.30.60.20 | 64 | 2 | 14470 | 40 |
DGKB,TNS3 |
1.349e-02 | -4.31 | PH | smart domains | SM00233 | 259 | 4 | 9717 | 35 |
PREX2,SNTB1,PREX1,FARP1 |
1.353e-02 | -4.30 | Immunoglobulins | gene3d domains | 2.60.40.10 | 721 | 6 | 14470 | 40 |
NRCAM,LRIG1,PTPRZ1,NTRK2,SORCS2,FGFRL1 |
1.356e-02 | -4.30 | arm | COSMIC cancer mutations | arm | 1331 | 9 | 16828 | 49 |
SLC6A11,SLC4A4,ADAM12,ZBTB20,FHOD3,TRPS1,SNTB1,SLC13A5,NPAS3 |
1.357e-02 | -4.30 | NFIX (nuclear factor I X) | protein interactions | 4784 | 198 | 3 | 19454 | 49 |
NFIA,SOX5,TRPS1 |
1.357e-02 | -4.30 | TPX2 (TPX2 microtubule nucleation factor) | protein interactions | 22974 | 198 | 3 | 19454 | 49 |
PRDM16,FARP1,PREX1 |
1.362e-02 | -4.30 | cell body | cellular component | GO:0044297 | 556 | 5 | 19108 | 49 |
SLC1A3,GRIP1,CTNND2,SORCS2,SLC1A2 |
1.365e-02 | -4.29 | sterol binding | molecular function | GO:0032934 | 67 | 2 | 18094 | 48 |
RORA,APOA1 |
1.366e-02 | -4.29 | retrograde trans-synaptic signaling | biological process | GO:0098917 | 5 | 1 | 18204 | 50 |
FARP1 |
1.366e-02 | -4.29 | otolith morphogenesis | biological process | GO:0032474 | 5 | 1 | 18204 | 50 |
LRIG1 |
1.366e-02 | -4.29 | synaptic signaling via neuropeptide | biological process | GO:0099538 | 5 | 1 | 18204 | 50 |
NTRK2 |
1.366e-02 | -4.29 | tendon development | biological process | GO:0035989 | 5 | 1 | 18204 | 50 |
COL11A1 |
1.366e-02 | -4.29 | tricarboxylic acid transport | biological process | GO:0006842 | 5 | 1 | 18204 | 50 |
SLC13A5 |
1.366e-02 | -4.29 | citrate transport | biological process | GO:0015746 | 5 | 1 | 18204 | 50 |
SLC13A5 |
1.367e-02 | -4.29 | neoplasm | COSMIC cancer mutations | neoplasm | 14787 | 48 | 16828 | 49 |
NTRK2,SLC4A4,SLC39A12,SLC13A5,NPAS3,SOX5,ITPR2,COL11A1,ITPK1,GRK5,EGF,SNTB1,TNS3,FGFRL1,PREX1,PRDM16,NFIA,ZBTB20,PREX2,MSI2,QKI,NCKAP5,DGKB,NRCAM,PTN,PTPRZ1,LPIN2,FKBP5,RFX4,TRPS1,GPC5,SORCS2,USP6NL,APOA1,NHSL1,FARP1,SLC1A2,CTNND2,SLC1A3,FHOD3,CTBP1,LRIG1,ELOVL2,SLC6A11,RORA,GRIP1,AQP4,GPM6B |
1.372e-02 | -4.29 | PE/DAG-bd | interpro domains | IPR002219 | 66 | 2 | 18521 | 50 |
TNS3,DGKB |
1.375e-02 | -4.29 | - | gene3d domains | 3.30.60.270 | 5 | 1 | 14470 | 40 |
SORCS2 |
1.375e-02 | -4.29 | - | gene3d domains | 2.10.70.80 | 5 | 1 | 14470 | 40 |
SORCS2 |
1.375e-02 | -4.29 | Apolipoprotein | gene3d domains | 1.20.120.20 | 5 | 1 | 14470 | 40 |
APOA1 |
1.377e-02 | -4.29 | positive regulation of synapse assembly | biological process | GO:0051965 | 65 | 2 | 18204 | 50 |
NTRK2,ADGRB3 |
1.383e-02 | -4.28 | UNKL (unk like zinc finger) | protein interactions | 64718 | 71 | 2 | 19454 | 49 |
CTBP1,QKI |
1.383e-02 | -4.28 | ANK2 (ankyrin 2) | protein interactions | 287 | 71 | 2 | 19454 | 49 |
NRCAM,FARP1 |
1.387e-02 | -4.28 | Glycerolipid metabolism | KEGG pathways | ko00561 | 59 | 2 | 7161 | 22 |
LPIN2,DGKB |
1.387e-02 | -4.28 | Glycerolipid metabolism | KEGG pathways | hsa00561 | 59 | 2 | 7161 | 22 |
DGKB,LPIN2 |
1.391e-02 | -4.28 | brain development | biological process | GO:0007420 | 724 | 6 | 18204 | 50 |
NRCAM,NTRK2,EGF,SLC1A2,RORA,RFX4 |
1.392e-02 | -4.27 | extracellular matrix | cellular component | GO:0031012 | 559 | 5 | 19108 | 49 |
LRIG1,APOA1,COL11A1,GPC5,PTPRZ1 |
1.396e-02 | -4.27 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 35 | 16828 | 49 |
RORA,PRDM16,GPM6B,NFIA,CTBP1,FHOD3,PREX1,ADAM12,LRIG1,ELOVL2,EGF,SNTB1,CTNND2,NHSL1,FARP1,TNS3,GPC5,ITPR2,SORCS2,USP6NL,COL11A1,GRK5,FKBP5,SLC13A5,TRPS1,SOX5,PTPRZ1,LPIN2,QKI,DGKB,PTN,NTRK2,SLC4A4,MSI2,PREX2 |
1.397e-02 | -4.27 | Sortilin_C | pfam domains | PF15901 | 5 | 1 | 17795 | 50 |
SORCS2 |
1.397e-02 | -4.27 | Sortilin-Vps10 | pfam domains | PF15902 | 5 | 1 | 17795 | 50 |
SORCS2 |
1.397e-02 | -4.27 | Na_sulph_symp | pfam domains | PF00939 | 5 | 1 | 17795 | 50 |
SLC13A5 |
1.402e-02 | -4.27 | external encapsulating structure | cellular component | GO:0030312 | 560 | 5 | 19108 | 49 |
LRIG1,APOA1,COL11A1,PTPRZ1,GPC5 |
1.404e-02 | -4.27 | CTF_NFI_1 | prosite domains | PS00349 | 4 | 1 | 12186 | 43 |
NFIA |
1.404e-02 | -4.27 | CTF_NFI_2 | prosite domains | PS51080 | 4 | 1 | 12186 | 43 |
NFIA |
1.404e-02 | -4.27 | D_2_HYDROXYACID_DH_3 | prosite domains | PS00671 | 4 | 1 | 12186 | 43 |
CTBP1 |
1.413e-02 | -4.26 | lower_leg | COSMIC cancer mutations | lower_leg | 174 | 3 | 16828 | 49 |
PREX2,SLC6A11,ADAM12 |
1.418e-02 | -4.26 | hepatocellular_carcinoma | COSMIC cancer mutations | hepatocellular_carcinoma | 14800 | 48 | 16828 | 49 |
ITPR2,ITPK1,COL11A1,GRK5,EGF,SNTB1,TNS3,FGFRL1,PREX1,PRDM16,NFIA,NTRK2,SLC4A4,SLC39A12,NPAS3,SLC13A5,SOX5,GPC5,USP6NL,SORCS2,APOA1,CTNND2,NHSL1,SLC1A2,FARP1,SLC1A3,CTBP1,FHOD3,ADAM12,SLC6A11,ELOVL2,LRIG1,RORA,GRIP1,GPM6B,AQP4,ZBTB20,PREX2,QKI,NCKAP5,DGKB,PTN,NRCAM,PTPRZ1,LPIN2,FKBP5,RFX4,TRPS1 |
1.418e-02 | -4.26 | liver-carcinoma-hepatocellular_carcinoma | COSMIC cancer mutations | liver-carcinoma-hepatocellular_carcinoma | 14800 | 48 | 16828 | 49 |
SLC4A4,NTRK2,SOX5,NPAS3,SLC13A5,SLC39A12,TNS3,SNTB1,EGF,GRK5,ITPK1,COL11A1,ITPR2,NFIA,PRDM16,PREX1,FGFRL1,PTN,NRCAM,DGKB,NCKAP5,QKI,PREX2,ZBTB20,TRPS1,RFX4,FKBP5,LPIN2,PTPRZ1,SLC1A3,CTNND2,NHSL1,FARP1,SLC1A2,APOA1,SORCS2,USP6NL,GPC5,GPM6B,AQP4,GRIP1,RORA,SLC6A11,LRIG1,ELOVL2,ADAM12,CTBP1,FHOD3 |
1.418e-02 | -4.26 | L-alpha-amino acid transmembrane transport | biological process | GO:1902475 | 66 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
1.420e-02 | -4.25 | GJA1 (gap junction protein alpha 1) | protein interactions | 2697 | 572 | 5 | 19454 | 49 |
FARP1,APOA1,SLC39A12,USP6NL,ITPR2 |
1.427e-02 | -4.25 | sensory perception of mechanical stimulus | biological process | GO:0050954 | 185 | 3 | 18204 | 50 |
SLC1A3,LRIG1,COL11A1 |
1.427e-02 | -4.25 | response to growth factor | biological process | GO:0070848 | 525 | 5 | 18204 | 50 |
NFIA,SOX5,FGFRL1,APOA1,NTRK2 |
1.429e-02 | -4.25 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 2081 | 12 | 16828 | 49 |
SLC4A4,PREX2,GRK5,NTRK2,CTBP1,FGFRL1,FHOD3,PTPRZ1,NFIA,SOX5,TRPS1,GRIP1 |
1.432e-02 | -4.25 | FEV (FEV transcription factor, ETS family member) | protein interactions | 54738 | 202 | 3 | 19454 | 49 |
NFIA,SOX5,TRPS1 |
1.448e-02 | -4.24 | skin-lower_leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma-superficial_spreading | 5 | 1 | 16828 | 49 |
PREX2 |
1.449e-02 | -4.23 | large_intestine-colon-carcinoma | COSMIC cancer mutations | large_intestine-colon-carcinoma | 2612 | 14 | 16828 | 49 |
SLC13A5,RORA,TRPS1,CTBP1,PTPRZ1,ADAM12,LRIG1,APOA1,FARP1,SLC1A3,GPC5,ITPR2,COL11A1,PREX2 |
1.450e-02 | -4.23 | Sodium-coupled sulphate, di- and tri-carboxylate transporters | REACTOME pathways | R-HSA-433137 | 5 | 1 | 10285 | 30 |
SLC13A5 |
1.450e-02 | -4.23 | Scavenging by Class B Receptors | REACTOME pathways | R-HSA-3000471 | 5 | 1 | 10285 | 30 |
APOA1 |
1.450e-02 | -4.23 | NGF-independant TRKA activation | REACTOME pathways | R-HSA-187024 | 5 | 1 | 10285 | 30 |
NTRK2 |
1.450e-02 | -4.23 | MET interacts with TNS proteins | REACTOME pathways | R-HSA-8875513 | 5 | 1 | 10285 | 30 |
TNS3 |
1.451e-02 | -4.23 | RBMS1 (RNA binding motif single stranded interacting protein 1) | protein interactions | 5937 | 203 | 3 | 19454 | 49 |
MSI2,GRK5,QKI |
1.468e-02 | -4.22 | phosphate-containing compound metabolic process | biological process | GO:0006796 | 1681 | 10 | 18204 | 50 |
NTRK2,APOA1,TNS3,CTBP1,GRK5,ELOVL2,ITPK1,RORA,PTPRZ1,DGKB |
1.470e-02 | -4.22 | NFIC (nuclear factor I C) | protein interactions | 4782 | 204 | 3 | 19454 | 49 |
NFIA,TRPS1,SOX5 |
1.480e-02 | -4.21 | protein-macromolecule adaptor activity | molecular function | GO:0030674 | 989 | 7 | 18094 | 48 |
FKBP5,PRDM16,COL11A1,CTBP1,QKI,LPIN2,GRIP1 |
1.481e-02 | -4.21 | blood vessel development | biological process | GO:0001568 | 530 | 5 | 18204 | 50 |
QKI,RORA,EGF,NTRK2,NRCAM |
1.482e-02 | -4.21 | B3GAT1 (beta-1,3-glucuronyltransferase 1) | protein interactions | 27087 | 377 | 4 | 19454 | 49 |
ITPR2,ELOVL2,FGFRL1,FARP1 |
1.502e-02 | -4.20 | SOX11 (SRY-box transcription factor 11) | protein interactions | 6664 | 6 | 1 | 19454 | 49 |
SOX5 |
1.502e-02 | -4.20 | PRLHR (prolactin releasing hormone receptor) | protein interactions | 2834 | 6 | 1 | 19454 | 49 |
GRIP1 |
1.502e-02 | -4.20 | CFHR1 (complement factor H related 1) | protein interactions | 3078 | 6 | 1 | 19454 | 49 |
APOA1 |
1.502e-02 | -4.20 | PBP2 (Pbp2p) | protein interactions | 852533 | 6 | 1 | 19454 | 49 |
QKI |
1.502e-02 | -4.20 | SOX1 (SRY-box transcription factor 1) | protein interactions | 6656 | 6 | 1 | 19454 | 49 |
SOX5 |
1.502e-02 | -4.20 | LCAT (lecithin-cholesterol acyltransferase) | protein interactions | 3931 | 6 | 1 | 19454 | 49 |
APOA1 |
1.502e-02 | -4.20 | Map3k12 (mitogen-activated protein kinase kinase kinase 12) | protein interactions | 26404 | 6 | 1 | 19454 | 49 |
USP6NL |
1.502e-02 | -4.20 | DAZ4 (deleted in azoospermia 4) | protein interactions | 57135 | 6 | 1 | 19454 | 49 |
QKI |
1.503e-02 | -4.20 | cell junction organization | biological process | GO:0034330 | 532 | 5 | 18204 | 50 |
FARP1,NFIA,NRCAM,ADGRB3,CTNND2 |
1.521e-02 | -4.19 | human chr7p21.2 | chromosome location | human chr7p21.2 | 8 | 1 | 26134 | 50 |
DGKB |
1.531e-02 | -4.18 | ERBB2 (erb-b2 receptor tyrosine kinase 2) | protein interactions | 2064 | 583 | 5 | 19454 | 49 |
TNS3,EGF,LRIG1,NTRK2,GPM6B |
1.547e-02 | -4.17 | GATAD2A (GATA zinc finger domain containing 2A) | protein interactions | 54815 | 208 | 3 | 19454 | 49 |
TRPS1,SOX5,PRDM16 |
1.559e-02 | -4.16 | PH | pfam domains | PF00169 | 187 | 3 | 17795 | 50 |
SNTB1,FARP1,PREX2 |
1.561e-02 | -4.16 | monoatomic ion transport | biological process | GO:0006811 | 964 | 7 | 18204 | 50 |
SLC1A2,SLC1A3,ITPR2,SLC39A12,SLC13A5,SLC4A4,SLC6A11 |
1.570e-02 | -4.15 | central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype | COSMIC cancer mutations | central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype | 181 | 3 | 16828 | 49 |
NCKAP5,EGF,NPAS3 |
1.573e-02 | -4.15 | MIR200A (microRNA 200a) | protein interactions | 406983 | 76 | 2 | 19454 | 49 |
MSI2,QKI |
1.581e-02 | -4.15 | histone H3K9 monomethyltransferase activity | molecular function | GO:0140948 | 6 | 1 | 18094 | 48 |
PRDM16 |
1.581e-02 | -4.15 | sodium:bicarbonate symporter activity | molecular function | GO:0008510 | 6 | 1 | 18094 | 48 |
SLC4A4 |
1.581e-02 | -4.15 | phosphatidylcholine-sterol O-acyltransferase activator activity | molecular function | GO:0060228 | 6 | 1 | 18094 | 48 |
APOA1 |
1.581e-02 | -4.15 | gamma-aminobutyric acid:sodium:chloride symporter activity | molecular function | GO:0005332 | 6 | 1 | 18094 | 48 |
SLC6A11 |
1.581e-02 | -4.15 | succinate transmembrane transporter activity | molecular function | GO:0015141 | 6 | 1 | 18094 | 48 |
SLC13A5 |
1.593e-02 | -4.14 | WNT_subtype | COSMIC cancer mutations | WNT_subtype | 182 | 3 | 16828 | 49 |
NCKAP5,NPAS3,EGF |
1.595e-02 | -4.14 | cell projection | cellular component | GO:0042995 | 2398 | 12 | 19108 | 49 |
SLC6A11,NRCAM,CTNND2,GRIP1,NTRK2,SORCS2,PREX1,SLC1A3,TNS3,SLC1A2,AQP4,FARP1 |
1.600e-02 | -4.13 | other | COSMIC cancer mutations | other | 14843 | 48 | 16828 | 49 |
FHOD3,CTBP1,ELOVL2,LRIG1,SLC6A11,RORA,GRIP1,AQP4,GPM6B,GPC5,USP6NL,SORCS2,APOA1,NHSL1,SLC1A2,FARP1,CTNND2,SLC1A3,PTPRZ1,LPIN2,FKBP5,RFX4,TRPS1,ZBTB20,PREX2,MSI2,QKI,NCKAP5,DGKB,PTN,NRCAM,FGFRL1,PREX1,PRDM16,NFIA,ITPR2,COL11A1,ITPK1,GRK5,EGF,SNTB1,TNS3,SLC39A12,SLC13A5,NPAS3,SOX5,NTRK2,SLC4A4 |
1.604e-02 | -4.13 | LRRNT | smart domains | SM00013 | 54 | 2 | 9717 | 35 |
NTRK2,LRIG1 |
1.609e-02 | -4.13 | RIH_assoc-dom | interpro domains | IPR013662 | 6 | 1 | 18521 | 50 |
ITPR2 |
1.609e-02 | -4.13 | RIH_dom | interpro domains | IPR000699 | 6 | 1 | 18521 | 50 |
ITPR2 |
1.609e-02 | -4.13 | Glypican | interpro domains | IPR001863 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | Ryanodine_IP3_receptor | interpro domains | IPR015925 | 6 | 1 | 18521 | 50 |
ITPR2 |
1.609e-02 | -4.13 | ELO_CS | interpro domains | IPR030457 | 6 | 1 | 18521 | 50 |
ELOVL2 |
1.609e-02 | -4.13 | Ins145_P3_rcpt | interpro domains | IPR014821 | 6 | 1 | 18521 | 50 |
ITPR2 |
1.609e-02 | -4.13 | RyR/IP3R_RIH_dom_sf | interpro domains | IPR035910 | 6 | 1 | 18521 | 50 |
ITPR2 |
1.609e-02 | -4.13 | Glypican_CS | interpro domains | IPR019803 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | LNS2/PITP | interpro domains | IPR031315 | 6 | 1 | 18521 | 50 |
LPIN2 |
1.610e-02 | -4.13 | central_nervous_system-brain-glioma | COSMIC cancer mutations | central_nervous_system-brain-glioma | 15470 | 49 | 16828 | 49 |
SNTB1,EGF,TNS3,ITPR2,GRK5,ITPK1,COL11A1,PRDM16,NFIA,PREX1,FGFRL1,NTRK2,SLC4A4,NPAS3,SLC13A5,SOX5,SLC39A12,APOA1,SLC1A3,CTNND2,SLC1A2,FARP1,NHSL1,GPC5,SORCS2,USP6NL,GRIP1,RORA,GPM6B,AQP4,CTBP1,FHOD3,SLC6A11,LRIG1,ELOVL2,ADAM12,DGKB,NCKAP5,QKI,NRCAM,PTN,ZBTB20,MSI2,PREX2,FKBP5,TRPS1,RFX4,PTPRZ1,LPIN2 |
1.613e-02 | -4.13 | TNS3 (tensin 3) | protein interactions | 64759 | 77 | 2 | 19454 | 49 |
APOA1,SNTB1 |
1.613e-02 | -4.13 | SDC1 (syndecan 1) | protein interactions | 6382 | 77 | 2 | 19454 | 49 |
FARP1,PTN |
1.616e-02 | -4.13 | NAHCO3TRSPRT | prints domains | PR01232 | 5 | 1 | 5227 | 17 |
SLC4A4 |
1.622e-02 | -4.12 | phosphorus metabolic process | biological process | GO:0006793 | 1707 | 10 | 18204 | 50 |
GRK5,DGKB,RORA,PTPRZ1,ITPK1,ELOVL2,APOA1,NTRK2,CTBP1,TNS3 |
1.637e-02 | -4.11 | amino acid neurotransmitter reuptake | biological process | GO:0051933 | 6 | 1 | 18204 | 50 |
SLC6A11 |
1.637e-02 | -4.11 | succinate transport | biological process | GO:0015744 | 6 | 1 | 18204 | 50 |
SLC13A5 |
1.637e-02 | -4.11 | positive regulation of cerebellar granule cell precursor proliferation | biological process | GO:0021940 | 6 | 1 | 18204 | 50 |
EGF |
1.637e-02 | -4.11 | cell surface receptor protein tyrosine phosphatase signaling pathway | biological process | GO:0007185 | 6 | 1 | 18204 | 50 |
PTN |
1.637e-02 | -4.11 | asymmetric neuroblast division | biological process | GO:0055059 | 6 | 1 | 18204 | 50 |
SOX5 |
1.637e-02 | -4.11 | regulation of synapse pruning | biological process | GO:1905806 | 6 | 1 | 18204 | 50 |
ADGRB3 |
1.637e-02 | -4.11 | intracellular water homeostasis | biological process | GO:0009992 | 6 | 1 | 18204 | 50 |
AQP4 |
1.637e-02 | -4.11 | inositol trisphosphate metabolic process | biological process | GO:0032957 | 6 | 1 | 18204 | 50 |
ITPK1 |
1.637e-02 | -4.11 | positive regulation of skeletal muscle acetylcholine-gated channel clustering | biological process | GO:1904395 | 6 | 1 | 18204 | 50 |
FARP1 |
1.637e-02 | -4.11 | cholesterol import | biological process | GO:0070508 | 6 | 1 | 18204 | 50 |
APOA1 |
1.637e-02 | -4.11 | clustering of voltage-gated sodium channels | biological process | GO:0045162 | 6 | 1 | 18204 | 50 |
NRCAM |
1.637e-02 | -4.11 | succinate transmembrane transport | biological process | GO:0071422 | 6 | 1 | 18204 | 50 |
SLC13A5 |
1.637e-02 | -4.11 | regulation of very-low-density lipoprotein particle remodeling | biological process | GO:0010901 | 6 | 1 | 18204 | 50 |
APOA1 |
1.637e-02 | -4.11 | gamma-aminobutyric acid biosynthetic process | biological process | GO:0009449 | 6 | 1 | 18204 | 50 |
SLC1A3 |
1.647e-02 | -4.11 | IP3 receptor type 1 binding core, RIH domain | gene3d domains | 1.25.10.30 | 6 | 1 | 14470 | 40 |
ITPR2 |
1.648e-02 | -4.11 | ANKFY1 (ankyrin repeat and FYVE domain containing 1) | protein interactions | 51479 | 213 | 3 | 19454 | 49 |
GRK5,FARP1,CTBP1 |
1.652e-02 | -4.10 | SGK1 (serum/glucocorticoid regulated kinase 1) | protein interactions | 6446 | 78 | 2 | 19454 | 49 |
SLC1A3,FKBP5 |
1.652e-02 | -4.10 | MIR34C (microRNA 34c) | protein interactions | 407042 | 78 | 2 | 19454 | 49 |
MSI2,QKI |
1.652e-02 | -4.10 | ANKRD40 (ankyrin repeat domain 40) | protein interactions | 91369 | 78 | 2 | 19454 | 49 |
SOX5,MSI2 |
1.668e-02 | -4.09 | transcription repressor complex | cellular component | GO:0017053 | 77 | 2 | 19108 | 49 |
PRDM16,CTBP1 |
1.668e-02 | -4.09 | NCK1 (NCK adaptor protein 1) | protein interactions | 4690 | 214 | 3 | 19454 | 49 |
NCKAP5,NHSL1,NTRK2 |
1.672e-02 | -4.09 | regulation of ATP metabolic process | biological process | GO:1903578 | 72 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
1.674e-02 | -4.09 | RIH_assoc | pfam domains | PF08454 | 6 | 1 | 17795 | 50 |
ITPR2 |
1.674e-02 | -4.09 | Glypican | pfam domains | PF01153 | 6 | 1 | 17795 | 50 |
GPC5 |
1.674e-02 | -4.09 | RYDR_ITPR | pfam domains | PF01365 | 6 | 1 | 17795 | 50 |
ITPR2 |
1.674e-02 | -4.09 | Ins145_P3_rec | pfam domains | PF08709 | 6 | 1 | 17795 | 50 |
ITPR2 |
1.693e-02 | -4.08 | DNAJB8 (DnaJ heat shock protein family (Hsp40) member B8) | protein interactions | 165721 | 79 | 2 | 19454 | 49 |
ZBTB20,FKBP5 |
1.693e-02 | -4.08 | KRTAP3-2 (keratin associated protein 3-2) | protein interactions | 83897 | 79 | 2 | 19454 | 49 |
SLC13A5,ADAM12 |
1.693e-02 | -4.08 | PRDM1 (PR/SET domain 1) | protein interactions | 639 | 79 | 2 | 19454 | 49 |
TRPS1,NFIA |
1.693e-02 | -4.08 | CDKN2D (cyclin dependent kinase inhibitor 2D) | protein interactions | 1032 | 79 | 2 | 19454 | 49 |
QKI,CTBP1 |
1.709e-02 | -4.07 | human chr2q21.2 | chromosome location | human chr2q21.2 | 9 | 1 | 26134 | 50 |
NCKAP5 |
1.709e-02 | -4.07 | GABA-ergic synapse | cellular component | GO:0098982 | 78 | 2 | 19108 | 49 |
SLC6A11,CTBP1 |
1.710e-02 | -4.07 | Signaling by MET | REACTOME pathways | R-HSA-6806834 | 69 | 2 | 10285 | 30 |
TNS3,LRIG1 |
1.713e-02 | -4.07 | vasculature development | biological process | GO:0001944 | 550 | 5 | 18204 | 50 |
NTRK2,NRCAM,EGF,RORA,QKI |
1.716e-02 | -4.07 | regulation of cartilage development | biological process | GO:0061035 | 73 | 2 | 18204 | 50 |
TRPS1,SOX5 |
1.716e-02 | -4.07 | vasculogenesis | biological process | GO:0001570 | 73 | 2 | 18204 | 50 |
QKI,NTRK2 |
1.717e-02 | -4.06 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 15 | 18204 | 50 |
SOX5,QKI,PTPRZ1,RORA,ADGRB3,APOA1,EGF,ZBTB20,PTN,GPM6B,TRPS1,ADAM12,PRDM16,NTRK2,SLC39A12 |
1.733e-02 | -4.06 | PPP1CA (protein phosphatase 1 catalytic subunit alpha) | protein interactions | 100009298 | 80 | 2 | 19454 | 49 |
PREX2,FARP1 |
1.735e-02 | -4.05 | skin-forearm-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-forearm-malignant_melanoma-superficial_spreading | 6 | 1 | 16828 | 49 |
PREX2 |
1.735e-02 | -4.05 | skin-head_neck-malignant_melanoma | COSMIC cancer mutations | skin-head_neck-malignant_melanoma | 6 | 1 | 16828 | 49 |
PREX2 |
1.735e-02 | -4.05 | autonomic_ganglia-paraganglioma-benign | COSMIC cancer mutations | autonomic_ganglia-paraganglioma-benign | 6 | 1 | 16828 | 49 |
NHSL1 |
1.738e-02 | -4.05 | signaling | biological process | GO:0023052 | 4968 | 21 | 18204 | 50 |
PREX1,GRIP1,GRK5,PTN,NFIA,ITPK1,DGKB,SORCS2,NTRK2,SLC39A12,SLC1A3,ADGRB3,SLC1A2,CTNND2,PREX2,FGFRL1,RORA,APOA1,EGF,ITPR2,FARP1 |
1.738e-02 | -4.05 | Activation of TRKA receptors | REACTOME pathways | R-HSA-187015 | 6 | 1 | 10285 | 30 |
NTRK2 |
1.750e-02 | -4.05 | Pum2 (pumilio RNA-binding family member 2) | protein interactions | 80913 | 7 | 1 | 19454 | 49 |
QKI |
1.750e-02 | -4.05 | ZFYVE28 (zinc finger FYVE-type containing 28) | protein interactions | 57732 | 7 | 1 | 19454 | 49 |
EGF |
1.750e-02 | -4.05 | C1QL3 (complement C1q like 3) | protein interactions | 389941 | 7 | 1 | 19454 | 49 |
ADGRB3 |
1.750e-02 | -4.05 | SLC16A5 (solute carrier family 16 member 5) | protein interactions | 9121 | 7 | 1 | 19454 | 49 |
PTPRZ1 |
1.750e-02 | -4.05 | FGF5 (fibroblast growth factor 5) | protein interactions | 2250 | 7 | 1 | 19454 | 49 |
EGF |
1.750e-02 | -4.05 | ABCC12 (ATP binding cassette subfamily C member 12) | protein interactions | 94160 | 7 | 1 | 19454 | 49 |
NPAS3 |
1.750e-02 | -4.05 | CDH10 (cadherin 10) | protein interactions | 1008 | 7 | 1 | 19454 | 49 |
PTN |
1.750e-02 | -4.05 | ZBTB45 (zinc finger and BTB domain containing 45) | protein interactions | 84878 | 7 | 1 | 19454 | 49 |
ZBTB20 |
1.750e-02 | -4.05 | CETP (cholesteryl ester transfer protein) | protein interactions | 1071 | 7 | 1 | 19454 | 49 |
APOA1 |
1.750e-02 | -4.05 | SAA2 (serum amyloid A2) | protein interactions | 6289 | 7 | 1 | 19454 | 49 |
APOA1 |
1.774e-02 | -4.03 | ZF_DAG_PE_1 | prosite domains | PS00479 | 58 | 2 | 12186 | 43 |
DGKB,TNS3 |
1.774e-02 | -4.03 | SOX17 (SRY-box transcription factor 17) | protein interactions | 64321 | 81 | 2 | 19454 | 49 |
NFIA,TRPS1 |
1.774e-02 | -4.03 | ARNT2 (aryl hydrocarbon receptor nuclear translocator 2) | protein interactions | 9915 | 81 | 2 | 19454 | 49 |
CTBP1,NPAS3 |
1.774e-02 | -4.03 | SPRY4 (sprouty RTK signaling antagonist 4) | protein interactions | 81848 | 81 | 2 | 19454 | 49 |
ADAM12,NTRK2 |
1.779e-02 | -4.03 | Neuronal System | REACTOME pathways | R-HSA-112316 | 349 | 4 | 10285 | 30 |
GRIP1,SLC1A2,SLC1A3,SLC6A11 |
1.782e-02 | -4.03 | cerebellar climbing fiber to Purkinje cell synapse | cellular component | GO:0150053 | 7 | 1 | 19108 | 49 |
ADGRB3 |
1.788e-02 | -4.02 | VPS10 | smart domains | SM00602 | 5 | 1 | 9717 | 35 |
SORCS2 |
1.791e-02 | -4.02 | monoatomic cation transport | biological process | GO:0006812 | 766 | 6 | 18204 | 50 |
SLC13A5,SLC1A3,ITPR2,SLC39A12,SLC4A4,SLC6A11 |
1.796e-02 | -4.02 | G alpha (q) signalling events | REACTOME pathways | R-HSA-416476 | 192 | 3 | 10285 | 30 |
GRK5,ITPR2,DGKB |
1.799e-02 | -4.02 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 25 | 18204 | 50 |
ZBTB20,ITPR2,PREX2,ADGRB3,SLC1A2,CTNND2,SORCS2,SLC13A5,SLC1A3,SLC39A12,PTN,DGKB,LPIN2,FARP1,APOA1,EGF,FGFRL1,RORA,AQP4,NTRK2,NFIA,ITPK1,PREX1,GRIP1,GRK5 |
1.815e-02 | -4.01 | alveolar | COSMIC cancer mutations | alveolar | 2414 | 13 | 16828 | 49 |
NCKAP5,SLC1A3,NHSL1,PREX2,GRK5,USP6NL,SORCS2,NPAS3,TRPS1,NFIA,CTBP1,FHOD3,FGFRL1 |
1.815e-02 | -4.01 | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | 2414 | 13 | 16828 | 49 |
NHSL1,SLC1A3,NCKAP5,SORCS2,USP6NL,GRK5,PREX2,NFIA,TRPS1,NPAS3,FHOD3,FGFRL1,CTBP1 |
1.816e-02 | -4.01 | B4GALT1 (beta-1,4-galactosyltransferase 1) | protein interactions | 2683 | 82 | 2 | 19454 | 49 |
SLC39A12,CTBP1 |
1.816e-02 | -4.01 | LRRC40 (leucine rich repeat containing 40) | protein interactions | 55631 | 82 | 2 | 19454 | 49 |
FKBP5,LRIG1 |
1.837e-02 | -4.00 | Internalization of ErbB1 | Pathway Interaction DB | erbb1_internalization_pathway | 34 | 2 | 2226 | 14 |
LRIG1,EGF |
1.838e-02 | -4.00 | animal organ development | biological process | GO:0048513 | 2846 | 14 | 18204 | 50 |
RFX4,PTN,NFIA,NRCAM,NTRK2,COL11A1,SLC1A2,LRIG1,RORA,SOX5,FGFRL1,FHOD3,EGF,APOA1 |
1.843e-02 | -3.99 | fatty acid elongase activity | molecular function | GO:0009922 | 7 | 1 | 18094 | 48 |
ELOVL2 |
1.843e-02 | -3.99 | G protein-coupled receptor kinase activity | molecular function | GO:0004703 | 7 | 1 | 18094 | 48 |
GRK5 |
1.843e-02 | -3.99 | heparan sulfate binding | molecular function | GO:1904399 | 7 | 1 | 18094 | 48 |
COL11A1 |
1.843e-02 | -3.99 | histone H3K9me2 methyltransferase activity | molecular function | GO:0140947 | 7 | 1 | 18094 | 48 |
PRDM16 |
1.843e-02 | -3.99 | apolipoprotein receptor binding | molecular function | GO:0034190 | 7 | 1 | 18094 | 48 |
APOA1 |
1.852e-02 | -3.99 | myotube differentiation | biological process | GO:0014902 | 76 | 2 | 18204 | 50 |
ADGRB3,ADAM12 |
1.858e-02 | -3.99 | EPHB6 (EPH receptor B6) | protein interactions | 2051 | 83 | 2 | 19454 | 49 |
USP6NL,FKBP5 |
1.858e-02 | -3.99 | PAX2 (paired box 2) | protein interactions | 5076 | 83 | 2 | 19454 | 49 |
TRPS1,NFIA |
1.875e-02 | -3.98 | Plakophilin/d_Catenin | interpro domains | IPR028435 | 7 | 1 | 18521 | 50 |
CTNND2 |
1.875e-02 | -3.98 | GPCR_kinase | interpro domains | IPR000239 | 7 | 1 | 18521 | 50 |
GRK5 |
1.875e-02 | -3.98 | Aquaporin_transptr | interpro domains | IPR034294 | 7 | 1 | 18521 | 50 |
AQP4 |
1.875e-02 | -3.98 | ELO_fam | interpro domains | IPR002076 | 7 | 1 | 18521 | 50 |
ELOVL2 |
1.875e-02 | -3.98 | head development | biological process | GO:0060322 | 774 | 6 | 18204 | 50 |
RORA,RFX4,NTRK2,NRCAM,SLC1A2,EGF |
1.885e-02 | -3.97 | UBE2I (ubiquitin conjugating enzyme E2 I) | protein interactions | 7329 | 615 | 5 | 19454 | 49 |
EGF,TRPS1,SOX5,CTBP1,GRIP1 |
1.889e-02 | -3.97 | haematopoietic_and_lymphoid_tissue | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue | 14368 | 47 | 16828 | 49 |
RORA,GRIP1,AQP4,FHOD3,CTBP1,ADAM12,ELOVL2,LRIG1,SLC6A11,SLC1A2,NHSL1,FARP1,CTNND2,SLC1A3,GPC5,USP6NL,SORCS2,FKBP5,RFX4,TRPS1,PTPRZ1,LPIN2,QKI,NCKAP5,DGKB,NRCAM,PTN,ZBTB20,PREX2,MSI2,PRDM16,NFIA,FGFRL1,PREX1,EGF,SNTB1,TNS3,ITPR2,COL11A1,ITPK1,GRK5,SLC13A5,NPAS3,SOX5,SLC39A12,NTRK2,SLC4A4 |
1.897e-02 | -3.96 | human chr12p11.23 | chromosome location | human chr12p11.23 | 10 | 1 | 26134 | 50 |
ITPR2 |
1.897e-02 | -3.96 | human chr10p12.33 | chromosome location | human chr10p12.33 | 10 | 1 | 26134 | 50 |
SLC39A12 |
1.898e-02 | -3.96 | regulation of cholesterol transport | biological process | GO:0032374 | 77 | 2 | 18204 | 50 |
EGF,APOA1 |
1.898e-02 | -3.96 | regulation of sterol transport | biological process | GO:0032371 | 77 | 2 | 18204 | 50 |
EGF,APOA1 |
1.900e-02 | -3.96 | MAPK12 (mitogen-activated protein kinase 12) | protein interactions | 6300 | 84 | 2 | 19454 | 49 |
FKBP5,SNTB1 |
1.904e-02 | -3.96 | FOXC1 (forkhead box C1) | protein interactions | 2296 | 225 | 3 | 19454 | 49 |
CTBP1,NFIA,SOX5 |
1.907e-02 | -3.96 | fatty acid elongation, unsaturated fatty acid | biological process | GO:0019368 | 7 | 1 | 18204 | 50 |
ELOVL2 |
1.907e-02 | -3.96 | regulation of oligodendrocyte progenitor proliferation | biological process | GO:0070445 | 7 | 1 | 18204 | 50 |
PTPRZ1 |
1.907e-02 | -3.96 | fatty acid elongation, polyunsaturated fatty acid | biological process | GO:0034626 | 7 | 1 | 18204 | 50 |
ELOVL2 |
1.907e-02 | -3.96 | glial cell fate specification | biological process | GO:0021780 | 7 | 1 | 18204 | 50 |
NFIA |
1.907e-02 | -3.96 | alpha-ketoglutarate transport | biological process | GO:0015742 | 7 | 1 | 18204 | 50 |
SLC13A5 |
1.907e-02 | -3.96 | fatty acid elongation, monounsaturated fatty acid | biological process | GO:0034625 | 7 | 1 | 18204 | 50 |
ELOVL2 |
1.907e-02 | -3.96 | regulation of 3'-UTR-mediated mRNA stabilization | biological process | GO:1905868 | 7 | 1 | 18204 | 50 |
QKI |
1.907e-02 | -3.96 | regulation of skeletal muscle acetylcholine-gated channel clustering | biological process | GO:1904393 | 7 | 1 | 18204 | 50 |
FARP1 |
1.907e-02 | -3.96 | high-density lipoprotein particle clearance | biological process | GO:0034384 | 7 | 1 | 18204 | 50 |
APOA1 |
1.907e-02 | -3.96 | trans-synaptic signaling by trans-synaptic complex | biological process | GO:0099545 | 7 | 1 | 18204 | 50 |
FARP1 |
1.930e-02 | -3.95 | WH_DNA-bd_sf | interpro domains | IPR036390 | 211 | 3 | 18521 | 50 |
PREX1,PREX2,RFX4 |
1.937e-02 | -3.94 | EGFTGF | prints domains | PR00009 | 6 | 1 | 5227 | 17 |
EGF |
1.943e-02 | -3.94 | CFAP298 (cilia and flagella associated protein 298) | protein interactions | 56683 | 85 | 2 | 19454 | 49 |
FKBP5,TRPS1 |
1.951e-02 | -3.94 | ELO | pfam domains | PF01151 | 7 | 1 | 17795 | 50 |
ELOVL2 |
1.953e-02 | -3.94 | trunk | COSMIC cancer mutations | trunk | 3554 | 17 | 16828 | 49 |
CTNND2,SLC1A3,NRCAM,EGF,NCKAP5,SNTB1,DGKB,COL11A1,PREX2,NTRK2,TRPS1,SOX5,NPAS3,FKBP5,PRDM16,SLC6A11,PTPRZ1 |
1.954e-02 | -3.94 | transmembrane receptor protein kinase activity | molecular function | GO:0019199 | 81 | 2 | 18094 | 48 |
NTRK2,FGFRL1 |
1.970e-02 | -3.93 | Bile secretion | KEGG pathways | hsa04976 | 71 | 2 | 7161 | 22 |
SLC4A4,AQP4 |
1.970e-02 | -3.93 | Bile secretion | KEGG pathways | ko04976 | 71 | 2 | 7161 | 22 |
AQP4,SLC4A4 |
1.973e-02 | -3.93 | regulation of neurogenesis | biological process | GO:0050767 | 377 | 4 | 18204 | 50 |
NTRK2,PTPRZ1,QKI,PTN |
1.984e-02 | -3.92 | Signal Transduction | REACTOME pathways | R-HSA-162582 | 2547 | 13 | 10285 | 30 |
FGFRL1,LRIG1,GRK5,CTBP1,PREX1,ADAM12,DGKB,NTRK2,EGF,TNS3,APOA1,GPC5,ITPR2 |
1.998e-02 | -3.91 | DEPP1 (DEPP autophagy regulator 1) | protein interactions | 11067 | 8 | 1 | 19454 | 49 |
QKI |
1.998e-02 | -3.91 | FSTL3 (follistatin like 3) | protein interactions | 10272 | 8 | 1 | 19454 | 49 |
ADAM12 |
1.998e-02 | -3.91 | MARCHF10 (membrane associated ring-CH-type finger 10) | protein interactions | 162333 | 8 | 1 | 19454 | 49 |
CTBP1 |
1.998e-02 | -3.91 | CNMD (chondromodulin) | protein interactions | 11061 | 8 | 1 | 19454 | 49 |
APOA1 |
1.998e-02 | -3.91 | PDE6B (phosphodiesterase 6B) | protein interactions | 5158 | 8 | 1 | 19454 | 49 |
CTBP1 |
1.998e-02 | -3.91 | HSD11B2 (hydroxysteroid 11-beta dehydrogenase 2) | protein interactions | 3291 | 8 | 1 | 19454 | 49 |
CTBP1 |
1.998e-02 | -3.91 | GLYAT (glycine-N-acyltransferase) | protein interactions | 10249 | 8 | 1 | 19454 | 49 |
PTN |
2.018e-02 | -3.90 | positive regulation of GTPase activity | biological process | GO:0043547 | 211 | 3 | 18204 | 50 |
PREX2,USP6NL,PREX1 |
2.019e-02 | -3.90 | PTPc_motif | smart domains | SM00404 | 61 | 2 | 9717 | 35 |
PTPRZ1,TNS3 |
2.021e-02 | -3.90 | skin-upper_leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma-nodular | 7 | 1 | 16828 | 49 |
PREX2 |
2.021e-02 | -3.90 | skin-face-malignant_melanoma-nodular | COSMIC cancer mutations | skin-face-malignant_melanoma-nodular | 7 | 1 | 16828 | 49 |
PREX2 |
2.025e-02 | -3.90 | Neurofascin interactions | REACTOME pathways | R-HSA-447043 | 7 | 1 | 10285 | 30 |
NRCAM |
2.025e-02 | -3.90 | NrCAM interactions | REACTOME pathways | R-HSA-447038 | 7 | 1 | 10285 | 30 |
NRCAM |
2.029e-02 | -3.90 | ZNF608 (zinc finger protein 608) | protein interactions | 57507 | 87 | 2 | 19454 | 49 |
NFIA,SOX5 |
2.029e-02 | -3.90 | Kctd5 (potassium channel tetramerisation domain containing 5) | protein interactions | 69259 | 87 | 2 | 19454 | 49 |
SLC1A3,TRPS1 |
2.029e-02 | -3.90 | NHLH1 (nescient helix-loop-helix 1) | protein interactions | 4807 | 87 | 2 | 19454 | 49 |
NFIA,TRPS1 |
2.029e-02 | -3.90 | MIR141 (microRNA 141) | protein interactions | 406933 | 87 | 2 | 19454 | 49 |
QKI,MSI2 |
2.034e-02 | -3.90 | extrinsic component of postsynaptic membrane | cellular component | GO:0098890 | 8 | 1 | 19108 | 49 |
FARP1 |
2.034e-02 | -3.90 | spherical high-density lipoprotein particle | cellular component | GO:0034366 | 8 | 1 | 19108 | 49 |
APOA1 |
2.042e-02 | -3.89 | enzyme regulator activity | molecular function | GO:0030234 | 1305 | 8 | 18094 | 48 |
PTN,EGF,USP6NL,PREX1,ADGRB3,FARP1,APOA1,PREX2 |
2.044e-02 | -3.89 | Signaling by EGFR | REACTOME pathways | R-HSA-177929 | 364 | 4 | 10285 | 30 |
ADAM12,LRIG1,EGF,ITPR2 |
2.062e-02 | -3.88 | CDC23 (cell division cycle 23) | protein interactions | 8697 | 232 | 3 | 19454 | 49 |
CTBP1,SOX5,FHOD3 |
2.073e-02 | -3.88 | ZF_DAG_PE_2 | prosite domains | PS50081 | 63 | 2 | 12186 | 43 |
DGKB,TNS3 |
2.073e-02 | -3.88 | stomach | COSMIC cancer mutations | stomach | 15550 | 49 | 16828 | 49 |
FGFRL1,PREX1,NFIA,PRDM16,ITPK1,COL11A1,GRK5,ITPR2,TNS3,EGF,SNTB1,SLC39A12,SOX5,NPAS3,SLC13A5,SLC4A4,NTRK2,ADAM12,SLC6A11,LRIG1,ELOVL2,CTBP1,FHOD3,GPM6B,AQP4,RORA,GRIP1,USP6NL,SORCS2,GPC5,CTNND2,FARP1,NHSL1,SLC1A2,SLC1A3,APOA1,LPIN2,PTPRZ1,RFX4,TRPS1,FKBP5,MSI2,PREX2,ZBTB20,PTN,NRCAM,QKI,NCKAP5,DGKB |
2.092e-02 | -3.87 | transmembrane transport | biological process | GO:0055085 | 1264 | 8 | 18204 | 50 |
SLC6A11,SLC4A4,SLC1A3,SLC39A12,ITPR2,SLC13A5,AQP4,SLC1A2 |
2.099e-02 | -3.86 | GLYPICAN | prosite domains | PS01207 | 6 | 1 | 12186 | 43 |
GPC5 |
2.099e-02 | -3.86 | ELO | prosite domains | PS01188 | 6 | 1 | 12186 | 43 |
ELOVL2 |
2.103e-02 | -3.86 | glutamate binding | molecular function | GO:0016595 | 8 | 1 | 18094 | 48 |
SLC1A3 |
2.106e-02 | -3.86 | eye-uveal_tract-malignant_melanoma-spindle | COSMIC cancer mutations | eye-uveal_tract-malignant_melanoma-spindle | 363 | 4 | 16828 | 49 |
FGFRL1,CTNND2,GRK5,PREX2 |
2.109e-02 | -3.86 | HMG20A (high mobility group 20A) | protein interactions | 10363 | 234 | 3 | 19454 | 49 |
NFIA,SNTB1,SOX5 |
2.115e-02 | -3.86 | Cys-rich_flank_reg_C | interpro domains | IPR000483 | 83 | 2 | 18521 | 50 |
LRIG1,NTRK2 |
2.117e-02 | -3.86 | intracellular chemical homeostasis | biological process | GO:0055082 | 581 | 5 | 18204 | 50 |
AQP4,ZBTB20,SLC1A3,SLC39A12,SLC4A4 |
2.117e-02 | -3.85 | SOX10 (SRY-box transcription factor 10) | protein interactions | 6663 | 89 | 2 | 19454 | 49 |
NFIA,TRPS1 |
2.125e-02 | -3.85 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 12 | 16828 | 49 |
SLC4A4,PREX2,GRK5,NTRK2,NFIA,SOX5,TRPS1,GRIP1,FHOD3,FGFRL1,CTBP1,PTPRZ1 |
2.126e-02 | -3.85 | femur | COSMIC cancer mutations | femur | 1197 | 8 | 16828 | 49 |
LRIG1,ELOVL2,SLC4A4,PREX1,PTPRZ1,GPC5,NCKAP5,SNTB1 |
2.130e-02 | -3.85 | leg | COSMIC cancer mutations | leg | 969 | 7 | 16828 | 49 |
EGF,ZBTB20,PTPRZ1,SLC4A4,COL11A1,SLC6A11,GRK5 |
2.135e-02 | -3.85 | regulation of bone mineralization | biological process | GO:0030500 | 82 | 2 | 18204 | 50 |
PTN,GPM6B |
2.140e-02 | -3.84 | RFX-like | interpro domains | IPR039779 | 8 | 1 | 18521 | 50 |
RFX4 |
2.140e-02 | -3.84 | PKD/Chitinase_dom | interpro domains | IPR022409 | 8 | 1 | 18521 | 50 |
SORCS2 |
2.140e-02 | -3.84 | DAD_dom | interpro domains | IPR014767 | 8 | 1 | 18521 | 50 |
FHOD3 |
2.140e-02 | -3.84 | Tensin_phosphatase | interpro domains | IPR029023 | 8 | 1 | 18521 | 50 |
TNS3 |
2.140e-02 | -3.84 | Tensin_C2-dom | interpro domains | IPR014020 | 8 | 1 | 18521 | 50 |
TNS3 |
2.140e-02 | -3.84 | PTB | interpro domains | IPR013625 | 8 | 1 | 18521 | 50 |
TNS3 |
2.142e-02 | -3.84 | LNS2 | smart domains | SM00775 | 6 | 1 | 9717 | 35 |
LPIN2 |
2.153e-02 | -3.84 | Ig_sub | interpro domains | IPR003599 | 394 | 4 | 18521 | 50 |
NRCAM,NTRK2,LRIG1,FGFRL1 |
2.174e-02 | -3.83 | pancreas-carcinoma-ductal_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-ductal_carcinoma | 15565 | 49 | 16828 | 49 |
AQP4,GPM6B,GRIP1,RORA,LRIG1,ELOVL2,SLC6A11,ADAM12,FHOD3,CTBP1,SLC1A3,SLC1A2,FARP1,NHSL1,CTNND2,APOA1,USP6NL,SORCS2,GPC5,TRPS1,RFX4,FKBP5,LPIN2,PTPRZ1,NRCAM,PTN,NCKAP5,DGKB,QKI,PREX2,MSI2,ZBTB20,NFIA,PRDM16,PREX1,FGFRL1,TNS3,SNTB1,EGF,GRK5,COL11A1,ITPK1,ITPR2,SOX5,SLC13A5,NPAS3,SLC39A12,SLC4A4,NTRK2 |
2.177e-02 | -3.83 | alkanesulfonate transmembrane transport | biological process | GO:0042918 | 8 | 1 | 18204 | 50 |
SLC6A11 |
2.177e-02 | -3.83 | tachykinin receptor signaling pathway | biological process | GO:0007217 | 8 | 1 | 18204 | 50 |
GRK5 |
2.177e-02 | -3.83 | positive regulation of epithelial tube formation | biological process | GO:1905278 | 8 | 1 | 18204 | 50 |
EGF |
2.177e-02 | -3.83 | positive regulation of CoA-transferase activity | biological process | GO:1905920 | 8 | 1 | 18204 | 50 |
APOA1 |
2.177e-02 | -3.83 | regulation of Cdc42 protein signal transduction | biological process | GO:0032489 | 8 | 1 | 18204 | 50 |
APOA1 |
2.177e-02 | -3.83 | taurine transmembrane transport | biological process | GO:0015734 | 8 | 1 | 18204 | 50 |
SLC6A11 |
2.177e-02 | -3.83 | regulation of hyaluronan biosynthetic process | biological process | GO:1900125 | 8 | 1 | 18204 | 50 |
EGF |
2.177e-02 | -3.83 | plasma membrane to endosome transport | biological process | GO:0048227 | 8 | 1 | 18204 | 50 |
USP6NL |
2.177e-02 | -3.83 | regulation of epithelial tube formation | biological process | GO:1905276 | 8 | 1 | 18204 | 50 |
EGF |
2.177e-02 | -3.83 | leukocyte chemotaxis involved in inflammatory response | biological process | GO:0002232 | 8 | 1 | 18204 | 50 |
PTN |
2.177e-02 | -3.83 | ERBB2-EGFR signaling pathway | biological process | GO:0038134 | 8 | 1 | 18204 | 50 |
EGF |
2.177e-02 | -3.83 | motor learning | biological process | GO:0061743 | 8 | 1 | 18204 | 50 |
ADGRB3 |
2.177e-02 | -3.83 | fatty acid elongation, saturated fatty acid | biological process | GO:0019367 | 8 | 1 | 18204 | 50 |
ELOVL2 |
2.177e-02 | -3.83 | gamma-aminobutyric acid metabolic process | biological process | GO:0009448 | 8 | 1 | 18204 | 50 |
SLC1A3 |
2.177e-02 | -3.83 | positive regulation of neuron projection arborization | biological process | GO:0150012 | 8 | 1 | 18204 | 50 |
GRIP1 |
2.191e-02 | -3.82 | - | gene3d domains | 2.60.40.1110 | 8 | 1 | 14470 | 40 |
TNS3 |
2.207e-02 | -3.81 | FOXI1 (forkhead box I1) | protein interactions | 2299 | 91 | 2 | 19454 | 49 |
TRPS1,NFIA |
2.207e-02 | -3.81 | NEIL3 (nei like DNA glycosylase 3) | protein interactions | 55247 | 91 | 2 | 19454 | 49 |
FKBP5,QKI |
2.210e-02 | -3.81 | response to stimulus | biological process | GO:0050896 | 7803 | 29 | 18204 | 50 |
AQP4,FGFRL1,SOX5,RORA,EGF,APOA1,FARP1,LPIN2,PREX1,GRK5,GRIP1,ITPK1,NFIA,NTRK2,COL11A1,ADGRB3,CTNND2,SLC1A2,PREX2,ZBTB20,ITPR2,SLC6A11,PTN,DGKB,SORCS2,SLC1A3,SLC39A12,SLC13A5,FKBP5 |
2.224e-02 | -3.81 | regulation of synaptic plasticity | biological process | GO:0048167 | 219 | 3 | 18204 | 50 |
SORCS2,NTRK2,PTN |
2.224e-02 | -3.81 | HNRNPL (heterogeneous nuclear ribonucleoprotein L) | protein interactions | 3191 | 1958 | 10 | 19454 | 49 |
QKI,MSI2,TRPS1,FKBP5,NFIA,FGFRL1,FARP1,ITPK1,ZBTB20,CTBP1 |
2.226e-02 | -3.80 | PTB | pfam domains | PF08416 | 8 | 1 | 17795 | 50 |
TNS3 |
2.226e-02 | -3.80 | PTEN_C2 | pfam domains | PF10409 | 8 | 1 | 17795 | 50 |
TNS3 |
2.233e-02 | -3.80 | regulation of stem cell differentiation | biological process | GO:2000736 | 84 | 2 | 18204 | 50 |
PTN,SOX5 |
2.233e-02 | -3.80 | L-amino acid transport | biological process | GO:0015807 | 84 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
2.245e-02 | -3.80 | SOBP (sine oculis binding protein homolog) | protein interactions | 55084 | 9 | 1 | 19454 | 49 |
CTBP1 |
2.245e-02 | -3.80 | ABCA6 (ATP binding cassette subfamily A member 6) | protein interactions | 23460 | 9 | 1 | 19454 | 49 |
APOA1 |
2.245e-02 | -3.80 | Prmt5 (protein arginine N-methyltransferase 5) | protein interactions | 27374 | 9 | 1 | 19454 | 49 |
FARP1 |
2.245e-02 | -3.80 | Kif18a (kinesin family member 18A) | protein interactions | 228421 | 9 | 1 | 19454 | 49 |
CTBP1 |
2.245e-02 | -3.80 | ABI3BP (ABI family member 3 binding protein) | protein interactions | 25890 | 9 | 1 | 19454 | 49 |
GRK5 |
2.245e-02 | -3.80 | SPEF2 (sperm flagellar 2) | protein interactions | 79925 | 9 | 1 | 19454 | 49 |
APOA1 |
2.245e-02 | -3.80 | Ywhag (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide) | protein interactions | 22628 | 9 | 1 | 19454 | 49 |
QKI |
2.250e-02 | -3.79 | response to mechanical stimulus | biological process | GO:0009612 | 220 | 3 | 18204 | 50 |
SLC1A3,PTN,COL11A1 |
2.253e-02 | -3.79 | SOX9 (SRY-box transcription factor 9) | protein interactions | 6662 | 92 | 2 | 19454 | 49 |
NFIA,TRPS1 |
2.256e-02 | -3.79 | GPCRKINASE | prints domains | PR00717 | 7 | 1 | 5227 | 17 |
GRK5 |
2.260e-02 | -3.79 | Tyr_Pase_dom | interpro domains | IPR000387 | 86 | 2 | 18521 | 50 |
PTPRZ1,TNS3 |
2.272e-02 | -3.78 | human chr6q26 | chromosome location | human chr6q26 | 12 | 1 | 26134 | 50 |
QKI |
2.274e-02 | -3.78 | lipid biosynthetic process | biological process | GO:0008610 | 592 | 5 | 18204 | 50 |
ELOVL2,LPIN2,DGKB,QKI,APOA1 |
2.275e-02 | -3.78 | C1 | smart domains | SM00109 | 65 | 2 | 9717 | 35 |
DGKB,TNS3 |
2.277e-02 | -3.78 | regulation of cell-substrate adhesion | biological process | GO:0010810 | 221 | 3 | 18204 | 50 |
PREX1,APOA1,GPM6B |
2.279e-02 | -3.78 | oesophagus | COSMIC cancer mutations | oesophagus | 14970 | 48 | 16828 | 49 |
PREX2,ZBTB20,PTN,NRCAM,QKI,DGKB,NCKAP5,LPIN2,PTPRZ1,RFX4,TRPS1,FKBP5,USP6NL,SORCS2,GPC5,CTNND2,NHSL1,FARP1,SLC1A2,SLC1A3,APOA1,ADAM12,SLC6A11,LRIG1,ELOVL2,CTBP1,FHOD3,GPM6B,AQP4,RORA,GRIP1,SLC4A4,NTRK2,SLC39A12,SOX5,NPAS3,SLC13A5,ITPK1,COL11A1,GRK5,ITPR2,TNS3,EGF,SNTB1,FGFRL1,PREX1,NFIA,PRDM16 |
2.283e-02 | -3.78 | Ectoderm Differentiation | WikiPathways | WP2858 | 143 | 3 | 5310 | 23 |
CTNND2,ELOVL2,CTBP1 |
2.283e-02 | -3.78 | chondrocyte differentiation | biological process | GO:0002062 | 85 | 2 | 18204 | 50 |
SOX5,COL11A1 |
2.285e-02 | -3.78 | platelet dense tubular network membrane | cellular component | GO:0031095 | 9 | 1 | 19108 | 49 |
ITPR2 |
2.285e-02 | -3.78 | astrocyte end-foot | cellular component | GO:0097450 | 9 | 1 | 19108 | 49 |
AQP4 |
2.299e-02 | -3.77 | TEX11 (testis expressed 11) | protein interactions | 56159 | 93 | 2 | 19454 | 49 |
SOX5,QKI |
2.299e-02 | -3.77 | MIR19B2 (microRNA 19b-2) | protein interactions | 406981 | 93 | 2 | 19454 | 49 |
QKI,MSI2 |
2.299e-02 | -3.77 | RBM23 (RNA binding motif protein 23) | protein interactions | 55147 | 93 | 2 | 19454 | 49 |
QKI,PTN |
2.306e-02 | -3.77 | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | 8 | 1 | 16828 | 49 |
QKI |
2.306e-02 | -3.77 | skin-chest-malignant_melanoma-nodular | COSMIC cancer mutations | skin-chest-malignant_melanoma-nodular | 8 | 1 | 16828 | 49 |
PREX2 |
2.309e-02 | -3.77 | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | COSMIC cancer mutations | salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma | 561 | 5 | 16828 | 49 |
ITPK1,GRK5,NRCAM,PRDM16,NTRK2 |
2.311e-02 | -3.77 | Release of Hh-Np from the secreting cell | REACTOME pathways | R-HSA-5362798 | 8 | 1 | 10285 | 30 |
GPC5 |
2.331e-02 | -3.76 | glycerolipid biosynthetic process | biological process | GO:0045017 | 223 | 3 | 18204 | 50 |
APOA1,LPIN2,DGKB |
2.345e-02 | -3.75 | QSER1 (glutamine and serine rich 1) | protein interactions | 79832 | 94 | 2 | 19454 | 49 |
SOX5,NFIA |
2.345e-02 | -3.75 | FOXP4 (forkhead box P4) | protein interactions | 116113 | 94 | 2 | 19454 | 49 |
SOX5,NFIA |
2.345e-02 | -3.75 | TTR (transthyretin) | protein interactions | 7276 | 94 | 2 | 19454 | 49 |
CTNND2,APOA1 |
2.361e-02 | -3.75 | regulation of biological quality | biological process | GO:0065008 | 2936 | 14 | 18204 | 50 |
NTRK2,NRCAM,SORCS2,GRIP1,PREX1,DGKB,ITPK1,PTN,APOA1,SLC4A4,FARP1,AQP4,ADGRB3,QKI |
2.363e-02 | -3.75 | chondroitin sulfate binding | molecular function | GO:0035374 | 9 | 1 | 18094 | 48 |
PTN |
2.363e-02 | -3.75 | gamma-aminobutyric acid transmembrane transporter activity | molecular function | GO:0015185 | 9 | 1 | 18094 | 48 |
SLC6A11 |
2.364e-02 | -3.74 | Triglyceride Biosynthesis | REACTOME pathways | R-HSA-75109 | 82 | 2 | 10285 | 30 |
LPIN2,ELOVL2 |
2.376e-02 | -3.74 | TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1) | protein interactions | 10454 | 245 | 3 | 19454 | 49 |
GRK5,FKBP5,FARP1 |
2.380e-02 | -3.74 | alcohol binding | molecular function | GO:0043178 | 90 | 2 | 18094 | 48 |
ITPR2,APOA1 |
2.381e-02 | -3.74 | collagen-containing extracellular matrix | cellular component | GO:0062023 | 428 | 4 | 19108 | 49 |
PTPRZ1,GPC5,COL11A1,APOA1 |
2.384e-02 | -3.74 | Regulation of RAC1 activity | Pathway Interaction DB | rac1_reg_pathway | 39 | 2 | 2226 | 14 |
PREX2,PREX1 |
2.385e-02 | -3.74 | striated muscle cell differentiation | biological process | GO:0051146 | 225 | 3 | 18204 | 50 |
FHOD3,ADGRB3,ADAM12 |
2.388e-02 | -3.73 | hand | COSMIC cancer mutations | hand | 566 | 5 | 16828 | 49 |
SLC13A5,PREX1,FARP1,SLC4A4,PREX2 |
2.404e-02 | -3.73 | Band3_cytoplasmic_dom | interpro domains | IPR013769 | 9 | 1 | 18521 | 50 |
SLC4A4 |
2.404e-02 | -3.73 | DNA-bd_RFX | interpro domains | IPR003150 | 9 | 1 | 18521 | 50 |
RFX4 |
2.438e-02 | -3.71 | SPIN1 (spindlin 1) | protein interactions | 10927 | 96 | 2 | 19454 | 49 |
PTN,GRK5 |
2.446e-02 | -3.71 | zinc ion import across plasma membrane | biological process | GO:0071578 | 9 | 1 | 18204 | 50 |
SLC39A12 |
2.446e-02 | -3.71 | positive regulation of protein localization to early endosome | biological process | GO:1902966 | 9 | 1 | 18204 | 50 |
EGF |
2.446e-02 | -3.71 | regulation of intestinal cholesterol absorption | biological process | GO:0030300 | 9 | 1 | 18204 | 50 |
APOA1 |
2.446e-02 | -3.71 | negative regulation of neurotransmitter transport | biological process | GO:0051589 | 9 | 1 | 18204 | 50 |
GPM6B |
2.446e-02 | -3.71 | diaphragm development | biological process | GO:0060539 | 9 | 1 | 18204 | 50 |
FGFRL1 |
2.446e-02 | -3.71 | regulation of cerebellar granule cell precursor proliferation | biological process | GO:0021936 | 9 | 1 | 18204 | 50 |
EGF |
2.446e-02 | -3.71 | regulation of protein localization to early endosome | biological process | GO:1902965 | 9 | 1 | 18204 | 50 |
EGF |
2.452e-02 | -3.71 | NCOR2 (nuclear receptor corepressor 2) | protein interactions | 9612 | 248 | 3 | 19454 | 49 |
SOX5,NFIA,CTBP1 |
2.454e-02 | -3.71 | acinar_carcinoma | COSMIC cancer mutations | acinar_carcinoma | 1978 | 11 | 16828 | 49 |
ADAM12,SORCS2,GRK5,FHOD3,SLC39A12,ZBTB20,PTPRZ1,CTNND2,NHSL1,SOX5,QKI |
2.454e-02 | -3.71 | pancreas-carcinoma-acinar_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-acinar_carcinoma | 1978 | 11 | 16828 | 49 |
FHOD3,ZBTB20,SLC39A12,PTPRZ1,SORCS2,ADAM12,GRK5,QKI,CTNND2,NHSL1,SOX5 |
2.456e-02 | -3.71 | Protein tyrosine phosphatase superfamily | gene3d domains | 3.90.190.10 | 88 | 2 | 14470 | 40 |
TNS3,PTPRZ1 |
2.459e-02 | -3.71 | human chr1p21.1 | chromosome location | human chr1p21.1 | 13 | 1 | 26134 | 50 |
COL11A1 |
2.461e-02 | -3.70 | - | gene3d domains | 1.25.40.610 | 9 | 1 | 14470 | 40 |
ADGRB3 |
2.470e-02 | -3.70 | WH-like_DNA-bd_sf | interpro domains | IPR036388 | 232 | 3 | 18521 | 50 |
PREX1,PREX2,RFX4 |
2.475e-02 | -3.70 | RHOQ (ras homolog family member Q) | protein interactions | 23433 | 441 | 4 | 19454 | 49 |
USP6NL,TNS3,FARP1,SNTB1 |
2.486e-02 | -3.69 | PCGF5 (polycomb group ring finger 5) | protein interactions | 84333 | 97 | 2 | 19454 | 49 |
CTBP1,QKI |
2.488e-02 | -3.69 | skin-foot-malignant_melanoma | COSMIC cancer mutations | skin-foot-malignant_melanoma | 84 | 2 | 16828 | 49 |
SLC6A11,ADAM12 |
2.491e-02 | -3.69 | BANK1 (B cell scaffold protein with ankyrin repeats 1) | protein interactions | 55024 | 10 | 1 | 19454 | 49 |
ITPR2 |
2.491e-02 | -3.69 | Mrpl13 (mitochondrial ribosomal protein L13) | protein interactions | 68537 | 10 | 1 | 19454 | 49 |
QKI |
2.491e-02 | -3.69 | GUCA1B (guanylate cyclase activator 1B) | protein interactions | 2979 | 10 | 1 | 19454 | 49 |
CTBP1 |
2.491e-02 | -3.69 | IGKV2-40 (immunoglobulin kappa variable 2-40) | protein interactions | 28916 | 10 | 1 | 19454 | 49 |
APOA1 |
2.491e-02 | -3.69 | Hsp90aa1 (heat shock protein 90, alpha (cytosolic), class A member 1) | protein interactions | 15519 | 10 | 1 | 19454 | 49 |
QKI |
2.491e-02 | -3.69 | GPLD1 (glycosylphosphatidylinositol specific phospholipase D1) | protein interactions | 2822 | 10 | 1 | 19454 | 49 |
APOA1 |
2.491e-02 | -3.69 | P2rx7 (purinergic receptor P2X 7) | protein interactions | 29665 | 10 | 1 | 19454 | 49 |
PTPRZ1 |
2.491e-02 | -3.69 | CDKL4 (cyclin dependent kinase like 4) | protein interactions | 344387 | 10 | 1 | 19454 | 49 |
FKBP5 |
2.491e-02 | -3.69 | GRM3 (glutamate metabotropic receptor 3) | protein interactions | 2913 | 10 | 1 | 19454 | 49 |
GRIP1 |
2.496e-02 | -3.69 | DNA-binding transcription factor activity, RNA polymerase II-specific | molecular function | GO:0000981 | 1355 | 8 | 18094 | 48 |
PRDM16,SOX5,NFIA,ZBTB20,RFX4,NPAS3,TRPS1,RORA |
2.501e-02 | -3.69 | Band_3_cyto | pfam domains | PF07565 | 9 | 1 | 17795 | 50 |
SLC4A4 |
2.501e-02 | -3.69 | RFX_DNA_binding | pfam domains | PF02257 | 9 | 1 | 17795 | 50 |
RFX4 |
2.534e-02 | -3.68 | DMD (dystrophin) | protein interactions | 1756 | 98 | 2 | 19454 | 49 |
TNS3,SNTB1 |
2.534e-02 | -3.68 | PSMF1 (proteasome inhibitor subunit 1) | protein interactions | 9491 | 98 | 2 | 19454 | 49 |
QKI,CTBP1 |
2.534e-02 | -3.68 | MED27 (mediator complex subunit 27) | protein interactions | 9442 | 98 | 2 | 19454 | 49 |
QKI,SOX5 |
2.536e-02 | -3.67 | perineuronal net | cellular component | GO:0072534 | 10 | 1 | 19108 | 49 |
PTPRZ1 |
2.539e-02 | -3.67 | regulation of purine nucleotide metabolic process | biological process | GO:1900542 | 90 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
2.551e-02 | -3.67 | lipid binding | molecular function | GO:0008289 | 861 | 6 | 18094 | 48 |
APOA1,ITPR2,PREX1,DGKB,GRK5,RORA |
2.568e-02 | -3.66 | spindle | COSMIC cancer mutations | spindle | 386 | 4 | 16828 | 49 |
FGFRL1,CTNND2,GRK5,PREX2 |
2.574e-02 | -3.66 | GATAZNFINGER | prints domains | PR00619 | 8 | 1 | 5227 | 17 |
TRPS1 |
2.581e-02 | -3.66 | PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) | protein interactions | 5562 | 253 | 3 | 19454 | 49 |
FKBP5,SLC4A4,CTBP1 |
2.581e-02 | -3.66 | connective tissue development | biological process | GO:0061448 | 232 | 3 | 18204 | 50 |
NFIA,SOX5,COL11A1 |
2.582e-02 | -3.66 | KRTAP9-8 (keratin associated protein 9-8) | protein interactions | 83901 | 99 | 2 | 19454 | 49 |
SLC13A5,ADAM12 |
2.582e-02 | -3.66 | ZFHX3 (zinc finger homeobox 3) | protein interactions | 463 | 99 | 2 | 19454 | 49 |
TRPS1,SOX5 |
2.586e-02 | -3.66 | parotid | COSMIC cancer mutations | parotid | 578 | 5 | 16828 | 49 |
ITPK1,GRK5,NRCAM,PRDM16,NTRK2 |
2.591e-02 | -3.65 | skin-upper_leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 49 |
PREX2 |
2.591e-02 | -3.65 | skin-chest-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-chest-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 49 |
PREX2 |
2.592e-02 | -3.65 | regulation of nucleotide metabolic process | biological process | GO:0006140 | 91 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
2.600e-02 | -3.65 | Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain | gene3d domains | 1.10.10.10 | 232 | 3 | 14470 | 40 |
PREX2,PREX1,RFX4 |
2.622e-02 | -3.64 | neurotrophin binding | molecular function | GO:0043121 | 10 | 1 | 18094 | 48 |
NTRK2 |
2.622e-02 | -3.64 | FK506 binding | molecular function | GO:0005528 | 10 | 1 | 18094 | 48 |
FKBP5 |
2.625e-02 | -3.64 | cell surface | cellular component | GO:0009986 | 896 | 6 | 19108 | 49 |
AQP4,SLC1A2,GPC5,SLC4A4,SLC1A3,NRCAM |
2.630e-02 | -3.64 | CIC (capicua transcriptional repressor) | protein interactions | 23152 | 671 | 5 | 19454 | 49 |
TRPS1,SOX5,FARP1,CTBP1,NFIA |
2.630e-02 | -3.64 | DTNB (dystrobrevin beta) | protein interactions | 1838 | 100 | 2 | 19454 | 49 |
SNTB1,TNS3 |
2.634e-02 | -3.64 | DYNLL2 (dynein light chain LC8-type 2) | protein interactions | 140735 | 255 | 3 | 19454 | 49 |
NFIA,NHSL1,TRPS1 |
2.641e-02 | -3.63 | positive regulation of nucleobase-containing compound metabolic process | biological process | GO:0045935 | 2118 | 11 | 18204 | 50 |
QKI,RORA,NPAS3,EGF,ZBTB20,SLC4A4,LPIN2,RFX4,NFIA,CTBP1,PRDM16 |
2.646e-02 | -3.63 | human chr6p24.2 | chromosome location | human chr6p24.2 | 14 | 1 | 26134 | 50 |
ELOVL2 |
2.653e-02 | -3.63 | haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_neoplasm | 11082 | 39 | 16828 | 49 |
DGKB,NCKAP5,QKI,PREX2,MSI2,SLC4A4,NTRK2,SOX5,RFX4,SLC13A5,FKBP5,NPAS3,LPIN2,PTPRZ1,SLC39A12,SLC1A3,TNS3,SLC1A2,NHSL1,FARP1,CTNND2,EGF,GRK5,COL11A1,ITPK1,USP6NL,SORCS2,ITPR2,GPC5,NFIA,PRDM16,GRIP1,RORA,LRIG1,ELOVL2,SLC6A11,ADAM12,PREX1,FHOD3 |
2.656e-02 | -3.63 | glycosaminoglycan binding | molecular function | GO:0005539 | 243 | 3 | 18094 | 48 |
FGFRL1,PTN,COL11A1 |
2.668e-02 | -3.62 | Diacylglycerol_kin_accessory | interpro domains | IPR000756 | 10 | 1 | 18521 | 50 |
DGKB |
2.668e-02 | -3.62 | MIR_motif | interpro domains | IPR016093 | 10 | 1 | 18521 | 50 |
ITPR2 |
2.668e-02 | -3.62 | HCO3_transpt_euk | interpro domains | IPR003020 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | HCO3_transpt-like_TM_dom | interpro domains | IPR011531 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | MIP_CS | interpro domains | IPR022357 | 10 | 1 | 18521 | 50 |
AQP4 |
2.668e-02 | -3.62 | PAS_fold_3 | interpro domains | IPR013655 | 10 | 1 | 18521 | 50 |
NPAS3 |
2.668e-02 | -3.62 | MIR_dom_sf | interpro domains | IPR036300 | 10 | 1 | 18521 | 50 |
ITPR2 |
2.668e-02 | -3.62 | DGK | interpro domains | IPR037607 | 10 | 1 | 18521 | 50 |
DGKB |
2.668e-02 | -3.62 | PTrfase/Anion_transptr | interpro domains | IPR016152 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.679e-02 | -3.62 | FBXL19 (F-box and leucine rich repeat protein 19) | protein interactions | 54620 | 101 | 2 | 19454 | 49 |
CTBP1,COL11A1 |
2.688e-02 | -3.62 | breast-carcinoma | COSMIC cancer mutations | breast-carcinoma | 15030 | 48 | 16828 | 49 |
GPC5,USP6NL,SORCS2,APOA1,SLC1A3,FARP1,SLC1A2,NHSL1,CTNND2,FHOD3,CTBP1,LRIG1,ELOVL2,SLC6A11,ADAM12,GRIP1,RORA,AQP4,GPM6B,ZBTB20,PREX2,NCKAP5,DGKB,QKI,PTN,NRCAM,PTPRZ1,LPIN2,FKBP5,TRPS1,RFX4,ITPR2,GRK5,COL11A1,ITPK1,SNTB1,EGF,TNS3,PREX1,FGFRL1,PRDM16,NFIA,NTRK2,SLC4A4,SLC39A12,SLC13A5,NPAS3,SOX5 |
2.706e-02 | -3.61 | pseudomyxoma_peritonei | COSMIC cancer mutations | pseudomyxoma_peritonei | 585 | 5 | 16828 | 49 |
NCKAP5,FARP1,COL11A1,TRPS1,TNS3 |
2.706e-02 | -3.61 | peritoneum-appendix-other-pseudomyxoma_peritonei | COSMIC cancer mutations | peritoneum-appendix-other-pseudomyxoma_peritonei | 585 | 5 | 16828 | 49 |
NCKAP5,TRPS1,TNS3,FARP1,COL11A1 |
2.714e-02 | -3.61 | cellular response to brain-derived neurotrophic factor stimulus | biological process | GO:1990416 | 10 | 1 | 18204 | 50 |
NTRK2 |
2.714e-02 | -3.61 | high-density lipoprotein particle assembly | biological process | GO:0034380 | 10 | 1 | 18204 | 50 |
APOA1 |
2.714e-02 | -3.61 | positive regulation of receptor clustering | biological process | GO:1903911 | 10 | 1 | 18204 | 50 |
FARP1 |
2.714e-02 | -3.61 | protein oxidation | biological process | GO:0018158 | 10 | 1 | 18204 | 50 |
APOA1 |
2.714e-02 | -3.61 | trans-synaptic signaling, modulating synaptic transmission | biological process | GO:0099550 | 10 | 1 | 18204 | 50 |
NTRK2 |
2.714e-02 | -3.61 | alpha-linolenic acid metabolic process | biological process | GO:0036109 | 10 | 1 | 18204 | 50 |
ELOVL2 |
2.714e-02 | -3.61 | neurotransmitter receptor transport, endosome to postsynaptic membrane | biological process | GO:0098887 | 10 | 1 | 18204 | 50 |
GRIP1 |
2.714e-02 | -3.61 | regulation of mesenchymal stem cell differentiation | biological process | GO:2000739 | 10 | 1 | 18204 | 50 |
SOX5 |
2.714e-02 | -3.61 | neurotransmitter receptor transport, endosome to plasma membrane | biological process | GO:0099639 | 10 | 1 | 18204 | 50 |
GRIP1 |
2.714e-02 | -3.61 | regulation of intestinal lipid absorption | biological process | GO:1904729 | 10 | 1 | 18204 | 50 |
APOA1 |
2.714e-02 | -3.61 | positive regulation of hepatocyte proliferation | biological process | GO:2000347 | 10 | 1 | 18204 | 50 |
PTN |
2.714e-02 | -3.61 | otolith development | biological process | GO:0048840 | 10 | 1 | 18204 | 50 |
LRIG1 |
2.714e-02 | -3.61 | regulation of CoA-transferase activity | biological process | GO:1905918 | 10 | 1 | 18204 | 50 |
APOA1 |
2.714e-02 | -3.61 | retinal rod cell development | biological process | GO:0046548 | 10 | 1 | 18204 | 50 |
NTRK2 |
2.723e-02 | -3.60 | appendix | COSMIC cancer mutations | appendix | 586 | 5 | 16828 | 49 |
NCKAP5,COL11A1,FARP1,TNS3,TRPS1 |
2.728e-02 | -3.60 | FNTB (farnesyltransferase, CAAX box, subunit beta) | protein interactions | 2342 | 102 | 2 | 19454 | 49 |
LPIN2,GRIP1 |
2.728e-02 | -3.60 | MIR7-1 (microRNA 7-1) | protein interactions | 407043 | 102 | 2 | 19454 | 49 |
MSI2,QKI |
2.731e-02 | -3.60 | Helical hairpin bin | gene3d domains | 1.10.287.570 | 10 | 1 | 14470 | 40 |
SLC4A4 |
2.737e-02 | -3.60 | Gtf2e2 (general transcription factor II E, polypeptide 2 (beta subunit)) | protein interactions | 68153 | 11 | 1 | 19454 | 49 |
NHSL1 |
2.737e-02 | -3.60 | IRAG1 (inositol 1,4,5-triphosphate receptor associated 1) | protein interactions | 10335 | 11 | 1 | 19454 | 49 |
ITPR2 |
2.737e-02 | -3.60 | GAL3ST1 (galactose-3-O-sulfotransferase 1) | protein interactions | 9514 | 11 | 1 | 19454 | 49 |
LRIG1 |
2.737e-02 | -3.60 | DAZ1 (deleted in azoospermia 1) | protein interactions | 1617 | 11 | 1 | 19454 | 49 |
QKI |
2.737e-02 | -3.60 | EVA1A (eva-1 homolog A, regulator of programmed cell death) | protein interactions | 84141 | 11 | 1 | 19454 | 49 |
PTN |
2.737e-02 | -3.60 | LCORL (ligand dependent nuclear receptor corepressor like) | protein interactions | 254251 | 11 | 1 | 19454 | 49 |
CTBP1 |
2.737e-02 | -3.60 | IL7 (interleukin 7) | protein interactions | 3574 | 11 | 1 | 19454 | 49 |
QKI |
2.737e-02 | -3.60 | ABCA13 (ATP binding cassette subfamily A member 13) | protein interactions | 154664 | 11 | 1 | 19454 | 49 |
APOA1 |
2.741e-02 | -3.60 | uveal_tract | COSMIC cancer mutations | uveal_tract | 587 | 5 | 16828 | 49 |
PREX2,GRK5,CTNND2,PREX1,FGFRL1 |
2.741e-02 | -3.60 | peritoneum | COSMIC cancer mutations | peritoneum | 587 | 5 | 16828 | 49 |
FARP1,COL11A1,TNS3,TRPS1,NCKAP5 |
2.775e-02 | -3.58 | HCO3_cotransp | pfam domains | PF00955 | 10 | 1 | 17795 | 50 |
SLC4A4 |
2.775e-02 | -3.58 | PAS_3 | pfam domains | PF08447 | 10 | 1 | 17795 | 50 |
NPAS3 |
2.775e-02 | -3.58 | DAGK_acc | pfam domains | PF00609 | 10 | 1 | 17795 | 50 |
DGKB |
2.775e-02 | -3.58 | MIR | pfam domains | PF02815 | 10 | 1 | 17795 | 50 |
ITPR2 |
2.786e-02 | -3.58 | perisynaptic extracellular matrix | cellular component | GO:0098966 | 11 | 1 | 19108 | 49 |
PTPRZ1 |
2.786e-02 | -3.58 | platelet dense tubular network | cellular component | GO:0031094 | 11 | 1 | 19108 | 49 |
ITPR2 |
2.789e-02 | -3.58 | DAD | prosite domains | PS51231 | 8 | 1 | 12186 | 43 |
FHOD3 |
2.789e-02 | -3.58 | GATA_ZN_FINGER_1 | prosite domains | PS00344 | 8 | 1 | 12186 | 43 |
TRPS1 |
2.789e-02 | -3.58 | C2_TENSIN | prosite domains | PS51182 | 8 | 1 | 12186 | 43 |
TNS3 |
2.789e-02 | -3.58 | PPASE_TENSIN | prosite domains | PS51181 | 8 | 1 | 12186 | 43 |
TNS3 |
2.802e-02 | -3.58 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | molecular function | GO:0000977 | 1385 | 8 | 18094 | 48 |
NFIA,SOX5,PRDM16,ZBTB20,RFX4,TRPS1,NPAS3,RORA |
2.828e-02 | -3.57 | MYCBP (MYC binding protein) | protein interactions | 26292 | 104 | 2 | 19454 | 49 |
PREX1,PTN |
2.832e-02 | -3.56 | human chr8q24.12 | chromosome location | human chr8q24.12 | 15 | 1 | 26134 | 50 |
SNTB1 |
2.845e-02 | -3.56 | protein domain specific binding | molecular function | GO:0019904 | 651 | 5 | 18094 | 48 |
QKI,ADAM12,CTBP1,SNTB1,TRPS1 |
2.846e-02 | -3.56 | PTEN_C2 | smart domains | SM01326 | 8 | 1 | 9717 | 35 |
TNS3 |
2.846e-02 | -3.56 | PKD | smart domains | SM00089 | 8 | 1 | 9717 | 35 |
SORCS2 |
2.849e-02 | -3.56 | transcription regulator activity | molecular function | GO:0140110 | 1937 | 10 | 18094 | 48 |
PRDM16,SOX5,NFIA,RFX4,ZBTB20,TRPS1,NPAS3,RORA,LPIN2,CTBP1 |
2.862e-02 | -3.55 | integrin-mediated signaling pathway | biological process | GO:0007229 | 96 | 2 | 18204 | 50 |
APOA1,PTN |
2.865e-02 | -3.55 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 46 | 16828 | 49 |
RFX4,SOX5,TRPS1,NPAS3,SLC13A5,FKBP5,LPIN2,SLC39A12,PTPRZ1,NRCAM,PTN,QKI,NCKAP5,DGKB,SLC4A4,MSI2,PREX2,ZBTB20,NTRK2,GPM6B,NFIA,RORA,PRDM16,GRIP1,ADAM12,SLC6A11,LRIG1,ELOVL2,CTBP1,FHOD3,FGFRL1,PREX1,CTNND2,SLC1A2,FARP1,TNS3,SLC1A3,EGF,SNTB1,ITPK1,USP6NL,SORCS2,COL11A1,GRK5,GPC5,ITPR2 |
2.865e-02 | -3.55 | soft_tissue-striated_muscle-rhabdomyosarcoma | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma | 594 | 5 | 16828 | 49 |
CTNND2,PREX2,TRPS1,DGKB,PRDM16 |
2.868e-02 | -3.55 | molecular function activator activity | molecular function | GO:0140677 | 1132 | 7 | 18094 | 48 |
EGF,PTN,USP6NL,PREX1,ADGRB3,PREX2,APOA1 |
2.875e-02 | -3.55 | skin-back-malignant_melanoma-nodular | COSMIC cancer mutations | skin-back-malignant_melanoma-nodular | 10 | 1 | 16828 | 49 |
PREX2 |
2.875e-02 | -3.55 | chiasm | COSMIC cancer mutations | chiasm | 10 | 1 | 16828 | 49 |
QKI |
2.880e-02 | -3.55 | Synthesis of pyrophosphates in the cytosol | REACTOME pathways | R-HSA-1855167 | 10 | 1 | 10285 | 30 |
ITPK1 |
2.880e-02 | -3.55 | Linoleic acid (LA) metabolism | REACTOME pathways | R-HSA-2046105 | 10 | 1 | 10285 | 30 |
ELOVL2 |
2.880e-02 | -3.55 | Bicarbonate transporters | REACTOME pathways | R-HSA-425381 | 10 | 1 | 10285 | 30 |
SLC4A4 |
2.880e-02 | -3.55 | ATP-dependent diacylglycerol kinase activity | molecular function | GO:0004143 | 11 | 1 | 18094 | 48 |
DGKB |
2.880e-02 | -3.55 | sulfur amino acid transmembrane transporter activity | molecular function | GO:0000099 | 11 | 1 | 18094 | 48 |
SLC1A2 |
2.880e-02 | -3.55 | structural constituent of myelin sheath | molecular function | GO:0019911 | 11 | 1 | 18094 | 48 |
GPM6B |
2.880e-02 | -3.55 | inositol phosphate kinase activity | molecular function | GO:0180030 | 11 | 1 | 18094 | 48 |
ITPK1 |
2.881e-02 | -3.55 | transport | biological process | GO:0006810 | 3615 | 16 | 18204 | 50 |
SLC1A2,AQP4,QKI,SLC4A4,APOA1,ITPR2,SLC6A11,USP6NL,GRIP1,GPM6B,SORCS2,NTRK2,SLC13A5,SLC1A3,SLC39A12,CTBP1 |
2.894e-02 | -3.54 | Ig-like_dom | interpro domains | IPR007110 | 432 | 4 | 18521 | 50 |
FGFRL1,NRCAM,LRIG1,NTRK2 |
2.907e-02 | -3.54 | viral process | biological process | GO:0016032 | 243 | 3 | 18204 | 50 |
CTBP1,NFIA,USP6NL |
2.917e-02 | -3.53 | nerve development | biological process | GO:0021675 | 97 | 2 | 18204 | 50 |
LRIG1,SLC1A3 |
2.917e-02 | -3.53 | acylglycerol metabolic process | biological process | GO:0006639 | 97 | 2 | 18204 | 50 |
LPIN2,DGKB |
2.929e-02 | -3.53 | PTN (pleiotrophin) | protein interactions | 5764 | 106 | 2 | 19454 | 49 |
PTN,PTPRZ1 |
2.931e-02 | -3.53 | Tyr_kinase_rcpt_2_CS | interpro domains | IPR002011 | 11 | 1 | 18521 | 50 |
NTRK2 |
2.931e-02 | -3.53 | GBD/FH3_dom | interpro domains | IPR014768 | 11 | 1 | 18521 | 50 |
FHOD3 |
2.931e-02 | -3.53 | PKD_dom | interpro domains | IPR000601 | 11 | 1 | 18521 | 50 |
SORCS2 |
2.931e-02 | -3.53 | Fib_collagen_C | interpro domains | IPR000885 | 11 | 1 | 18521 | 50 |
COL11A1 |
2.931e-02 | -3.53 | PKD_dom_sf | interpro domains | IPR035986 | 11 | 1 | 18521 | 50 |
SORCS2 |
2.931e-02 | -3.53 | GAIN_dom_N | interpro domains | IPR032471 | 11 | 1 | 18521 | 50 |
ADGRB3 |
2.941e-02 | -3.53 | Gap junction | KEGG pathways | ko04540 | 88 | 2 | 7161 | 22 |
ITPR2,EGF |
2.941e-02 | -3.53 | Gap junction | KEGG pathways | hsa04540 | 88 | 2 | 7161 | 22 |
ITPR2,EGF |
2.941e-02 | -3.53 | molecular adaptor activity | molecular function | GO:0060090 | 1138 | 7 | 18094 | 48 |
PRDM16,COL11A1,FKBP5,GRIP1,QKI,LPIN2,CTBP1 |
2.971e-02 | -3.52 | response to abiotic stimulus | biological process | GO:0009628 | 1100 | 7 | 18204 | 50 |
COL11A1,ITPR2,SLC1A3,SLC39A12,RORA,PTN,SLC1A2 |
2.972e-02 | -3.52 | neutral lipid metabolic process | biological process | GO:0006638 | 98 | 2 | 18204 | 50 |
DGKB,LPIN2 |
2.980e-02 | -3.51 | CHMP2A (charged multivesicular body protein 2A) | protein interactions | 27243 | 107 | 2 | 19454 | 49 |
MSI2,FKBP5 |
2.981e-02 | -3.51 | lipid phosphorylation | biological process | GO:0046834 | 11 | 1 | 18204 | 50 |
DGKB |
2.981e-02 | -3.51 | negative regulation of heterotypic cell-cell adhesion | biological process | GO:0034115 | 11 | 1 | 18204 | 50 |
APOA1 |
2.981e-02 | -3.51 | dendrite arborization | biological process | GO:0140059 | 11 | 1 | 18204 | 50 |
PTN |
2.981e-02 | -3.51 | synaptic vesicle clustering | biological process | GO:0097091 | 11 | 1 | 18204 | 50 |
CTBP1 |
2.981e-02 | -3.51 | regulation of cell-cell adhesion involved in gastrulation | biological process | GO:0070587 | 11 | 1 | 18204 | 50 |
APOA1 |
2.981e-02 | -3.51 | intracellular mRNA localization | biological process | GO:0008298 | 11 | 1 | 18204 | 50 |
QKI |
2.981e-02 | -3.51 | peptidyl-methionine modification | biological process | GO:0018206 | 11 | 1 | 18204 | 50 |
APOA1 |
2.981e-02 | -3.51 | glutamate secretion | biological process | GO:0014047 | 11 | 1 | 18204 | 50 |
NTRK2 |
2.982e-02 | -3.51 | Pcbp2 (poly(rC) binding protein 2) | protein interactions | 18521 | 12 | 1 | 19454 | 49 |
FARP1 |
2.982e-02 | -3.51 | XDH (xanthine dehydrogenase) | protein interactions | 7498 | 12 | 1 | 19454 | 49 |
GRIP1 |
2.982e-02 | -3.51 | NTF4 (neurotrophin 4) | protein interactions | 4909 | 12 | 1 | 19454 | 49 |
NTRK2 |
2.982e-02 | -3.51 | IL15 (interleukin 15) | protein interactions | 3600 | 12 | 1 | 19454 | 49 |
LRIG1 |
2.982e-02 | -3.51 | TREM2 (triggering receptor expressed on myeloid cells 2) | protein interactions | 54209 | 12 | 1 | 19454 | 49 |
APOA1 |
2.982e-02 | -3.51 | CA4 (carbonic anhydrase 4) | protein interactions | 762 | 12 | 1 | 19454 | 49 |
SLC4A4 |
2.990e-02 | -3.51 | response to xenobiotic stimulus | biological process | GO:0009410 | 429 | 4 | 18204 | 50 |
SLC1A3,SLC1A2,SLC6A11,RORA |
2.992e-02 | -3.51 | MCM6 (minichromosome maintenance complex component 6) | protein interactions | 4175 | 268 | 3 | 19454 | 49 |
PRDM16,TRPS1,FKBP5 |
2.993e-02 | -3.51 | astrocytoma_Grade_II | COSMIC cancer mutations | astrocytoma_Grade_II | 601 | 5 | 16828 | 49 |
FARP1,COL11A1,PREX2,ZBTB20,PREX1 |
3.016e-02 | -3.50 | SNCA (synuclein alpha) | protein interactions | 6622 | 696 | 5 | 19454 | 49 |
NTRK2,GRIP1,FARP1,APOA1,GRK5 |
3.018e-02 | -3.50 | human chr7p12.3 | chromosome location | human chr7p12.3 | 16 | 1 | 26134 | 50 |
TNS3 |
3.031e-02 | -3.50 | PAX8 (paired box 8) | protein interactions | 7849 | 108 | 2 | 19454 | 49 |
NFIA,TRPS1 |
3.031e-02 | -3.50 | FKBP1A (FKBP prolyl isomerase 1A) | protein interactions | 2280 | 108 | 2 | 19454 | 49 |
CTBP1,MSI2 |
3.031e-02 | -3.50 | EN1 (engrailed homeobox 1) | protein interactions | 2019 | 108 | 2 | 19454 | 49 |
NFIA,TRPS1 |
3.031e-02 | -3.50 | CAMKV (CaM kinase like vesicle associated) | protein interactions | 79012 | 108 | 2 | 19454 | 49 |
FARP1,FKBP5 |
3.034e-02 | -3.50 | trans-synaptic signaling | biological process | GO:0099537 | 431 | 4 | 18204 | 50 |
NTRK2,SLC1A2,SLC1A3,FARP1 |
3.035e-02 | -3.49 | fibrillar collagen trimer | cellular component | GO:0005583 | 12 | 1 | 19108 | 49 |
COL11A1 |
3.035e-02 | -3.49 | synapse-associated extracellular matrix | cellular component | GO:0099535 | 12 | 1 | 19108 | 49 |
PTPRZ1 |
3.035e-02 | -3.49 | banded collagen fibril | cellular component | GO:0098643 | 12 | 1 | 19108 | 49 |
COL11A1 |
3.039e-02 | -3.49 | skin-hand-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-hand-carcinoma-squamous_cell_carcinoma | 407 | 4 | 16828 | 49 |
SLC4A4,FARP1,PREX1,SLC13A5 |
3.044e-02 | -3.49 | Prot-tyrosine_phosphatase-like | interpro domains | IPR029021 | 101 | 2 | 18521 | 50 |
TNS3,PTPRZ1 |
3.049e-02 | -3.49 | LRRCT | pfam domains | PF01463 | 11 | 1 | 17795 | 50 |
LRIG1 |
3.049e-02 | -3.49 | COLFI | pfam domains | PF01410 | 11 | 1 | 17795 | 50 |
COL11A1 |
3.049e-02 | -3.49 | GAIN | pfam domains | PF16489 | 11 | 1 | 17795 | 50 |
ADGRB3 |
3.063e-02 | -3.49 | spleen | COSMIC cancer mutations | spleen | 408 | 4 | 16828 | 49 |
SLC6A11,COL11A1,PTPRZ1,FHOD3 |
3.079e-02 | -3.48 | positive regulation of catalytic activity | biological process | GO:0043085 | 868 | 6 | 18204 | 50 |
EGF,APOA1,NTRK2,PREX2,USP6NL,PREX1 |
3.083e-02 | -3.48 | MIR34B (microRNA 34b) | protein interactions | 407041 | 109 | 2 | 19454 | 49 |
MSI2,QKI |
3.085e-02 | -3.48 | response to alkaloid | biological process | GO:0043279 | 100 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
3.087e-02 | -3.48 | eye | COSMIC cancer mutations | eye | 606 | 5 | 16828 | 49 |
PREX2,GRK5,CTNND2,PREX1,FGFRL1 |
3.104e-02 | -3.47 | regulation of cellular component organization | biological process | GO:0051128 | 2455 | 12 | 18204 | 50 |
ADGRB3,EGF,APOA1,FARP1,PREX1,USP6NL,GRIP1,PTN,GPM6B,NTRK2,NRCAM,SLC39A12 |
3.132e-02 | -3.46 | RFX_DBD | prosite domains | PS51526 | 9 | 1 | 12186 | 43 |
RFX4 |
3.138e-02 | -3.46 | protein binding involved in heterotypic cell-cell adhesion | molecular function | GO:0086080 | 12 | 1 | 18094 | 48 |
NRCAM |
3.138e-02 | -3.46 | macrolide binding | molecular function | GO:0005527 | 12 | 1 | 18094 | 48 |
FKBP5 |
3.138e-02 | -3.46 | inositol 1,4,5 trisphosphate binding | molecular function | GO:0070679 | 12 | 1 | 18094 | 48 |
ITPR2 |
3.142e-02 | -3.46 | cholesterol homeostasis | biological process | GO:0042632 | 101 | 2 | 18204 | 50 |
RORA,APOA1 |
3.158e-02 | -3.46 | skin-back-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-back-malignant_melanoma-superficial_spreading | 11 | 1 | 16828 | 49 |
PREX2 |
3.158e-02 | -3.46 | skin-hand-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-hand-malignant_melanoma-acral_lentiginous | 11 | 1 | 16828 | 49 |
PREX2 |
3.164e-02 | -3.45 | Creatine metabolism | REACTOME pathways | R-HSA-71288 | 11 | 1 | 10285 | 30 |
SLC6A11 |
3.179e-02 | -3.45 | NAD+ Signalling and Aging | SMPDB pathways | SMP0084271 | 11 | 1 | 1369 | 4 |
RORA |
3.188e-02 | -3.45 | HYPK (huntingtin interacting protein K) | protein interactions | 25764 | 111 | 2 | 19454 | 49 |
APOA1,QKI |
3.193e-02 | -3.44 | MAD_homology1_Dwarfin-type | interpro domains | IPR003619 | 12 | 1 | 18521 | 50 |
NFIA |
3.199e-02 | -3.44 | sterol homeostasis | biological process | GO:0055092 | 102 | 2 | 18204 | 50 |
RORA,APOA1 |
3.204e-02 | -3.44 | human chr9q21.33 | chromosome location | human chr9q21.33 | 17 | 1 | 26134 | 50 |
NTRK2 |
3.207e-02 | -3.44 | bile_duct | COSMIC cancer mutations | bile_duct | 15095 | 48 | 16828 | 49 |
ITPR2,GRK5,ITPK1,COL11A1,SNTB1,EGF,TNS3,PREX1,FGFRL1,PRDM16,NFIA,NTRK2,SLC4A4,SLC39A12,NPAS3,SLC13A5,SOX5,GPC5,SORCS2,USP6NL,APOA1,SLC1A3,CTNND2,FARP1,NHSL1,SLC1A2,CTBP1,FHOD3,SLC6A11,LRIG1,ELOVL2,ADAM12,GRIP1,RORA,GPM6B,AQP4,ZBTB20,MSI2,PREX2,DGKB,QKI,PTN,NRCAM,PTPRZ1,LPIN2,FKBP5,TRPS1,RFX4 |
3.207e-02 | -3.44 | biliary_tract-bile_duct-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-bile_duct-carcinoma-adenocarcinoma | 15095 | 48 | 16828 | 49 |
FKBP5,RFX4,TRPS1,PTPRZ1,LPIN2,QKI,DGKB,NRCAM,PTN,ZBTB20,MSI2,PREX2,RORA,GRIP1,GPM6B,AQP4,CTBP1,FHOD3,ADAM12,SLC6A11,LRIG1,ELOVL2,APOA1,CTNND2,FARP1,SLC1A2,NHSL1,SLC1A3,GPC5,USP6NL,SORCS2,NPAS3,SLC13A5,SOX5,SLC39A12,NTRK2,SLC4A4,PRDM16,NFIA,FGFRL1,PREX1,EGF,SNTB1,TNS3,ITPR2,ITPK1,COL11A1,GRK5 |
3.208e-02 | -3.44 | HCO3TRNSPORT | prints domains | PR01231 | 10 | 1 | 5227 | 17 |
SLC4A4 |
3.226e-02 | -3.43 | NCAN (neurocan) | protein interactions | 1463 | 13 | 1 | 19454 | 49 |
PTN |
3.226e-02 | -3.43 | PCDHB5 (protocadherin beta 5) | protein interactions | 26167 | 13 | 1 | 19454 | 49 |
DGKB |
3.226e-02 | -3.43 | CD40LG (CD40 ligand) | protein interactions | 959 | 13 | 1 | 19454 | 49 |
APOA1 |
3.226e-02 | -3.43 | PRRX1 (paired related homeobox 1) | protein interactions | 5396 | 13 | 1 | 19454 | 49 |
FKBP5 |
3.226e-02 | -3.43 | CACNB4 (calcium voltage-gated channel auxiliary subunit beta 4) | protein interactions | 785 | 13 | 1 | 19454 | 49 |
PTN |
3.226e-02 | -3.43 | DNTT (DNA nucleotidylexotransferase) | protein interactions | 1791 | 13 | 1 | 19454 | 49 |
APOA1 |
3.226e-02 | -3.43 | Rbm47 (RNA binding motif protein 47) | protein interactions | 245945 | 13 | 1 | 19454 | 49 |
QKI |
3.226e-02 | -3.43 | NOL4L (nucleolar protein 4 like) | protein interactions | 140688 | 13 | 1 | 19454 | 49 |
CTBP1 |
3.226e-02 | -3.43 | CABP1 (calcium binding protein 1) | protein interactions | 9478 | 13 | 1 | 19454 | 49 |
GRK5 |
3.226e-02 | -3.43 | PCDHA2 (protocadherin alpha 2) | protein interactions | 56146 | 13 | 1 | 19454 | 49 |
NFIA |
3.226e-02 | -3.43 | PLEKHH1 (pleckstrin homology, MyTH4 and FERM domain containing H1) | protein interactions | 57475 | 13 | 1 | 19454 | 49 |
FKBP5 |
3.226e-02 | -3.43 | PSD2 (pleckstrin and Sec7 domain containing 2) | protein interactions | 84249 | 13 | 1 | 19454 | 49 |
FARP1 |
3.245e-02 | -3.43 | skin-knee-malignant_melanoma | COSMIC cancer mutations | skin-knee-malignant_melanoma | 97 | 2 | 16828 | 49 |
ADAM12,SLC6A11 |
3.248e-02 | -3.43 | negative regulation of neuroblast proliferation | biological process | GO:0007406 | 12 | 1 | 18204 | 50 |
PTN |
3.248e-02 | -3.43 | neuronal ion channel clustering | biological process | GO:0045161 | 12 | 1 | 18204 | 50 |
NRCAM |
3.248e-02 | -3.43 | positive regulation of protein localization to endosome | biological process | GO:1905668 | 12 | 1 | 18204 | 50 |
EGF |
3.248e-02 | -3.43 | negative regulation of protein localization to cell surface | biological process | GO:2000009 | 12 | 1 | 18204 | 50 |
GPM6B |
3.248e-02 | -3.43 | auditory behavior | biological process | GO:0031223 | 12 | 1 | 18204 | 50 |
SLC1A3 |
3.248e-02 | -3.43 | microglia differentiation | biological process | GO:0014004 | 12 | 1 | 18204 | 50 |
QKI |
3.248e-02 | -3.43 | regulation of intestinal absorption | biological process | GO:1904478 | 12 | 1 | 18204 | 50 |
APOA1 |
3.248e-02 | -3.43 | sulfur amino acid transport | biological process | GO:0000101 | 12 | 1 | 18204 | 50 |
SLC1A2 |
3.250e-02 | -3.43 | DNA-binding transcription repressor activity, RNA polymerase II-specific | molecular function | GO:0001227 | 263 | 3 | 18094 | 48 |
ZBTB20,PRDM16,TRPS1 |
3.257e-02 | -3.42 | regulation of biomineral tissue development | biological process | GO:0070167 | 103 | 2 | 18204 | 50 |
PTN,GPM6B |
3.276e-02 | -3.42 | steroid binding | molecular function | GO:0005496 | 107 | 2 | 18094 | 48 |
RORA,APOA1 |
3.284e-02 | -3.42 | chylomicron | cellular component | GO:0042627 | 13 | 1 | 19108 | 49 |
APOA1 |
3.294e-02 | -3.41 | SATB1 (SATB homeobox 1) | protein interactions | 6304 | 113 | 2 | 19454 | 49 |
SOX5,CTBP1 |
3.300e-02 | -3.41 | 1D-myo-inositol hexakisphosphate biosynthesis II (mammalian) | BIOCYC pathways | META_PWY-6362 | 15 | 1 | 902 | 2 |
ITPK1 |
3.300e-02 | -3.41 | 1D-myo-inositol hexakisphosphate biosynthesis II (mammalian) | BIOCYC pathways | HUMAN_PWY-6362 | 15 | 1 | 902 | 2 |
ITPK1 |
3.306e-02 | -3.41 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 2 | 16828 | 49 |
NCKAP5,CTNND2 |
3.310e-02 | -3.41 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 46 | 16828 | 49 |
SNTB1,EGF,SLC1A3,TNS3,SLC1A2,FARP1,CTNND2,ITPR2,GPC5,GRK5,COL11A1,SORCS2,USP6NL,ITPK1,PRDM16,GRIP1,RORA,NFIA,GPM6B,PREX1,FGFRL1,FHOD3,CTBP1,ELOVL2,LRIG1,SLC6A11,ADAM12,DGKB,NCKAP5,QKI,NRCAM,PTN,NTRK2,ZBTB20,PREX2,MSI2,SLC4A4,FKBP5,SLC13A5,NPAS3,SOX5,TRPS1,RFX4,PTPRZ1,SLC39A12,LPIN2 |
3.310e-02 | -3.41 | bladder | COSMIC cancer mutations | bladder | 14112 | 46 | 16828 | 49 |
PTN,NRCAM,NCKAP5,DGKB,QKI,PREX2,MSI2,ZBTB20,TRPS1,RFX4,FKBP5,LPIN2,PTPRZ1,SLC1A3,FARP1,SLC1A2,CTNND2,USP6NL,SORCS2,GPC5,GPM6B,GRIP1,RORA,ELOVL2,LRIG1,SLC6A11,ADAM12,FHOD3,CTBP1,SLC4A4,NTRK2,SOX5,SLC13A5,NPAS3,SLC39A12,TNS3,SNTB1,EGF,GRK5,COL11A1,ITPK1,ITPR2,NFIA,PRDM16,PREX1,FGFRL1 |
3.315e-02 | -3.41 | regulation of steroid metabolic process | biological process | GO:0019218 | 104 | 2 | 18204 | 50 |
APOA1,RORA |
3.321e-02 | -3.40 | MH1 | pfam domains | PF03165 | 12 | 1 | 17795 | 50 |
NFIA |
3.347e-02 | -3.40 | LSM3 (LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated) | protein interactions | 27258 | 114 | 2 | 19454 | 49 |
FARP1,QKI |
3.352e-02 | -3.40 | tibia | COSMIC cancer mutations | tibia | 836 | 6 | 16828 | 49 |
NCKAP5,QKI,PREX2,CTNND2,ADAM12,USP6NL |
3.369e-02 | -3.39 | PRKACA (protein kinase cAMP-activated catalytic subunit alpha) | protein interactions | 5566 | 486 | 4 | 19454 | 49 |
SNTB1,SLC4A4,FKBP5,ITPR2 |
3.373e-02 | -3.39 | inner ear morphogenesis | biological process | GO:0042472 | 105 | 2 | 18204 | 50 |
LRIG1,COL11A1 |
3.386e-02 | -3.39 | Glycerophospholipid metabolism | KEGG pathways | ko00564 | 95 | 2 | 7161 | 22 |
DGKB,LPIN2 |
3.386e-02 | -3.39 | Pancreatic secretion | KEGG pathways | ko04972 | 95 | 2 | 7161 | 22 |
SLC4A4,ITPR2 |
3.386e-02 | -3.39 | Pancreatic secretion | KEGG pathways | hsa04972 | 95 | 2 | 7161 | 22 |
SLC4A4,ITPR2 |
3.386e-02 | -3.39 | Glycerophospholipid metabolism | KEGG pathways | hsa00564 | 95 | 2 | 7161 | 22 |
LPIN2,DGKB |
3.389e-02 | -3.38 | human chr12q14.3 | chromosome location | human chr12q14.3 | 18 | 1 | 26134 | 50 |
GRIP1 |
3.389e-02 | -3.38 | human chr7q31.32 | chromosome location | human chr7q31.32 | 18 | 1 | 26134 | 50 |
PTPRZ1 |
3.390e-02 | -3.38 | RCOR1 (REST corepressor 1) | protein interactions | 23186 | 487 | 4 | 19454 | 49 |
CTBP1,SOX5,TRPS1,PRDM16 |
3.395e-02 | -3.38 | high-density lipoprotein particle binding | molecular function | GO:0008035 | 13 | 1 | 18094 | 48 |
APOA1 |
3.395e-02 | -3.38 | histone H3K9 methyltransferase activity | molecular function | GO:0046974 | 13 | 1 | 18094 | 48 |
PRDM16 |
3.401e-02 | -3.38 | TBXT (T-box transcription factor T) | protein interactions | 6862 | 115 | 2 | 19454 | 49 |
TRPS1,NFIA |
3.401e-02 | -3.38 | DTNA (dystrobrevin alpha) | protein interactions | 1837 | 115 | 2 | 19454 | 49 |
SNTB1,NTRK2 |
3.415e-02 | -3.38 | FTO Obesity Variant Mechanism | WikiPathways | WP3407 | 8 | 1 | 5310 | 23 |
PRDM16 |
3.425e-02 | -3.37 | Hemostasis | REACTOME pathways | R-HSA-109582 | 632 | 5 | 10285 | 30 |
EGF,ITPK1,DGKB,ITPR2,APOA1 |
3.425e-02 | -3.37 | signal transduction | biological process | GO:0007165 | 4637 | 19 | 18204 | 50 |
SORCS2,NTRK2,SLC39A12,PREX1,GRIP1,GRK5,PTN,NFIA,ITPK1,DGKB,EGF,APOA1,ITPR2,FARP1,ADGRB3,CTNND2,FGFRL1,PREX2,RORA |
3.439e-02 | -3.37 | ear | COSMIC cancer mutations | ear | 624 | 5 | 16828 | 49 |
ZBTB20,NPAS3,FGFRL1,SLC6A11,GRK5 |
3.440e-02 | -3.37 | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | 12 | 1 | 16828 | 49 |
QKI |
3.440e-02 | -3.37 | skin-abdomen-malignant_melanoma-nodular | COSMIC cancer mutations | skin-abdomen-malignant_melanoma-nodular | 12 | 1 | 16828 | 49 |
PREX2 |
3.440e-02 | -3.37 | DNA-binding transcription factor activity | molecular function | GO:0003700 | 1441 | 8 | 18094 | 48 |
RORA,NPAS3,TRPS1,ZBTB20,RFX4,SOX5,NFIA,PRDM16 |
3.446e-02 | -3.37 | Defective EXT1 causes exostoses 1, TRPS2 and CHDS | REACTOME pathways | R-HSA-3656253 | 12 | 1 | 10285 | 30 |
GPC5 |
3.446e-02 | -3.37 | Repression of WNT target genes | REACTOME pathways | R-HSA-4641265 | 12 | 1 | 10285 | 30 |
CTBP1 |
3.446e-02 | -3.37 | Defective EXT2 causes exostoses 2 | REACTOME pathways | R-HSA-3656237 | 12 | 1 | 10285 | 30 |
GPC5 |
3.454e-02 | -3.37 | ATP-grasp | interpro domains | IPR011761 | 13 | 1 | 18521 | 50 |
ITPK1 |
3.454e-02 | -3.37 | FA | interpro domains | IPR014847 | 13 | 1 | 18521 | 50 |
FARP1 |
3.455e-02 | -3.37 | phosphotransferase activity, alcohol group as acceptor | molecular function | GO:0016773 | 686 | 5 | 18094 | 48 |
NTRK2,FGFRL1,ITPK1,DGKB,GRK5 |
3.470e-02 | -3.36 | DNAJC27 (DnaJ heat shock protein family (Hsp40) member C27) | protein interactions | 51277 | 14 | 1 | 19454 | 49 |
FKBP5 |
3.470e-02 | -3.36 | DACT2 (dishevelled binding antagonist of beta catenin 2) | protein interactions | 168002 | 14 | 1 | 19454 | 49 |
ZBTB20 |
3.470e-02 | -3.36 | TRAC (T cell receptor alpha constant) | protein interactions | 28755 | 14 | 1 | 19454 | 49 |
ITPK1 |
3.470e-02 | -3.36 | ROBO3 (roundabout guidance receptor 3) | protein interactions | 64221 | 14 | 1 | 19454 | 49 |
APOA1 |
3.470e-02 | -3.36 | SLC1A2 (solute carrier family 1 member 2) | protein interactions | 6506 | 14 | 1 | 19454 | 49 |
SLC1A2 |
3.470e-02 | -3.36 | Cstf2t (cleavage stimulation factor, 3' pre-RNA subunit 2, tau) | protein interactions | 83410 | 14 | 1 | 19454 | 49 |
CTBP1 |
3.474e-02 | -3.36 | MIP | prosite domains | PS00221 | 10 | 1 | 12186 | 43 |
AQP4 |
3.474e-02 | -3.36 | MIR | prosite domains | PS50919 | 10 | 1 | 12186 | 43 |
ITPR2 |
3.475e-02 | -3.36 | Visual phototransduction | REACTOME pathways | R-HSA-2187338 | 101 | 2 | 10285 | 30 |
GPC5,APOA1 |
3.485e-02 | -3.36 | regulation of anatomical structure morphogenesis | biological process | GO:0022603 | 894 | 6 | 18204 | 50 |
SLC39A12,EGF,NTRK2,GRIP1,ADGRB3,ADAM12 |
3.496e-02 | -3.35 | PPARG (peroxisome proliferator activated receptor gamma) | protein interactions | 5468 | 285 | 3 | 19454 | 49 |
GRIP1,ZBTB20,TRPS1 |
3.501e-02 | -3.35 | large_intestine-colon-adenoma | COSMIC cancer mutations | large_intestine-colon-adenoma | 627 | 5 | 16828 | 49 |
COL11A1,CTNND2,FHOD3,PREX1,NCKAP5 |
3.505e-02 | -3.35 | sulfur compound binding | molecular function | GO:1901681 | 271 | 3 | 18094 | 48 |
PTN,FGFRL1,COL11A1 |
3.505e-02 | -3.35 | transcription coactivator activity | molecular function | GO:0003713 | 271 | 3 | 18094 | 48 |
CTBP1,LPIN2,PRDM16 |
3.514e-02 | -3.35 | positive regulation of neuron projection regeneration | biological process | GO:0070572 | 13 | 1 | 18204 | 50 |
PTN |
3.514e-02 | -3.35 | cerebellar Purkinje cell differentiation | biological process | GO:0021702 | 13 | 1 | 18204 | 50 |
RORA |
3.514e-02 | -3.35 | heterochromatin organization | biological process | GO:0070828 | 13 | 1 | 18204 | 50 |
PRDM16 |
3.514e-02 | -3.35 | phospholipid efflux | biological process | GO:0033700 | 13 | 1 | 18204 | 50 |
APOA1 |
3.514e-02 | -3.35 | positive regulation of axon regeneration | biological process | GO:0048680 | 13 | 1 | 18204 | 50 |
PTN |
3.514e-02 | -3.35 | glial cell fate commitment | biological process | GO:0021781 | 13 | 1 | 18204 | 50 |
NFIA |
3.514e-02 | -3.35 | T-helper 17 cell differentiation | biological process | GO:0072539 | 13 | 1 | 18204 | 50 |
RORA |
3.514e-02 | -3.35 | very long-chain fatty acid biosynthetic process | biological process | GO:0042761 | 13 | 1 | 18204 | 50 |
ELOVL2 |
3.514e-02 | -3.35 | regulation of protein localization to endosome | biological process | GO:1905666 | 13 | 1 | 18204 | 50 |
EGF |
3.532e-02 | -3.34 | extrinsic component of synaptic membrane | cellular component | GO:0099243 | 14 | 1 | 19108 | 49 |
FARP1 |
3.533e-02 | -3.34 | TYR_PHOSPHATASE_2 | prosite domains | PS50056 | 84 | 2 | 12186 | 43 |
PTPRZ1,TNS3 |
3.538e-02 | -3.34 | DNA-binding transcription repressor activity | molecular function | GO:0001217 | 272 | 3 | 18094 | 48 |
TRPS1,PRDM16,ZBTB20 |
3.538e-02 | -3.34 | phosphatase activity | molecular function | GO:0016791 | 272 | 3 | 18094 | 48 |
PTPRZ1,LPIN2,TNS3 |
3.546e-02 | -3.34 | DAGKa | smart domains | SM00045 | 10 | 1 | 9717 | 35 |
DGKB |
3.546e-02 | -3.34 | MIR | smart domains | SM00472 | 10 | 1 | 9717 | 35 |
ITPR2 |
3.553e-02 | -3.34 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 48 | 16828 | 49 |
SLC13A5,NPAS3,SOX5,SLC39A12,NTRK2,SLC4A4,PRDM16,NFIA,PREX1,FGFRL1,SNTB1,EGF,TNS3,ITPR2,GRK5,COL11A1,ITPK1,FKBP5,TRPS1,RFX4,PTPRZ1,LPIN2,NCKAP5,DGKB,QKI,PTN,NRCAM,ZBTB20,PREX2,MSI2,GRIP1,RORA,AQP4,GPM6B,FHOD3,CTBP1,ELOVL2,LRIG1,SLC6A11,ADAM12,SLC1A3,FARP1,SLC1A2,NHSL1,CTNND2,GPC5,SORCS2,USP6NL |
3.558e-02 | -3.34 | NAT10 (N-acetyltransferase 10) | protein interactions | 55226 | 287 | 3 | 19454 | 49 |
PRDM16,GRK5,FKBP5 |
3.558e-02 | -3.34 | PARD3 (par-3 family cell polarity regulator) | protein interactions | 56288 | 287 | 3 | 19454 | 49 |
FARP1,NTRK2,USP6NL |
3.574e-02 | -3.33 | human chr6q24.1 | chromosome location | human chr6q24.1 | 19 | 1 | 26134 | 50 |
NHSL1 |
3.574e-02 | -3.33 | human chr5p15.2 | chromosome location | human chr5p15.2 | 19 | 1 | 26134 | 50 |
CTNND2 |
3.575e-02 | -3.33 | LRRCT | smart domains | SM00082 | 83 | 2 | 9717 | 35 |
NTRK2,LRIG1 |
3.585e-02 | -3.33 | Estrogen signaling pathway | KEGG pathways | hsa04915 | 98 | 2 | 7161 | 22 |
ITPR2,FKBP5 |
3.585e-02 | -3.33 | Estrogen signaling pathway | KEGG pathways | ko04915 | 98 | 2 | 7161 | 22 |
FKBP5,ITPR2 |
3.593e-02 | -3.33 | FA | pfam domains | PF08736 | 13 | 1 | 17795 | 50 |
FARP1 |
3.593e-02 | -3.33 | Ldl_recept_b | pfam domains | PF00058 | 13 | 1 | 17795 | 50 |
EGF |
3.610e-02 | -3.32 | skin-trunk-malignant_melanoma | COSMIC cancer mutations | skin-trunk-malignant_melanoma | 2647 | 13 | 16828 | 49 |
COL11A1,PREX2,CTNND2,SLC1A3,NRCAM,EGF,NCKAP5,SNTB1,DGKB,PTPRZ1,TRPS1,SOX5,PRDM16 |
3.612e-02 | -3.32 | long-chain fatty acid metabolic process | biological process | GO:0001676 | 109 | 2 | 18204 | 50 |
QKI,ELOVL2 |
3.612e-02 | -3.32 | postsynapse organization | biological process | GO:0099173 | 109 | 2 | 18204 | 50 |
FARP1,CTNND2 |
3.620e-02 | -3.32 | regulation of canonical Wnt signaling pathway | biological process | GO:0060828 | 265 | 3 | 18204 | 50 |
EGF,CTNND2,GPC5 |
3.620e-02 | -3.32 | ANKRD26 (ankyrin repeat domain containing 26) | protein interactions | 22852 | 119 | 2 | 19454 | 49 |
NCKAP5,NTRK2 |
3.631e-02 | -3.32 | neuronal cell body | cellular component | GO:0043025 | 489 | 4 | 19108 | 49 |
SORCS2,CTNND2,GRIP1,SLC1A3 |
3.652e-02 | -3.31 | BCOR (BCL6 corepressor) | protein interactions | 54880 | 290 | 3 | 19454 | 49 |
SOX5,NFIA,CTBP1 |
3.652e-02 | -3.31 | phosphatidate phosphatase activity | molecular function | GO:0008195 | 14 | 1 | 18094 | 48 |
LPIN2 |
3.652e-02 | -3.31 | Choline metabolism in cancer | KEGG pathways | hsa05231 | 99 | 2 | 7161 | 22 |
DGKB,EGF |
3.652e-02 | -3.31 | Choline metabolism in cancer | KEGG pathways | ko05231 | 99 | 2 | 7161 | 22 |
DGKB,EGF |
3.670e-02 | -3.30 | positive regulation of cell development | biological process | GO:0010720 | 458 | 4 | 18204 | 50 |
PTN,QKI,PTPRZ1,NTRK2 |
3.672e-02 | -3.30 | positive regulation of cell junction assembly | biological process | GO:1901890 | 110 | 2 | 18204 | 50 |
ADGRB3,NTRK2 |
3.672e-02 | -3.30 | positive regulation of canonical Wnt signaling pathway | biological process | GO:0090263 | 110 | 2 | 18204 | 50 |
EGF,GPC5 |
3.677e-02 | -3.30 | transcription coregulator binding | molecular function | GO:0001221 | 114 | 2 | 18094 | 48 |
CTBP1,RORA |
3.684e-02 | -3.30 | positive regulation of cell differentiation | biological process | GO:0045597 | 906 | 6 | 18204 | 50 |
PTN,SOX5,PTPRZ1,QKI,NRCAM,NTRK2 |
3.695e-02 | -3.30 | small molecule biosynthetic process | biological process | GO:0044283 | 459 | 4 | 18204 | 50 |
ELOVL2,QKI,APOA1,SLC1A3 |
3.695e-02 | -3.30 | synaptic signaling | biological process | GO:0099536 | 459 | 4 | 18204 | 50 |
SLC1A2,SLC1A3,NTRK2,FARP1 |
3.714e-02 | -3.29 | Cenpf (centromere protein F) | protein interactions | 108000 | 15 | 1 | 19454 | 49 |
USP6NL |
3.714e-02 | -3.29 | TESPA1 (thymocyte expressed, positive selection associated 1) | protein interactions | 9840 | 15 | 1 | 19454 | 49 |
ITPR2 |
3.714e-02 | -3.29 | DTWD1 (DTW domain containing 1) | protein interactions | 56986 | 15 | 1 | 19454 | 49 |
APOA1 |
3.714e-02 | -3.29 | GRM7 (glutamate metabotropic receptor 7) | protein interactions | 2917 | 15 | 1 | 19454 | 49 |
GRIP1 |
3.715e-02 | -3.29 | MIP | interpro domains | IPR000425 | 14 | 1 | 18521 | 50 |
AQP4 |
3.715e-02 | -3.29 | LDLR_classB_rpt | interpro domains | IPR000033 | 14 | 1 | 18521 | 50 |
EGF |
3.715e-02 | -3.29 | Aquaporin-like | interpro domains | IPR023271 | 14 | 1 | 18521 | 50 |
AQP4 |
3.715e-02 | -3.29 | ZIP | interpro domains | IPR003689 | 14 | 1 | 18521 | 50 |
SLC39A12 |
3.719e-02 | -3.29 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 48 | 16828 | 49 |
FGFRL1,PREX1,PRDM16,NFIA,ITPR2,ITPK1,COL11A1,GRK5,EGF,SNTB1,TNS3,SLC39A12,NPAS3,SLC13A5,SOX5,NTRK2,SLC4A4,CTBP1,FHOD3,ADAM12,SLC6A11,LRIG1,ELOVL2,RORA,GRIP1,GPM6B,AQP4,GPC5,SORCS2,USP6NL,APOA1,CTNND2,FARP1,SLC1A2,SLC1A3,PTPRZ1,LPIN2,FKBP5,RFX4,TRPS1,ZBTB20,MSI2,PREX2,QKI,DGKB,NCKAP5,PTN,NRCAM |
3.721e-02 | -3.29 | skin-shoulder-malignant_melanoma-nodular | COSMIC cancer mutations | skin-shoulder-malignant_melanoma-nodular | 13 | 1 | 16828 | 49 |
PREX2 |
3.721e-02 | -3.29 | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | 13 | 1 | 16828 | 49 |
QKI |
3.721e-02 | -3.29 | skin-scalp-malignant_melanoma-nodular | COSMIC cancer mutations | skin-scalp-malignant_melanoma-nodular | 13 | 1 | 16828 | 49 |
PREX2 |
3.728e-02 | -3.29 | CLEC7A (Dectin-1) induces NFAT activation | REACTOME pathways | R-HSA-5607763 | 13 | 1 | 10285 | 30 |
ITPR2 |
3.728e-02 | -3.29 | Passive transport by Aquaporins | REACTOME pathways | R-HSA-432047 | 13 | 1 | 10285 | 30 |
AQP4 |
3.728e-02 | -3.29 | Scavenging of heme from plasma | REACTOME pathways | R-HSA-2168880 | 13 | 1 | 10285 | 30 |
APOA1 |
3.728e-02 | -3.29 | FGFRL1 modulation of FGFR1 signaling | REACTOME pathways | R-HSA-5658623 | 13 | 1 | 10285 | 30 |
FGFRL1 |
3.728e-02 | -3.29 | ERBB2 Activates PTK6 Signaling | REACTOME pathways | R-HSA-8847993 | 13 | 1 | 10285 | 30 |
EGF |
3.729e-02 | -3.29 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 13 | 16828 | 49 |
SORCS2,GRK5,PREX2,DGKB,CTNND2,FGFRL1,PTPRZ1,ELOVL2,NPAS3,RORA,PRDM16,AQP4,NFIA |
3.729e-02 | -3.29 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 13 | 16828 | 49 |
DGKB,PRDM16,NPAS3,RORA,CTNND2,AQP4,NFIA,PTPRZ1,FGFRL1,GRK5,ELOVL2,PREX2,SORCS2 |
3.732e-02 | -3.29 | MED15 (mediator complex subunit 15) | protein interactions | 51586 | 121 | 2 | 19454 | 49 |
QKI,NFIA |
3.754e-02 | -3.28 | basal plasma membrane | cellular component | GO:0009925 | 288 | 3 | 19108 | 49 |
AQP4,SLC4A4,SLC1A3 |
3.759e-02 | -3.28 | human chr18q12.2 | chromosome location | human chr18q12.2 | 20 | 1 | 26134 | 50 |
FHOD3 |
3.779e-02 | -3.28 | negative regulation of cell adhesion molecule production | biological process | GO:0060354 | 14 | 1 | 18204 | 50 |
APOA1 |
3.779e-02 | -3.28 | cellular response to ethanol | biological process | GO:0071361 | 14 | 1 | 18204 | 50 |
ITPR2 |
3.779e-02 | -3.28 | fatty acid elongation | biological process | GO:0030497 | 14 | 1 | 18204 | 50 |
ELOVL2 |
3.779e-02 | -3.28 | glutathione biosynthetic process | biological process | GO:0006750 | 14 | 1 | 18204 | 50 |
SLC1A2 |
3.779e-02 | -3.28 | sodium ion export across plasma membrane | biological process | GO:0036376 | 14 | 1 | 18204 | 50 |
SLC4A4 |
3.779e-02 | -3.28 | cellular response to lithium ion | biological process | GO:0071285 | 14 | 1 | 18204 | 50 |
SLC13A5 |
3.779e-02 | -3.28 | negative regulation of long-term synaptic potentiation | biological process | GO:1900272 | 14 | 1 | 18204 | 50 |
PTN |
3.779e-02 | -3.28 | mechanosensory behavior | biological process | GO:0007638 | 14 | 1 | 18204 | 50 |
SLC1A3 |
3.779e-02 | -3.28 | cerebrospinal fluid circulation | biological process | GO:0090660 | 14 | 1 | 18204 | 50 |
AQP4 |
3.779e-02 | -3.28 | neuron remodeling | biological process | GO:0016322 | 14 | 1 | 18204 | 50 |
ADGRB3 |
3.779e-02 | -3.28 | positive regulation of phospholipid transport | biological process | GO:2001140 | 14 | 1 | 18204 | 50 |
APOA1 |
3.779e-02 | -3.28 | neurotransmitter receptor transport to postsynaptic membrane | biological process | GO:0098969 | 14 | 1 | 18204 | 50 |
GRIP1 |
3.780e-02 | -3.28 | low-density lipoprotein particle | cellular component | GO:0034362 | 15 | 1 | 19108 | 49 |
APOA1 |
3.780e-02 | -3.28 | axolemma | cellular component | GO:0030673 | 15 | 1 | 19108 | 49 |
SLC1A2 |
3.788e-02 | -3.27 | AVPR2 (arginine vasopressin receptor 2) | protein interactions | 554 | 122 | 2 | 19454 | 49 |
ELOVL2,GRK5 |
3.794e-02 | -3.27 | rhythmic process | biological process | GO:0048511 | 270 | 3 | 18204 | 50 |
NTRK2,RORA,PTN |
3.795e-02 | -3.27 | Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | REACTOME pathways | R-HSA-425366 | 106 | 2 | 10285 | 30 |
SLC13A5,SLC6A11 |
3.803e-02 | -3.27 | Glycerol uptake facilitator protein | gene3d domains | 1.20.1080.10 | 14 | 1 | 14470 | 40 |
AQP4 |
3.803e-02 | -3.27 | - | gene3d domains | 2.60.200.40 | 14 | 1 | 14470 | 40 |
DGKB |
3.815e-02 | -3.27 | NC1_FIB | prosite domains | PS51461 | 11 | 1 | 12186 | 43 |
COL11A1 |
3.815e-02 | -3.27 | GBD_FH3 | prosite domains | PS51232 | 11 | 1 | 12186 | 43 |
FHOD3 |
3.815e-02 | -3.27 | GATA_ZN_FINGER_2 | prosite domains | PS50114 | 11 | 1 | 12186 | 43 |
TRPS1 |
3.815e-02 | -3.27 | RECEPTOR_TYR_KIN_II | prosite domains | PS00239 | 11 | 1 | 12186 | 43 |
NTRK2 |
3.815e-02 | -3.27 | PKD | prosite domains | PS50093 | 11 | 1 | 12186 | 43 |
SORCS2 |
3.822e-02 | -3.26 | cellular response to organic cyclic compound | biological process | GO:0071407 | 464 | 4 | 18204 | 50 |
RORA,SLC1A3,ITPR2,SLC1A2 |
3.829e-02 | -3.26 | carboxylic acid biosynthetic process | biological process | GO:0046394 | 271 | 3 | 18204 | 50 |
SLC1A3,ELOVL2,QKI |
3.837e-02 | -3.26 | Gastrin-CREB signalling pathway via PKC and MAPK | REACTOME pathways | R-HSA-881907 | 443 | 4 | 10285 | 30 |
GRK5,ITPR2,DGKB,EGF |
3.844e-02 | -3.26 | PAX7 (paired box 7) | protein interactions | 5081 | 123 | 2 | 19454 | 49 |
NFIA,TRPS1 |
3.864e-02 | -3.25 | GATA | pfam domains | PF00320 | 14 | 1 | 17795 | 50 |
TRPS1 |
3.864e-02 | -3.25 | Zip | pfam domains | PF02535 | 14 | 1 | 17795 | 50 |
SLC39A12 |
3.864e-02 | -3.25 | MIP | pfam domains | PF00230 | 14 | 1 | 17795 | 50 |
AQP4 |
3.873e-02 | -3.25 | positive regulation of hydrolase activity | biological process | GO:0051345 | 466 | 4 | 18204 | 50 |
USP6NL,APOA1,PREX1,PREX2 |
3.894e-02 | -3.25 | COLFI | smart domains | SM00038 | 11 | 1 | 9717 | 35 |
COL11A1 |
3.900e-02 | -3.24 | vascular process in circulatory system | biological process | GO:0003018 | 273 | 3 | 18204 | 50 |
SLC4A4,SLC1A2,SLC1A3 |
3.901e-02 | -3.24 | HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) | protein interactions | 3156 | 124 | 2 | 19454 | 49 |
CTBP1,SORCS2 |
3.908e-02 | -3.24 | C4-dicarboxylate transmembrane transporter activity | molecular function | GO:0015556 | 15 | 1 | 18094 | 48 |
SLC13A5 |
3.908e-02 | -3.24 | monocarboxylate:sodium symporter activity | molecular function | GO:0140161 | 15 | 1 | 18094 | 48 |
SLC6A11 |
3.924e-02 | -3.24 | Fatty acid biosynthesis, elongation, endoplasmic reticulum | KEGG pathways | M00415 | 13 | 1 | 7161 | 22 |
ELOVL2 |
3.924e-02 | -3.24 | Fatty acid biosynthesis, elongation, endoplasmic reticulum | KEGG pathways | hsa_M00415 | 13 | 1 | 7161 | 22 |
ELOVL2 |
3.936e-02 | -3.24 | organic acid biosynthetic process | biological process | GO:0016053 | 274 | 3 | 18204 | 50 |
SLC1A3,ELOVL2,QKI |
3.943e-02 | -3.23 | human chr10q26.11 | chromosome location | human chr10q26.11 | 21 | 1 | 26134 | 50 |
GRK5 |
3.943e-02 | -3.23 | human chr10q26.2 | chromosome location | human chr10q26.2 | 21 | 1 | 26134 | 50 |
ADAM12 |
3.943e-02 | -3.23 | human chr13q31.3 | chromosome location | human chr13q31.3 | 21 | 1 | 26134 | 50 |
GPC5 |
3.943e-02 | -3.23 | cell migration | biological process | GO:0016477 | 921 | 6 | 18204 | 50 |
APOA1,NRCAM,NTRK2,GPC5,PTN,PREX1 |
3.947e-02 | -3.23 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 6 | 19454 | 49 |
SLC1A3,FARP1,PREX1,PREX2,TNS3,USP6NL |
3.947e-02 | -3.23 | pulmonary_blastoma | COSMIC cancer mutations | pulmonary_blastoma | 648 | 5 | 16828 | 49 |
TRPS1,ADAM12,NCKAP5,FGFRL1,FHOD3 |
3.947e-02 | -3.23 | pleura-pulmonary_blastoma | COSMIC cancer mutations | pleura-pulmonary_blastoma | 648 | 5 | 16828 | 49 |
FGFRL1,FHOD3,NCKAP5,ADAM12,TRPS1 |
3.956e-02 | -3.23 | import into cell | biological process | GO:0098657 | 687 | 5 | 18204 | 50 |
SLC1A2,SLC1A3,SLC39A12,SLC6A11,CTBP1 |
3.956e-02 | -3.23 | MKKS (MKKS centrosomal shuttling protein) | protein interactions | 8195 | 16 | 1 | 19454 | 49 |
PTN |
3.956e-02 | -3.23 | TXNDC2 (thioredoxin domain containing 2) | protein interactions | 84203 | 16 | 1 | 19454 | 49 |
APOA1 |
3.956e-02 | -3.23 | MAML2 (mastermind like transcriptional coactivator 2) | protein interactions | 84441 | 16 | 1 | 19454 | 49 |
CTBP1 |
3.956e-02 | -3.23 | HHV8GK18_gp78 (ORF69) | protein interactions | 4961444 | 16 | 1 | 19454 | 49 |
CTBP1 |
3.956e-02 | -3.23 | TWIST2 (twist family bHLH transcription factor 2) | protein interactions | 117581 | 16 | 1 | 19454 | 49 |
ZBTB20 |
3.956e-02 | -3.23 | NBL1 (NBL1, DAN family BMP antagonist) | protein interactions | 4681 | 16 | 1 | 19454 | 49 |
LRIG1 |
3.956e-02 | -3.23 | PIPOX (pipecolic acid and sarcosine oxidase) | protein interactions | 51268 | 16 | 1 | 19454 | 49 |
FKBP5 |
3.956e-02 | -3.23 | RHO (rhodopsin) | protein interactions | 6010 | 16 | 1 | 19454 | 49 |
GRK5 |
3.956e-02 | -3.23 | ESM1 (endothelial cell specific molecule 1) | protein interactions | 11082 | 16 | 1 | 19454 | 49 |
ADAM12 |
3.956e-02 | -3.23 | Sumo3 (small ubiquitin-like modifier 3) | protein interactions | 20610 | 16 | 1 | 19454 | 49 |
ITPR2 |
3.963e-02 | -3.23 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 47 | 16828 | 49 |
ITPR2,GRK5,ITPK1,COL11A1,SNTB1,EGF,TNS3,PREX1,FGFRL1,PRDM16,NFIA,NTRK2,SLC4A4,SLC39A12,NPAS3,SLC13A5,SOX5,GPC5,SORCS2,USP6NL,SLC1A3,CTNND2,FARP1,NHSL1,SLC1A2,CTBP1,FHOD3,SLC6A11,LRIG1,ELOVL2,ADAM12,GRIP1,RORA,AQP4,ZBTB20,MSI2,PREX2,DGKB,NCKAP5,QKI,NRCAM,PTN,PTPRZ1,LPIN2,FKBP5,TRPS1,RFX4 |
3.975e-02 | -3.23 | PPIase_FKBP_dom | interpro domains | IPR001179 | 15 | 1 | 18521 | 50 |
FKBP5 |
3.975e-02 | -3.23 | Znf_GATA | interpro domains | IPR000679 | 15 | 1 | 18521 | 50 |
TRPS1 |
3.975e-02 | -3.23 | Diacylglycerol_kinase_cat_dom | interpro domains | IPR001206 | 15 | 1 | 18521 | 50 |
DGKB |
3.975e-02 | -3.23 | FH2_Formin | interpro domains | IPR015425 | 15 | 1 | 18521 | 50 |
FHOD3 |
3.975e-02 | -3.23 | FH2_Formin_sf | interpro domains | IPR042201 | 15 | 1 | 18521 | 50 |
FHOD3 |
3.981e-02 | -3.22 | fatty acid biosynthetic process | biological process | GO:0006633 | 115 | 2 | 18204 | 50 |
ELOVL2,QKI |
3.998e-02 | -3.22 | cellular homeostasis | biological process | GO:0019725 | 689 | 5 | 18204 | 50 |
SLC39A12,SLC1A3,AQP4,ZBTB20,SLC4A4 |
4.008e-02 | -3.22 | telencephalon development | biological process | GO:0021537 | 276 | 3 | 18204 | 50 |
SLC1A2,NTRK2,RFX4 |
4.008e-02 | -3.22 | sensory organ morphogenesis | biological process | GO:0090596 | 276 | 3 | 18204 | 50 |
COL11A1,NTRK2,LRIG1 |
4.008e-02 | -3.22 | transcription cis-regulatory region binding | molecular function | GO:0000976 | 1485 | 8 | 18094 | 48 |
RORA,NPAS3,TRPS1,RFX4,ZBTB20,PRDM16,SOX5,NFIA |
4.010e-02 | -3.22 | Synthesis of PE | REACTOME pathways | R-HSA-1483213 | 14 | 1 | 10285 | 30 |
LPIN2 |
4.010e-02 | -3.22 | CDC42 (cell division cycle 42) | protein interactions | 998 | 1280 | 7 | 19454 | 49 |
PREX2,USP6NL,ELOVL2,ITPR2,PREX1,SLC1A3,FARP1 |
4.016e-02 | -3.21 | CDK18 (cyclin dependent kinase 18) | protein interactions | 5129 | 126 | 2 | 19454 | 49 |
FKBP5,TRPS1 |
4.027e-02 | -3.21 | asymmetric, glutamatergic, excitatory synapse | cellular component | GO:0098985 | 16 | 1 | 19108 | 49 |
ADGRB3 |
4.028e-02 | -3.21 | phospholipid binding | molecular function | GO:0005543 | 489 | 4 | 18094 | 48 |
ITPR2,GRK5,APOA1,PREX1 |
4.033e-02 | -3.21 | Inositol Phosphate Metabolism | SMPDB pathways | SMP0000462 | 14 | 1 | 1369 | 4 |
ITPK1 |
4.035e-02 | -3.21 | transcription regulatory region nucleic acid binding | molecular function | GO:0001067 | 1487 | 8 | 18094 | 48 |
RFX4,ZBTB20,SOX5,NFIA,PRDM16,RORA,TRPS1,NPAS3 |
4.043e-02 | -3.21 | regulation of phospholipid transport | biological process | GO:2001138 | 15 | 1 | 18204 | 50 |
APOA1 |
4.043e-02 | -3.21 | positive regulation of cholesterol metabolic process | biological process | GO:0090205 | 15 | 1 | 18204 | 50 |
APOA1 |
4.043e-02 | -3.21 | glucocorticoid metabolic process | biological process | GO:0008211 | 15 | 1 | 18204 | 50 |
APOA1 |
4.043e-02 | -3.21 | regulation of neuron projection arborization | biological process | GO:0150011 | 15 | 1 | 18204 | 50 |
GRIP1 |
4.043e-02 | -3.21 | peripheral nervous system neuron development | biological process | GO:0048935 | 15 | 1 | 18204 | 50 |
NTRK2 |
4.043e-02 | -3.21 | protein homotrimerization | biological process | GO:0070207 | 15 | 1 | 18204 | 50 |
SLC1A2 |
4.043e-02 | -3.21 | neurotransmitter receptor transport to plasma membrane | biological process | GO:0098877 | 15 | 1 | 18204 | 50 |
GRIP1 |
4.043e-02 | -3.21 | peripheral nervous system neuron differentiation | biological process | GO:0048934 | 15 | 1 | 18204 | 50 |
NTRK2 |
4.043e-02 | -3.21 | synapse maturation | biological process | GO:0060074 | 15 | 1 | 18204 | 50 |
NFIA |
4.043e-02 | -3.21 | detection of mechanical stimulus involved in sensory perception of sound | biological process | GO:0050910 | 15 | 1 | 18204 | 50 |
COL11A1 |
4.043e-02 | -3.21 | exit from mitosis | biological process | GO:0010458 | 15 | 1 | 18204 | 50 |
NFIA |
4.043e-02 | -3.21 | endosome to plasma membrane protein transport | biological process | GO:0099638 | 15 | 1 | 18204 | 50 |
GRIP1 |
4.043e-02 | -3.21 | gamma-aminobutyric acid transport | biological process | GO:0015812 | 15 | 1 | 18204 | 50 |
SLC6A11 |
4.043e-02 | -3.21 | neuroblast division | biological process | GO:0055057 | 15 | 1 | 18204 | 50 |
SOX5 |
4.043e-02 | -3.21 | establishment of protein localization to postsynaptic membrane | biological process | GO:1903540 | 15 | 1 | 18204 | 50 |
GRIP1 |
4.043e-02 | -3.21 | cerebellar Purkinje cell layer formation | biological process | GO:0021694 | 15 | 1 | 18204 | 50 |
RORA |
4.069e-02 | -3.20 | Formin, FH2 domain | gene3d domains | 1.20.58.2220 | 15 | 1 | 14470 | 40 |
FHOD3 |
4.074e-02 | -3.20 | EPB41L4A (erythrocyte membrane protein band 4.1 like 4A) | protein interactions | 64097 | 127 | 2 | 19454 | 49 |
FARP1,USP6NL |
4.074e-02 | -3.20 | KRTAP12-2 (keratin associated protein 12-2) | protein interactions | 353323 | 127 | 2 | 19454 | 49 |
ADAM12,SLC13A5 |
4.086e-02 | -3.20 | G protein-coupled receptor signaling pathway | biological process | GO:0007186 | 1178 | 7 | 18204 | 50 |
APOA1,SORCS2,DGKB,PREX2,GRK5,ADGRB3,PREX1 |
4.101e-02 | -3.19 | Ig-like_dom_sf | interpro domains | IPR036179 | 483 | 4 | 18521 | 50 |
FGFRL1,NRCAM,LRIG1,NTRK2 |
4.121e-02 | -3.19 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 14 | 16828 | 49 |
PRDM16,NPAS3,SLC39A12,FHOD3,LPIN2,ELOVL2,ADAM12,EGF,TNS3,NRCAM,NTRK2,MSI2,COL11A1,SLC4A4 |
4.121e-02 | -3.19 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 14 | 16828 | 49 |
NPAS3,PRDM16,ADAM12,LPIN2,ELOVL2,FHOD3,SLC39A12,TNS3,NRCAM,EGF,SLC4A4,COL11A1,MSI2,NTRK2 |
4.127e-02 | -3.19 | human chr3q13.31 | chromosome location | human chr3q13.31 | 22 | 1 | 26134 | 50 |
ZBTB20 |
4.132e-02 | -3.19 | TEAD2 (TEA domain transcription factor 2) | protein interactions | 8463 | 128 | 2 | 19454 | 49 |
ZBTB20,TRPS1 |
4.132e-02 | -3.19 | MYB (MYB proto-oncogene, transcription factor) | protein interactions | 4602 | 128 | 2 | 19454 | 49 |
TRPS1,NFIA |
4.134e-02 | -3.19 | FH2 | pfam domains | PF02181 | 15 | 1 | 17795 | 50 |
FHOD3 |
4.134e-02 | -3.19 | FKBP_C | pfam domains | PF00254 | 15 | 1 | 17795 | 50 |
FKBP5 |
4.134e-02 | -3.19 | DAGK_cat | pfam domains | PF00781 | 15 | 1 | 17795 | 50 |
DGKB |
4.151e-02 | -3.18 | DISINTEGRIN | prints domains | PR00289 | 13 | 1 | 5227 | 17 |
ADAM12 |
4.158e-02 | -3.18 | SH3 domain binding | molecular function | GO:0017124 | 122 | 2 | 18094 | 48 |
QKI,ADAM12 |
4.163e-02 | -3.18 | water channel activity | molecular function | GO:0015250 | 16 | 1 | 18094 | 48 |
AQP4 |
4.163e-02 | -3.18 | oxysterol binding | molecular function | GO:0008142 | 16 | 1 | 18094 | 48 |
RORA |
4.163e-02 | -3.18 | sodium:chloride symporter activity | molecular function | GO:0015378 | 16 | 1 | 18094 | 48 |
SLC6A11 |
4.170e-02 | -3.18 | synapse assembly | biological process | GO:0007416 | 118 | 2 | 18204 | 50 |
FARP1,NRCAM |
4.190e-02 | -3.17 | Lima1 (LIM domain and actin binding 1) | protein interactions | 65970 | 129 | 2 | 19454 | 49 |
ITPR2,ZBTB20 |
4.193e-02 | -3.17 | cell surface receptor signaling pathway | biological process | GO:0007166 | 1992 | 10 | 18204 | 50 |
GRK5,CTNND2,ADGRB3,FGFRL1,NFIA,PTN,APOA1,EGF,NTRK2,FARP1 |
4.198e-02 | -3.17 | Shcbp1 (Shc SH2-domain binding protein 1) | protein interactions | 20419 | 17 | 1 | 19454 | 49 |
GPC5 |
4.198e-02 | -3.17 | PLCE1 (phospholipase C epsilon 1) | protein interactions | 51196 | 17 | 1 | 19454 | 49 |
FKBP5 |
4.198e-02 | -3.17 | MSANTD2 (Myb/SANT DNA binding domain containing 2) | protein interactions | 79684 | 17 | 1 | 19454 | 49 |
SOX5 |
4.198e-02 | -3.17 | TAC3 (tachykinin precursor 3) | protein interactions | 6866 | 17 | 1 | 19454 | 49 |
PTN |
4.198e-02 | -3.17 | NFASC (neurofascin) | protein interactions | 23114 | 17 | 1 | 19454 | 49 |
NRCAM |
4.198e-02 | -3.17 | TAGAP (T cell activation RhoGTPase activating protein) | protein interactions | 117289 | 17 | 1 | 19454 | 49 |
SNTB1 |
4.198e-02 | -3.17 | Nufip2 (nuclear FMR1 interacting protein 2) | protein interactions | 68564 | 17 | 1 | 19454 | 49 |
CTBP1 |
4.198e-02 | -3.17 | HPR (haptoglobin-related protein) | protein interactions | 3250 | 17 | 1 | 19454 | 49 |
APOA1 |
4.198e-02 | -3.17 | UBA7 (ubiquitin like modifier activating enzyme 7) | protein interactions | 7318 | 17 | 1 | 19454 | 49 |
GRIP1 |
4.198e-02 | -3.17 | CNTN2 (contactin 2) | protein interactions | 6900 | 17 | 1 | 19454 | 49 |
NRCAM |
4.198e-02 | -3.17 | Pef1 (penta-EF hand domain containing 1) | protein interactions | 67898 | 17 | 1 | 19454 | 49 |
QKI |
4.198e-02 | -3.17 | STK32A (serine/threonine kinase 32A) | protein interactions | 202374 | 17 | 1 | 19454 | 49 |
FKBP5 |
4.235e-02 | -3.16 | Ez/rad/moesin-like | interpro domains | IPR000798 | 16 | 1 | 18521 | 50 |
FARP1 |
4.235e-02 | -3.16 | Disintegrin_CS | interpro domains | IPR018358 | 16 | 1 | 18521 | 50 |
ADAM12 |
4.240e-02 | -3.16 | ZnF_GATA | smart domains | SM00401 | 12 | 1 | 9717 | 35 |
TRPS1 |
4.240e-02 | -3.16 | DWA | smart domains | SM00523 | 12 | 1 | 9717 | 35 |
NFIA |
4.252e-02 | -3.16 | Composition of Lipid Particles | WikiPathways | WP3601 | 10 | 1 | 5310 | 23 |
APOA1 |
4.267e-02 | -3.15 | neuron projection terminus | cellular component | GO:0044306 | 128 | 2 | 19108 | 49 |
SLC1A2,NTRK2 |
4.273e-02 | -3.15 | presynaptic active zone cytoplasmic component | cellular component | GO:0098831 | 17 | 1 | 19108 | 49 |
CTBP1 |
4.282e-02 | -3.15 | hypothalamus | COSMIC cancer mutations | hypothalamus | 15 | 1 | 16828 | 49 |
QKI |
4.290e-02 | -3.15 | ERBB2 Regulates Cell Motility | REACTOME pathways | R-HSA-6785631 | 15 | 1 | 10285 | 30 |
EGF |
4.290e-02 | -3.15 | alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | REACTOME pathways | R-HSA-2046104 | 15 | 1 | 10285 | 30 |
ELOVL2 |
4.290e-02 | -3.15 | alpha-linolenic acid (ALA) metabolism | REACTOME pathways | R-HSA-2046106 | 15 | 1 | 10285 | 30 |
ELOVL2 |
4.290e-02 | -3.15 | Depolymerisation of the Nuclear Lamina | REACTOME pathways | R-HSA-4419969 | 15 | 1 | 10285 | 30 |
LPIN2 |
4.307e-02 | -3.14 | estrous cycle | biological process | GO:0044849 | 16 | 1 | 18204 | 50 |
PTN |
4.307e-02 | -3.14 | regulation of hepatocyte proliferation | biological process | GO:2000345 | 16 | 1 | 18204 | 50 |
PTN |
4.307e-02 | -3.14 | asymmetric cell division | biological process | GO:0008356 | 16 | 1 | 18204 | 50 |
SOX5 |
4.307e-02 | -3.14 | non-proteinogenic amino acid biosynthetic process | biological process | GO:0170043 | 16 | 1 | 18204 | 50 |
SLC1A3 |
4.307e-02 | -3.14 | response to lithium ion | biological process | GO:0010226 | 16 | 1 | 18204 | 50 |
SLC13A5 |
4.307e-02 | -3.14 | positive regulation of dendrite development | biological process | GO:1900006 | 16 | 1 | 18204 | 50 |
PTN |
4.307e-02 | -3.14 | nonribosomal peptide biosynthetic process | biological process | GO:0019184 | 16 | 1 | 18204 | 50 |
SLC1A2 |
4.308e-02 | -3.14 | ZNF609 (zinc finger protein 609) | protein interactions | 23060 | 131 | 2 | 19454 | 49 |
SOX5,NFIA |
4.308e-02 | -3.14 | NCOA2 (nuclear receptor coactivator 2) | protein interactions | 10499 | 131 | 2 | 19454 | 49 |
NFIA,RORA |
4.312e-02 | -3.14 | C11orf52 (chromosome 11 open reading frame 52) | protein interactions | 91894 | 310 | 3 | 19454 | 49 |
USP6NL,FARP1,GRIP1 |
4.352e-02 | -3.13 | skin-chest-malignant_melanoma | COSMIC cancer mutations | skin-chest-malignant_melanoma | 114 | 2 | 16828 | 49 |
SLC6A11,PREX2 |
4.362e-02 | -3.13 | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 891 | 6 | 16828 | 49 |
LRIG1,SLC6A11,PTPRZ1,ITPR2,NPAS3,NCKAP5 |
4.377e-02 | -3.13 | developmental maturation | biological process | GO:0021700 | 286 | 3 | 18204 | 50 |
NFIA,ADGRB3,NRCAM |
4.392e-02 | -3.13 | large_intestine-caecum-carcinoma-adenocarcinoma | COSMIC cancer mutations | large_intestine-caecum-carcinoma-adenocarcinoma | 14236 | 46 | 16828 | 49 |
SLC39A12,SOX5,NPAS3,SLC13A5,SLC4A4,NTRK2,PREX1,FGFRL1,NFIA,PRDM16,GRK5,ITPK1,COL11A1,ITPR2,TNS3,SNTB1,EGF,LPIN2,PTPRZ1,TRPS1,RFX4,FKBP5,PREX2,ZBTB20,NRCAM,NCKAP5,DGKB,QKI,SLC6A11,LRIG1,ELOVL2,ADAM12,CTBP1,FHOD3,AQP4,GRIP1,RORA,USP6NL,SORCS2,GPC5,SLC1A3,CTNND2,NHSL1,FARP1,SLC1A2,APOA1 |
4.400e-02 | -3.12 | basal part of cell | cellular component | GO:0045178 | 307 | 3 | 19108 | 49 |
SLC1A3,AQP4,SLC4A4 |
4.415e-02 | -3.12 | ossification | biological process | GO:0001503 | 287 | 3 | 18204 | 50 |
PTN,GPM6B,COL11A1 |
4.417e-02 | -3.12 | transmembrane receptor protein tyrosine phosphatase activity | molecular function | GO:0005001 | 17 | 1 | 18094 | 48 |
PTPRZ1 |
4.417e-02 | -3.12 | transmembrane receptor protein phosphatase activity | molecular function | GO:0019198 | 17 | 1 | 18094 | 48 |
PTPRZ1 |
4.427e-02 | -3.12 | DUT (deoxyuridine triphosphatase) | protein interactions | 1854 | 133 | 2 | 19454 | 49 |
CTBP1,FKBP5 |
4.440e-02 | -3.11 | TLCD1 (TLC domain containing 1) | protein interactions | 116238 | 18 | 1 | 19454 | 49 |
SLC39A12 |
4.440e-02 | -3.11 | RAI2 (retinoic acid induced 2) | protein interactions | 10742 | 18 | 1 | 19454 | 49 |
CTBP1 |
4.440e-02 | -3.11 | CYP2E1 (cytochrome P450 family 2 subfamily E member 1) | protein interactions | 1571 | 18 | 1 | 19454 | 49 |
PTN |
4.440e-02 | -3.11 | DCAF17 (DDB1 and CUL4 associated factor 17) | protein interactions | 80067 | 18 | 1 | 19454 | 49 |
PREX1 |
4.440e-02 | -3.11 | TOR2A (torsin family 2 member A) | protein interactions | 27433 | 18 | 1 | 19454 | 49 |
CTBP1 |
4.464e-02 | -3.11 | MINTRINSICP | prints domains | PR00783 | 14 | 1 | 5227 | 17 |
AQP4 |
4.493e-02 | -3.10 | ATP-NAD_kinase_N | interpro domains | IPR017438 | 17 | 1 | 18521 | 50 |
DGKB |
4.493e-02 | -3.10 | CA_dom | interpro domains | IPR001148 | 17 | 1 | 18521 | 50 |
PTPRZ1 |
4.493e-02 | -3.10 | NAD/diacylglycerol_kinase_sf | interpro domains | IPR016064 | 17 | 1 | 18521 | 50 |
DGKB |
4.493e-02 | -3.10 | CA_dom_sf | interpro domains | IPR036398 | 17 | 1 | 18521 | 50 |
PTPRZ1 |
4.494e-02 | -3.10 | LDLRB | prosite domains | PS51120 | 13 | 1 | 12186 | 43 |
EGF |
4.494e-02 | -3.10 | ATP_GRASP | prosite domains | PS50975 | 13 | 1 | 12186 | 43 |
ITPK1 |
4.507e-02 | -3.10 | ductal_carcinoma | COSMIC cancer mutations | ductal_carcinoma | 15798 | 49 | 16828 | 49 |
GRIP1,RORA,AQP4,GPM6B,FHOD3,CTBP1,LRIG1,ELOVL2,SLC6A11,ADAM12,APOA1,SLC1A3,SLC1A2,NHSL1,FARP1,CTNND2,GPC5,USP6NL,SORCS2,FKBP5,TRPS1,RFX4,PTPRZ1,LPIN2,NCKAP5,DGKB,QKI,NRCAM,PTN,ZBTB20,PREX2,MSI2,PRDM16,NFIA,PREX1,FGFRL1,SNTB1,EGF,TNS3,ITPR2,GRK5,COL11A1,ITPK1,SLC13A5,NPAS3,SOX5,SLC39A12,NTRK2,SLC4A4 |
4.512e-02 | -3.10 | caecum | COSMIC cancer mutations | caecum | 14248 | 46 | 16828 | 49 |
SORCS2,USP6NL,GPC5,NHSL1,SLC1A2,FARP1,CTNND2,SLC1A3,APOA1,ADAM12,LRIG1,ELOVL2,SLC6A11,FHOD3,CTBP1,AQP4,RORA,GRIP1,PREX2,ZBTB20,NRCAM,QKI,NCKAP5,DGKB,LPIN2,PTPRZ1,RFX4,TRPS1,FKBP5,COL11A1,ITPK1,GRK5,ITPR2,TNS3,EGF,SNTB1,FGFRL1,PREX1,NFIA,PRDM16,SLC4A4,NTRK2,SLC39A12,SOX5,SLC13A5,NPAS3 |
4.519e-02 | -3.10 | dystrophin-associated glycoprotein complex | cellular component | GO:0016010 | 18 | 1 | 19108 | 49 |
SNTB1 |
4.525e-02 | -3.10 | kinase activity | molecular function | GO:0016301 | 739 | 5 | 18094 | 48 |
GRK5,DGKB,ITPK1,FGFRL1,NTRK2 |
4.547e-02 | -3.09 | JAK3 (Janus kinase 3) | protein interactions | 3718 | 135 | 2 | 19454 | 49 |
APOA1,FKBP5 |
4.547e-02 | -3.09 | SOX15 (SRY-box transcription factor 15) | protein interactions | 6665 | 135 | 2 | 19454 | 49 |
NFIA,TRPS1 |
4.547e-02 | -3.09 | NTRK2 (neurotrophic receptor tyrosine kinase 2) | protein interactions | 4915 | 135 | 2 | 19454 | 49 |
NTRK2,USP6NL |
4.547e-02 | -3.09 | Myo1c (myosin IC) | protein interactions | 17913 | 135 | 2 | 19454 | 49 |
ITPR2,TRPS1 |
4.556e-02 | -3.09 | LGALS1 (galectin 1) | protein interactions | 3956 | 317 | 3 | 19454 | 49 |
NRCAM,PTPRZ1,FKBP5 |
4.558e-02 | -3.09 | cellular process | biological process | GO:0009987 | 14996 | 46 | 18204 | 50 |
COL11A1,NRCAM,NTRK2,NFIA,ITPK1,ADAM12,PREX1,GRIP1,USP6NL,GRK5,LPIN2,FARP1,SLC4A4,APOA1,EGF,SOX5,FGFRL1,PTPRZ1,RORA,AQP4,PRDM16,CTBP1,FKBP5,NHSL1,GPC5,SORCS2,SLC13A5,SLC1A3,SLC39A12,PTN,ELOVL2,GPM6B,DGKB,RFX4,MSI2,TNS3,NCKAP5,SLC6A11,FHOD3,ITPR2,ZBTB20,PREX2,QKI,ADGRB3,SLC1A2,CTNND2 |
4.560e-02 | -3.09 | positive regulation of cell-substrate adhesion | biological process | GO:0010811 | 124 | 2 | 18204 | 50 |
PREX1,APOA1 |
4.560e-02 | -3.09 | regulation of ossification | biological process | GO:0030278 | 124 | 2 | 18204 | 50 |
PTN,GPM6B |
4.560e-02 | -3.09 | action potential | biological process | GO:0001508 | 124 | 2 | 18204 | 50 |
NTRK2,NRCAM |
4.560e-02 | -3.09 | positive regulation of lipid metabolic process | biological process | GO:0045834 | 124 | 2 | 18204 | 50 |
APOA1,ZBTB20 |
4.570e-02 | -3.09 | Constitutive Signaling by EGFRvIII | REACTOME pathways | R-HSA-5637810 | 16 | 1 | 10285 | 30 |
EGF |
4.570e-02 | -3.09 | PI3K events in ERBB2 signaling | REACTOME pathways | R-HSA-1963642 | 16 | 1 | 10285 | 30 |
EGF |
4.570e-02 | -3.09 | GRB2 events in ERBB2 signaling | REACTOME pathways | R-HSA-1963640 | 16 | 1 | 10285 | 30 |
EGF |
4.570e-02 | -3.09 | Signaling by EGFRvIII in Cancer | REACTOME pathways | R-HSA-5637812 | 16 | 1 | 10285 | 30 |
EGF |
4.570e-02 | -3.09 | regulation of Golgi organization | biological process | GO:1903358 | 17 | 1 | 18204 | 50 |
USP6NL |
4.570e-02 | -3.09 | reverse cholesterol transport | biological process | GO:0043691 | 17 | 1 | 18204 | 50 |
APOA1 |
4.570e-02 | -3.09 | regulation of receptor clustering | biological process | GO:1903909 | 17 | 1 | 18204 | 50 |
FARP1 |
4.570e-02 | -3.09 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 50 |
SLC1A2 |
4.570e-02 | -3.09 | phospholipid homeostasis | biological process | GO:0055091 | 17 | 1 | 18204 | 50 |
APOA1 |
4.570e-02 | -3.09 | T-helper 17 type immune response | biological process | GO:0072538 | 17 | 1 | 18204 | 50 |
RORA |
4.570e-02 | -3.09 | retinal rod cell differentiation | biological process | GO:0060221 | 17 | 1 | 18204 | 50 |
NTRK2 |
4.570e-02 | -3.09 | ureter development | biological process | GO:0072189 | 17 | 1 | 18204 | 50 |
NFIA |
4.570e-02 | -3.09 | white fat cell differentiation | biological process | GO:0050872 | 17 | 1 | 18204 | 50 |
CTBP1 |
4.570e-02 | -3.09 | postsynaptic actin cytoskeleton organization | biological process | GO:0098974 | 17 | 1 | 18204 | 50 |
FARP1 |
4.570e-02 | -3.09 | high-density lipoprotein particle remodeling | biological process | GO:0034375 | 17 | 1 | 18204 | 50 |
APOA1 |
4.570e-02 | -3.09 | cGMP metabolic process | biological process | GO:0046068 | 17 | 1 | 18204 | 50 |
RORA |
4.585e-02 | -3.08 | FA | smart domains | SM01195 | 13 | 1 | 9717 | 35 |
FARP1 |
4.599e-02 | -3.08 | - | gene3d domains | 2.60.120.1000 | 17 | 1 | 14470 | 40 |
COL11A1 |
4.599e-02 | -3.08 | Alpha carbonic anhydrase | gene3d domains | 3.10.200.10 | 17 | 1 | 14470 | 40 |
PTPRZ1 |
4.606e-02 | -3.08 | extraskeletal | COSMIC cancer mutations | extraskeletal | 903 | 6 | 16828 | 49 |
SLC6A11,LRIG1,NPAS3,NCKAP5,ITPR2,PTPRZ1 |
4.608e-02 | -3.08 | SNX9 (sorting nexin 9) | protein interactions | 51429 | 136 | 2 | 19454 | 49 |
SLC1A3,CTBP1 |
4.631e-02 | -3.07 | modulation of chemical synaptic transmission | biological process | GO:0050804 | 494 | 4 | 18204 | 50 |
SLC1A3,SORCS2,NTRK2,PTN |
4.660e-02 | -3.07 | regulation of trans-synaptic signaling | biological process | GO:0099177 | 495 | 4 | 18204 | 50 |
PTN,SORCS2,NTRK2,SLC1A3 |
4.662e-02 | -3.07 | heat shock protein binding | molecular function | GO:0031072 | 130 | 2 | 18094 | 48 |
APOA1,FKBP5 |
4.671e-02 | -3.06 | transmembrane receptor protein tyrosine kinase activator activity | molecular function | GO:0030297 | 18 | 1 | 18094 | 48 |
EGF |
4.671e-02 | -3.06 | intracellularly gated calcium channel activity | molecular function | GO:0015278 | 18 | 1 | 18094 | 48 |
ITPR2 |
4.671e-02 | -3.06 | monoatomic anion:sodium symporter activity | molecular function | GO:0015373 | 18 | 1 | 18094 | 48 |
SLC6A11 |
4.673e-02 | -3.06 | Carb_anhydrase | pfam domains | PF00194 | 17 | 1 | 17795 | 50 |
PTPRZ1 |
4.673e-02 | -3.06 | PRDM2_PR | pfam domains | PF21549 | 17 | 1 | 17795 | 50 |
PRDM16 |
4.677e-02 | -3.06 | human chr7q31.1 | chromosome location | human chr7q31.1 | 25 | 1 | 26134 | 50 |
NRCAM |
4.681e-02 | -3.06 | INKA1 (inka box actin regulator 1) | protein interactions | 389119 | 19 | 1 | 19454 | 49 |
ZBTB20 |
4.681e-02 | -3.06 | TNR (tenascin R) | protein interactions | 7143 | 19 | 1 | 19454 | 49 |
PTPRZ1 |
4.681e-02 | -3.06 | HMGCLL1 (3-hydroxy-3-methylglutaryl-CoA lyase like 1) | protein interactions | 54511 | 19 | 1 | 19454 | 49 |
APOA1 |
4.681e-02 | -3.06 | PDIK1L (PDLIM1 interacting kinase 1 like) | protein interactions | 149420 | 19 | 1 | 19454 | 49 |
FKBP5 |
4.681e-02 | -3.06 | APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic subunit 3G) | protein interactions | 60489 | 19 | 1 | 19454 | 49 |
PTN |
4.681e-02 | -3.06 | SPZ1 (spermatogenic leucine zipper 1) | protein interactions | 84654 | 19 | 1 | 19454 | 49 |
SNTB1 |
4.681e-02 | -3.06 | CEP68 (centrosomal protein 68) | protein interactions | 23177 | 19 | 1 | 19454 | 49 |
CTBP1 |
4.681e-02 | -3.06 | FBLN7 (fibulin 7) | protein interactions | 129804 | 19 | 1 | 19454 | 49 |
APOA1 |
4.681e-02 | -3.06 | HSPBAP1 (HSPB1 associated protein 1) | protein interactions | 79663 | 19 | 1 | 19454 | 49 |
PTN |
4.681e-02 | -3.06 | RCVRN (recoverin) | protein interactions | 5957 | 19 | 1 | 19454 | 49 |
GRK5 |
4.693e-02 | -3.06 | ear morphogenesis | biological process | GO:0042471 | 126 | 2 | 18204 | 50 |
COL11A1,LRIG1 |
4.722e-02 | -3.05 | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_IV | 15813 | 49 | 16828 | 49 |
NFIA,PRDM16,PREX1,FGFRL1,TNS3,SNTB1,EGF,GRK5,ITPK1,COL11A1,ITPR2,SOX5,NPAS3,SLC13A5,SLC39A12,SLC4A4,NTRK2,GPM6B,AQP4,GRIP1,RORA,SLC6A11,LRIG1,ELOVL2,ADAM12,CTBP1,FHOD3,SLC1A3,CTNND2,SLC1A2,NHSL1,FARP1,APOA1,USP6NL,SORCS2,GPC5,TRPS1,RFX4,FKBP5,LPIN2,PTPRZ1,NRCAM,PTN,NCKAP5,DGKB,QKI,MSI2,PREX2,ZBTB20 |
4.728e-02 | -3.05 | localization | biological process | GO:0051179 | 4474 | 18 | 18204 | 50 |
SLC13A5,SLC39A12,SLC1A3,SORCS2,NTRK2,NRCAM,CTBP1,GRIP1,USP6NL,PTN,GPM6B,APOA1,ITPR2,SLC4A4,SLC6A11,SLC1A2,AQP4,QKI |
4.730e-02 | -3.05 | GRK6 (G protein-coupled receptor kinase 6) | protein interactions | 2870 | 138 | 2 | 19454 | 49 |
FKBP5,GRK5 |
4.752e-02 | -3.05 | PPIase_dom_sf | interpro domains | IPR046357 | 18 | 1 | 18521 | 50 |
FKBP5 |
4.752e-02 | -3.05 | Leu-rich_rpt_4 | interpro domains | IPR025875 | 18 | 1 | 18521 | 50 |
LRIG1 |
4.760e-02 | -3.05 | response to amino acid | biological process | GO:0043200 | 127 | 2 | 18204 | 50 |
NTRK2,SLC1A2 |
4.760e-02 | -3.05 | cardiac ventricle development | biological process | GO:0003231 | 127 | 2 | 18204 | 50 |
COL11A1,FGFRL1 |
4.760e-02 | -3.05 | cardiac chamber morphogenesis | biological process | GO:0003206 | 127 | 2 | 18204 | 50 |
COL11A1,FGFRL1 |
4.772e-02 | -3.04 | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-abdomen-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 120 | 2 | 16828 | 49 |
CTNND2,PRDM16 |
4.793e-02 | -3.04 | skin-back-malignant_melanoma | COSMIC cancer mutations | skin-back-malignant_melanoma | 280 | 3 | 16828 | 49 |
SLC6A11,PREX2,ADAM12 |
4.821e-02 | -3.03 | Signalling by NGF | REACTOME pathways | R-HSA-166520 | 477 | 4 | 10285 | 30 |
NTRK2,EGF,ITPR2,PREX1 |
4.822e-02 | -3.03 | regulation of hydrolase activity | biological process | GO:0051336 | 726 | 5 | 18204 | 50 |
PREX2,NTRK2,PREX1,APOA1,USP6NL |
4.822e-02 | -3.03 | cell population proliferation | biological process | GO:0008283 | 726 | 5 | 18204 | 50 |
APOA1,EGF,RORA,NFIA,SOX5 |
4.827e-02 | -3.03 | glial cell development | biological process | GO:0021782 | 128 | 2 | 18204 | 50 |
NTRK2,GPM6B |
4.832e-02 | -3.03 | positive regulation of circadian rhythm | biological process | GO:0042753 | 18 | 1 | 18204 | 50 |
RORA |
4.832e-02 | -3.03 | negative regulation of anoikis | biological process | GO:2000811 | 18 | 1 | 18204 | 50 |
NTRK2 |
4.832e-02 | -3.03 | neuron projection arborization | biological process | GO:0140058 | 18 | 1 | 18204 | 50 |
PTN |
4.832e-02 | -3.03 | cardiac myofibril assembly | biological process | GO:0055003 | 18 | 1 | 18204 | 50 |
FHOD3 |
4.832e-02 | -3.03 | dendritic spine morphogenesis | biological process | GO:0060997 | 18 | 1 | 18204 | 50 |
CTNND2 |
4.839e-02 | -3.03 | optic_nerve | COSMIC cancer mutations | optic_nerve | 17 | 1 | 16828 | 49 |
QKI |
4.839e-02 | -3.03 | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | 17 | 1 | 16828 | 49 |
QKI |
4.848e-02 | -3.03 | Trafficking of GluR2-containing AMPA receptors | REACTOME pathways | R-HSA-416993 | 17 | 1 | 10285 | 30 |
GRIP1 |
4.848e-02 | -3.03 | Elevation of cytosolic Ca2+ levels | REACTOME pathways | R-HSA-139853 | 17 | 1 | 10285 | 30 |
ITPR2 |
4.853e-02 | -3.03 | SATB2 (SATB homeobox 2) | protein interactions | 23314 | 140 | 2 | 19454 | 49 |
NFIA,SOX5 |
4.863e-02 | -3.02 | - | gene3d domains | 3.10.50.40 | 18 | 1 | 14470 | 40 |
FKBP5 |
4.880e-02 | -3.02 | DTX2 (deltex E3 ubiquitin ligase 2) | protein interactions | 113878 | 326 | 3 | 19454 | 49 |
NFIA,CTBP1,USP6NL |
4.893e-02 | -3.02 | phosphorylation | biological process | GO:0016310 | 729 | 5 | 18204 | 50 |
NTRK2,GRK5,ITPK1,CTBP1,DGKB |
4.911e-02 | -3.01 | sequence-specific double-stranded DNA binding | molecular function | GO:1990837 | 1547 | 8 | 18094 | 48 |
RORA,NPAS3,TRPS1,RFX4,ZBTB20,NFIA,PRDM16,SOX5 |
4.916e-02 | -3.01 | LLGL1 (LLGL scribble cell polarity complex component 1) | protein interactions | 3996 | 141 | 2 | 19454 | 49 |
FKBP5,NTRK2 |
4.916e-02 | -3.01 | MAEA (macrophage erythroblast attacher, E3 ubiquitin ligase) | protein interactions | 10296 | 141 | 2 | 19454 | 49 |
NCKAP5,GRK5 |
4.916e-02 | -3.01 | AP3M1 (adaptor related protein complex 3 subunit mu 1) | protein interactions | 26985 | 141 | 2 | 19454 | 49 |
AQP4,GRK5 |
4.921e-02 | -3.01 | DOK5 (docking protein 5) | protein interactions | 55816 | 20 | 1 | 19454 | 49 |
NTRK2 |
4.921e-02 | -3.01 | PON1 (paraoxonase 1) | protein interactions | 5444 | 20 | 1 | 19454 | 49 |
APOA1 |
4.921e-02 | -3.01 | LBP (lipopolysaccharide binding protein) | protein interactions | 3929 | 20 | 1 | 19454 | 49 |
APOA1 |
4.921e-02 | -3.01 | Trappc8 (trafficking protein particle complex 8) | protein interactions | 75964 | 20 | 1 | 19454 | 49 |
FARP1 |
4.921e-02 | -3.01 | ANXA13 (annexin A13) | protein interactions | 312 | 20 | 1 | 19454 | 49 |
MSI2 |
4.921e-02 | -3.01 | NCAM2 (neural cell adhesion molecule 2) | protein interactions | 4685 | 20 | 1 | 19454 | 49 |
CTNND2 |
4.921e-02 | -3.01 | SERPINA4 (serpin family A member 4) | protein interactions | 5267 | 20 | 1 | 19454 | 49 |
CTBP1 |
4.921e-02 | -3.01 | SNCB (synuclein beta) | protein interactions | 6620 | 20 | 1 | 19454 | 49 |
GRK5 |
4.921e-02 | -3.01 | FNDC1 (fibronectin type III domain containing 1) | protein interactions | 84624 | 20 | 1 | 19454 | 49 |
APOA1 |
4.921e-02 | -3.01 | ADRA1D (adrenoceptor alpha 1D) | protein interactions | 146 | 20 | 1 | 19454 | 49 |
SNTB1 |
4.921e-02 | -3.01 | TOR4A (torsin family 4 member A) | protein interactions | 54863 | 20 | 1 | 19454 | 49 |
GRK5 |
4.921e-02 | -3.01 | Pspc1 (paraspeckle protein 1) | protein interactions | 66645 | 20 | 1 | 19454 | 49 |
CTBP1 |
4.921e-02 | -3.01 | PDZD2 (PDZ domain containing 2) | protein interactions | 23037 | 20 | 1 | 19454 | 49 |
CTNND2 |
4.924e-02 | -3.01 | water transmembrane transporter activity | molecular function | GO:0005372 | 19 | 1 | 18094 | 48 |
AQP4 |
4.924e-02 | -3.01 | secondary active monocarboxylate transmembrane transporter activity | molecular function | GO:0015355 | 19 | 1 | 18094 | 48 |
SLC6A11 |
4.924e-02 | -3.01 | lipid phosphatase activity | molecular function | GO:0042577 | 19 | 1 | 18094 | 48 |
LPIN2 |
4.924e-02 | -3.01 | ankyrin binding | molecular function | GO:0030506 | 19 | 1 | 18094 | 48 |
NRCAM |
4.930e-02 | -3.01 | LY | smart domains | SM00135 | 14 | 1 | 9717 | 35 |
EGF |
4.930e-02 | -3.01 | DAGKc | smart domains | SM00046 | 14 | 1 | 9717 | 35 |
DGKB |
4.930e-02 | -3.01 | EGFR-dependent Endothelin signaling events | Pathway Interaction DB | et_egfrpathway | 8 | 1 | 2226 | 14 |
EGF |
4.933e-02 | -3.01 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma | 476 | 4 | 16828 | 49 |
SORCS2,CTNND2,COL11A1,GPC5 |
4.933e-02 | -3.01 | parathyroid | COSMIC cancer mutations | parathyroid | 476 | 4 | 16828 | 49 |
TRPS1,TNS3,GPC5,GRIP1 |
4.941e-02 | -3.01 | LRR_4 | pfam domains | PF12799 | 18 | 1 | 17795 | 50 |
LRIG1 |
4.941e-02 | -3.01 | ADAM_CR | pfam domains | PF08516 | 18 | 1 | 17795 | 50 |
ADAM12 |
4.951e-02 | -3.01 | cellular response to organonitrogen compound | biological process | GO:0071417 | 505 | 4 | 18204 | 50 |
ITPR2,SLC1A3,SLC1A2,LPIN2 |
4.956e-02 | -3.00 | RBBP4 (RB binding protein 4, chromatin remodeling factor) | protein interactions | 5928 | 551 | 4 | 19454 | 49 |
CTBP1,ZBTB20,TRPS1,PRDM16 |
4.968e-02 | -3.00 | Notch signaling pathway | Pathway Interaction DB | notch_pathway | 58 | 2 | 2226 | 14 |
CTBP1,ADAM12 |
4.978e-02 | -3.00 | GIT1 (GIT ArfGAP 1) | protein interactions | 28964 | 142 | 2 | 19454 | 49 |
PTPRZ1,GRK5 |
4.978e-02 | -3.00 | SDC2 (syndecan 2) | protein interactions | 6383 | 142 | 2 | 19454 | 49 |
FARP1,FGFRL1 |
4.978e-02 | -3.00 | GOLM1 (golgi membrane protein 1) | protein interactions | 51280 | 142 | 2 | 19454 | 49 |
SLC13A5,SLC39A12 |
4.991e-02 | -3.00 | NCOR1 (nuclear receptor corepressor 1) | protein interactions | 9611 | 329 | 3 | 19454 | 49 |
SOX5,CTBP1,NFIA |